id	sid	tid	token	lemma	pos
chd-148	1	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	VERB
chd-148	1	2	e1	e1	NOUN
chd-148	1	3	cancer	cancer	NOUN
chd-148	1	4	health	health	NOUN
chd-148	1	5	disparities	disparity	NOUN
chd-148	1	6	research	research	VERB
chd-148	1	7	liver	liver	NOUN
chd-148	1	8	cancer	cancer	NOUN
chd-148	1	9	incidence	incidence	NOUN
chd-148	1	10	and	and	CCONJ
chd-148	1	11	mortality	mortality	NOUN
chd-148	1	12	:	:	PUNCT
chd-148	1	13	disparities	disparity	NOUN
chd-148	1	14	based	base	VERB
chd-148	1	15	on	on	ADP
chd-148	1	16	age	age	NOUN
chd-148	1	17	,	,	PUNCT
chd-148	1	18	ethnicity	ethnicity	NOUN
chd-148	1	19	,	,	PUNCT
chd-148	1	20	health	health	NOUN
chd-148	1	21	and	and	CCONJ
chd-148	1	22	nutrition	nutrition	NOUN
chd-148	1	23	,	,	PUNCT
chd-148	1	24	molecular	molecular	ADJ
chd-148	1	25	factors	factor	NOUN
chd-148	1	26	,	,	PUNCT
chd-148	1	27	and	and	CCONJ
chd-148	1	28	geography	geography	NOUN
chd-148	1	29	santosh	santosh	PROPN
chd-148	1	30	kumar	kumar	PROPN
chd-148	1	31	singh	singh	PROPN
chd-148	1	32	and	and	CCONJ
chd-148	1	33	rajesh	rajesh	PROPN
chd-148	1	34	singha	singha	PROPN
chd-148	1	35	*	*	PROPN
chd-148	1	36	adepartment	adepartment	PROPN
chd-148	1	37	of	of	ADP
chd-148	1	38	microbiology	microbiology	NOUN
chd-148	1	39	,	,	PUNCT
chd-148	1	40	biochemistry	biochemistry	NOUN
chd-148	1	41	and	and	CCONJ
chd-148	1	42	immunology	immunology	NOUN
chd-148	1	43	,	,	PUNCT
chd-148	1	44	cancer	cancer	NOUN
chd-148	1	45	health	health	PROPN
chd-148	1	46	equity	equity	PROPN
chd-148	1	47	institute	institute	PROPN
chd-148	1	48	,	,	PUNCT
chd-148	1	49	morehouse	morehouse	PROPN
chd-148	1	50	school	school	NOUN
chd-148	1	51	of	of	ADP
chd-148	1	52	medicine	medicine	NOUN
chd-148	1	53	,	,	PUNCT
chd-148	1	54	atlanta	atlanta	PROPN
chd-148	1	55	,	,	PUNCT
chd-148	1	56	ga	ga	PROPN
chd-148	1	57	,	,	PUNCT
chd-148	1	58	usa	usa	PROPN
chd-148	1	59	,	,	PUNCT
chd-148	1	60	30310	30310	NUM
chd-148	1	61	*	*	PUNCT
chd-148	1	62	corresponding	correspond	VERB
chd-148	1	63	author	author	NOUN
chd-148	1	64	:	:	PUNCT
chd-148	1	65	rajesh	rajesh	PROPN
chd-148	1	66	singh	singh	PROPN
chd-148	1	67	,	,	PUNCT
chd-148	1	68	e	e	NOUN
chd-148	1	69	-	-	NOUN
chd-148	1	70	mail	mail	NOUN
chd-148	1	71	:	:	PUNCT
chd-148	1	72	rsingh@msm.edu	rsingh@msm.edu	VERB
chd-148	1	73	abstract	abstract	ADJ
chd-148	1	74	liver	liver	NOUN
chd-148	1	75	cancer	cancer	NOUN
chd-148	1	76	(	(	PUNCT
chd-148	1	77	lca	lca	PROPN
chd-148	1	78	)	)	PUNCT
chd-148	1	79	is	be	AUX
chd-148	1	80	the	the	DET
chd-148	1	81	fifth	fifth	ADJ
chd-148	1	82	and	and	CCONJ
chd-148	1	83	eighth	eighth	ADJ
chd-148	1	84	leading	leading	NOUN
chd-148	1	85	cause	cause	NOUN
chd-148	1	86	of	of	ADP
chd-148	1	87	cancer	cancer	NOUN
chd-148	1	88	death	death	NOUN
chd-148	1	89	for	for	ADP
chd-148	1	90	men	man	NOUN
chd-148	1	91	and	and	CCONJ
chd-148	1	92	women	woman	NOUN
chd-148	1	93	,	,	PUNCT
chd-148	1	94	respectively	respectively	ADV
chd-148	1	95	.	.	PUNCT
chd-148	2	1	however	however	ADV
chd-148	2	2	,	,	PUNCT
chd-148	2	3	despite	despite	SCONJ
chd-148	2	4	improvements	improvement	NOUN
chd-148	2	5	in	in	ADP
chd-148	2	6	treatment	treatment	NOUN
chd-148	2	7	strategies	strategy	NOUN
chd-148	2	8	and	and	CCONJ
chd-148	2	9	options	option	NOUN
chd-148	2	10	,	,	PUNCT
chd-148	2	11	it	it	PRON
chd-148	2	12	has	have	AUX
chd-148	2	13	limited	limit	VERB
chd-148	2	14	therapeutic	therapeutic	ADJ
chd-148	2	15	options	option	NOUN
chd-148	2	16	.	.	PUNCT
chd-148	3	1	worldwide	worldwide	ADV
chd-148	3	2	,	,	PUNCT
chd-148	3	3	the	the	DET
chd-148	3	4	prevalence	prevalence	NOUN
chd-148	3	5	of	of	ADP
chd-148	3	6	lca	lca	PROPN
chd-148	3	7	varies	vary	VERB
chd-148	3	8	widely	widely	ADV
chd-148	3	9	.	.	PUNCT
chd-148	4	1	various	various	ADJ
chd-148	4	2	factors	factor	NOUN
chd-148	4	3	are	be	AUX
chd-148	4	4	associated	associate	VERB
chd-148	4	5	with	with	ADP
chd-148	4	6	the	the	DET
chd-148	4	7	development	development	NOUN
chd-148	4	8	of	of	ADP
chd-148	4	9	lca	lca	PROPN
chd-148	4	10	,	,	PUNCT
chd-148	4	11	and	and	CCONJ
chd-148	4	12	its	its	PRON
chd-148	4	13	incidence	incidence	NOUN
chd-148	4	14	,	,	PUNCT
chd-148	4	15	morbidity	morbidity	NOUN
chd-148	4	16	,	,	PUNCT
chd-148	4	17	and	and	CCONJ
chd-148	4	18	mortality	mortality	NOUN
chd-148	4	19	rates	rate	NOUN
chd-148	4	20	differ	differ	VERB
chd-148	4	21	due	due	ADJ
chd-148	4	22	to	to	ADP
chd-148	4	23	disparities	disparity	NOUN
chd-148	4	24	that	that	PRON
chd-148	4	25	are	be	AUX
chd-148	4	26	multifactorial	multifactorial	ADJ
chd-148	4	27	and	and	CCONJ
chd-148	4	28	complex	complex	ADJ
chd-148	4	29	,	,	PUNCT
chd-148	4	30	including	include	VERB
chd-148	4	31	genetic	genetic	ADJ
chd-148	4	32	and	and	CCONJ
chd-148	4	33	geographic	geographic	ADJ
chd-148	4	34	factors	factor	NOUN
chd-148	4	35	.	.	PUNCT
chd-148	5	1	the	the	DET
chd-148	5	2	frequency	frequency	NOUN
chd-148	5	3	of	of	ADP
chd-148	5	4	lca	lca	PROPN
chd-148	5	5	varies	vary	VERB
chd-148	5	6	by	by	ADP
chd-148	5	7	race	race	NOUN
chd-148	5	8	/	/	SYM
chd-148	5	9	ethnicity	ethnicity	NOUN
chd-148	5	10	,	,	PUNCT
chd-148	5	11	age	age	NOUN
chd-148	5	12	and	and	CCONJ
chd-148	5	13	sex	sex	NOUN
chd-148	5	14	and	and	CCONJ
chd-148	5	15	relates	relate	VERB
chd-148	5	16	to	to	ADP
chd-148	5	17	viral	viral	ADJ
chd-148	5	18	infections	infection	NOUN
chd-148	5	19	,	,	PUNCT
chd-148	5	20	lifestyle	lifestyle	NOUN
chd-148	5	21	,	,	PUNCT
chd-148	5	22	nutrition	nutrition	NOUN
chd-148	5	23	,	,	PUNCT
chd-148	5	24	obesity	obesity	NOUN
chd-148	5	25	,	,	PUNCT
chd-148	5	26	and	and	CCONJ
chd-148	5	27	health	health	NOUN
chd-148	5	28	.	.	PUNCT
chd-148	6	1	in	in	ADP
chd-148	6	2	addition	addition	NOUN
chd-148	6	3	,	,	PUNCT
chd-148	6	4	various	various	ADJ
chd-148	6	5	molecular	molecular	ADJ
chd-148	6	6	factors	factor	NOUN
chd-148	6	7	,	,	PUNCT
chd-148	6	8	including	include	VERB
chd-148	6	9	cytokines	cytokine	NOUN
chd-148	6	10	,	,	PUNCT
chd-148	6	11	hormones	hormone	NOUN
chd-148	6	12	,	,	PUNCT
chd-148	6	13	apoptosis	apoptosis	NOUN
chd-148	6	14	,	,	PUNCT
chd-148	6	15	and	and	CCONJ
chd-148	6	16	mutations	mutation	NOUN
chd-148	6	17	,	,	PUNCT
chd-148	6	18	are	be	AUX
chd-148	6	19	involved	involve	VERB
chd-148	6	20	in	in	ADP
chd-148	6	21	disparities	disparity	NOUN
chd-148	6	22	in	in	ADP
chd-148	6	23	the	the	DET
chd-148	6	24	progression	progression	NOUN
chd-148	6	25	and	and	CCONJ
chd-148	6	26	mortality	mortality	NOUN
chd-148	6	27	of	of	ADP
chd-148	6	28	lca	lca	PROPN
chd-148	6	29	.	.	PUNCT
chd-148	7	1	here	here	ADV
chd-148	7	2	,	,	PUNCT
chd-148	7	3	we	we	PRON
chd-148	7	4	provide	provide	VERB
chd-148	7	5	an	an	DET
chd-148	7	6	overall	overall	ADJ
chd-148	7	7	perspective	perspective	NOUN
chd-148	7	8	on	on	ADP
chd-148	7	9	lca	lca	PROPN
chd-148	7	10	by	by	ADP
chd-148	7	11	presenting	present	VERB
chd-148	7	12	available	available	ADJ
chd-148	7	13	information	information	NOUN
chd-148	7	14	on	on	ADP
chd-148	7	15	these	these	DET
chd-148	7	16	associated	associate	VERB
chd-148	7	17	factors	factor	NOUN
chd-148	7	18	and	and	CCONJ
chd-148	7	19	discussing	discuss	VERB
chd-148	7	20	their	their	PRON
chd-148	7	21	importance	importance	NOUN
chd-148	7	22	in	in	ADP
chd-148	7	23	its	its	PRON
chd-148	7	24	disproportionate	disproportionate	ADJ
chd-148	7	25	incidences	incidence	NOUN
chd-148	7	26	and	and	CCONJ
chd-148	7	27	clinical	clinical	ADJ
chd-148	7	28	outcomes	outcome	NOUN
chd-148	7	29	.	.	PUNCT
chd-148	8	1	keywords	keyword	NOUN
chd-148	8	2	:	:	PUNCT
chd-148	8	3	liver	liver	NOUN
chd-148	8	4	cancer	cancer	NOUN
chd-148	8	5	,	,	PUNCT
chd-148	8	6	health	health	NOUN
chd-148	8	7	disparity	disparity	NOUN
chd-148	8	8	,	,	PUNCT
chd-148	8	9	nutrition	nutrition	NOUN
chd-148	8	10	and	and	CCONJ
chd-148	8	11	health	health	NOUN
chd-148	8	12	,	,	PUNCT
chd-148	8	13	morbidity	morbidity	NOUN
chd-148	8	14	citation	citation	NOUN
chd-148	8	15	:	:	PUNCT
chd-148	8	16	sk	sk	ADP
chd-148	8	17	singh	singh	PROPN
chd-148	8	18	and	and	CCONJ
chd-148	8	19	r	r	PROPN
chd-148	8	20	singh	singh	PROPN
chd-148	8	21	(	(	PUNCT
chd-148	8	22	2019	2019	NUM
chd-148	8	23	)	)	PUNCT
chd-148	8	24	liver	liver	NOUN
chd-148	8	25	cancer	cancer	NOUN
chd-148	8	26	incidence	incidence	NOUN
chd-148	8	27	and	and	CCONJ
chd-148	8	28	mortality	mortality	NOUN
chd-148	8	29	:	:	PUNCT
chd-148	8	30	disparities	disparity	NOUN
chd-148	8	31	based	base	VERB
chd-148	8	32	on	on	ADP
chd-148	8	33	age	age	NOUN
chd-148	8	34	,	,	PUNCT
chd-148	8	35	ethnicity	ethnicity	NOUN
chd-148	8	36	,	,	PUNCT
chd-148	8	37	health	health	NOUN
chd-148	8	38	and	and	CCONJ
chd-148	8	39	nutrition	nutrition	NOUN
chd-148	8	40	,	,	PUNCT
chd-148	8	41	molecular	molecular	ADJ
chd-148	8	42	factors	factor	NOUN
chd-148	8	43	,	,	PUNCT
chd-148	8	44	and	and	CCONJ
chd-148	8	45	geography	geography	NOUN
chd-148	8	46	.	.	PUNCT
chd-148	9	1	cancer	cancer	NOUN
chd-148	9	2	health	health	NOUN
chd-148	9	3	disparities	disparity	NOUN
chd-148	9	4	4	4	NUM
chd-148	9	5	:	:	PUNCT
chd-148	9	6	e1	e1	NOUN
chd-148	9	7	-	-	PUNCT
chd-148	9	8	e10	e10	NOUN
chd-148	9	9	.	.	PUNCT
chd-148	10	1	doi:10.9777	doi:10.9777	VERB
chd-148	10	2	/	/	SYM
chd-148	10	3	chd.2019.1014	chd.2019.1014	PROPN
chd-148	10	4	mailto:rsingh@msm.edu	mailto:rsingh@msm.edu	PROPN
chd-148	10	5	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-148	10	6	e2	e2	PROPN
chd-148	10	7	cancer	cancer	NOUN
chd-148	10	8	health	health	NOUN
chd-148	10	9	disparities	disparity	NOUN
chd-148	10	10	research	research	NOUN
chd-148	10	11	introduction	introduction	NOUN
chd-148	10	12	in	in	ADP
chd-148	10	13	the	the	DET
chd-148	10	14	united	united	PROPN
chd-148	10	15	states	states	PROPN
chd-148	10	16	,	,	PUNCT
chd-148	10	17	liver	liver	NOUN
chd-148	10	18	cancer	cancer	NOUN
chd-148	10	19	(	(	PUNCT
chd-148	10	20	lca	lca	PROPN
chd-148	10	21	)	)	PUNCT
chd-148	10	22	,	,	PUNCT
chd-148	10	23	including	include	VERB
chd-148	10	24	intrahepatic	intrahepatic	ADJ
chd-148	10	25	bile	bile	NOUN
chd-148	10	26	duct	duct	NOUN
chd-148	10	27	cancer	cancer	NOUN
chd-148	10	28	,	,	PUNCT
chd-148	10	29	is	be	AUX
chd-148	10	30	the	the	DET
chd-148	10	31	fifth	fifth	ADJ
chd-148	10	32	and	and	CCONJ
chd-148	10	33	eighth	eighth	ADJ
chd-148	10	34	leading	leading	NOUN
chd-148	10	35	cause	cause	NOUN
chd-148	10	36	of	of	ADP
chd-148	10	37	cancer	cancer	NOUN
chd-148	10	38	for	for	ADP
chd-148	10	39	men	man	NOUN
chd-148	10	40	and	and	CCONJ
chd-148	10	41	women	woman	NOUN
chd-148	10	42	,	,	PUNCT
chd-148	10	43	respectively	respectively	ADV
chd-148	10	44	(	(	PUNCT
chd-148	10	45	chen	chen	PROPN
chd-148	10	46	,	,	PUNCT
chd-148	10	47	2018	2018	NUM
chd-148	10	48	)	)	PUNCT
chd-148	10	49	.	.	PUNCT
chd-148	11	1	for	for	ADP
chd-148	11	2	the	the	DET
chd-148	11	3	united	united	PROPN
chd-148	11	4	states	states	PROPN
chd-148	11	5	,	,	PUNCT
chd-148	11	6	42,030	42,030	NUM
chd-148	11	7	cases	case	NOUN
chd-148	11	8	are	be	AUX
chd-148	11	9	expected	expect	VERB
chd-148	11	10	to	to	PART
chd-148	11	11	be	be	AUX
chd-148	11	12	diagnosed	diagnose	VERB
chd-148	11	13	in	in	ADP
chd-148	11	14	2019	2019	NUM
chd-148	11	15	,	,	PUNCT
chd-148	11	16	and	and	CCONJ
chd-148	11	17	31,780	31,780	NUM
chd-148	11	18	deaths	death	NOUN
chd-148	11	19	are	be	AUX
chd-148	11	20	predicted	predict	VERB
chd-148	11	21	(	(	PUNCT
chd-148	11	22	siegel	siegel	PROPN
chd-148	11	23	et	et	PROPN
chd-148	11	24	al	al	PROPN
chd-148	11	25	.	.	PROPN
chd-148	11	26	,	,	PUNCT
chd-148	11	27	2019	2019	NUM
chd-148	11	28	)	)	PUNCT
chd-148	11	29	.	.	PUNCT
chd-148	12	1	the	the	DET
chd-148	12	2	death	death	NOUN
chd-148	12	3	rates	rate	NOUN
chd-148	12	4	for	for	ADP
chd-148	12	5	lca	lca	PROPN
chd-148	12	6	are	be	AUX
chd-148	12	7	increasing	increase	VERB
chd-148	12	8	at	at	ADP
chd-148	12	9	a	a	DET
chd-148	12	10	faster	fast	ADJ
chd-148	12	11	pace	pace	NOUN
chd-148	12	12	than	than	ADP
chd-148	12	13	those	those	PRON
chd-148	12	14	for	for	ADP
chd-148	12	15	other	other	ADJ
chd-148	12	16	cancers	cancer	NOUN
chd-148	12	17	(	(	PUNCT
chd-148	12	18	islami	islami	PROPN
chd-148	12	19	et	et	PROPN
chd-148	12	20	al	al	PROPN
chd-148	12	21	.	.	PROPN
chd-148	12	22	,	,	PUNCT
chd-148	12	23	2017	2017	NUM
chd-148	12	24	;	;	PUNCT
chd-148	12	25	jemal	jemal	PROPN
chd-148	12	26	et	et	PROPN
chd-148	12	27	al	al	PROPN
chd-148	12	28	.	.	PROPN
chd-148	12	29	,	,	PUNCT
chd-148	12	30	2017	2017	NUM
chd-148	12	31	)	)	PUNCT
chd-148	12	32	.	.	PUNCT
chd-148	13	1	in	in	ADP
chd-148	13	2	the	the	DET
chd-148	13	3	united	united	PROPN
chd-148	13	4	states	states	PROPN
chd-148	13	5	,	,	PUNCT
chd-148	13	6	the	the	DET
chd-148	13	7	incidence	incidence	NOUN
chd-148	13	8	of	of	ADP
chd-148	13	9	liver	liver	NOUN
chd-148	13	10	cancer	cancer	NOUN
chd-148	13	11	is	be	AUX
chd-148	13	12	projected	project	VERB
chd-148	13	13	to	to	PART
chd-148	13	14	rise	rise	VERB
chd-148	13	15	continuously	continuously	ADV
chd-148	13	16	from	from	ADP
chd-148	13	17	the	the	DET
chd-148	13	18	mid-1970s	mid-1970	NOUN
chd-148	13	19	through	through	ADP
chd-148	13	20	2030	2030	NUM
chd-148	13	21	.	.	PUNCT
chd-148	14	1	a	a	DET
chd-148	14	2	factor	factor	NOUN
chd-148	14	3	contributing	contribute	VERB
chd-148	14	4	to	to	ADP
chd-148	14	5	this	this	DET
chd-148	14	6	increase	increase	NOUN
chd-148	14	7	is	be	AUX
chd-148	14	8	the	the	DET
chd-148	14	9	hepatitis	hepatitis	PROPN
chd-148	14	10	c	c	PROPN
chd-148	14	11	virus	virus	NOUN
chd-148	14	12	(	(	PUNCT
chd-148	14	13	hcv	hcv	NOUN
chd-148	14	14	)	)	PUNCT
chd-148	14	15	infections	infection	NOUN
chd-148	14	16	in	in	ADP
chd-148	14	17	those	those	PRON
chd-148	14	18	called	call	VERB
chd-148	14	19	“	"	PUNCT
chd-148	14	20	baby	baby	NOUN
chd-148	14	21	boomers	boomer	NOUN
chd-148	14	22	,	,	PUNCT
chd-148	14	23	”	"	PUNCT
chd-148	14	24	who	who	PRON
chd-148	14	25	were	be	AUX
chd-148	14	26	born	bear	VERB
chd-148	14	27	during	during	ADP
chd-148	14	28	1945	1945	NUM
chd-148	14	29	to	to	ADP
chd-148	14	30	1965	1965	NUM
chd-148	14	31	(	(	PUNCT
chd-148	14	32	geboy	geboy	NOUN
chd-148	14	33	et	et	NOUN
chd-148	14	34	al	al	PROPN
chd-148	14	35	.	.	PROPN
chd-148	14	36	,	,	PUNCT
chd-148	14	37	2016	2016	NUM
chd-148	14	38	)	)	PUNCT
chd-148	14	39	.	.	PUNCT
chd-148	15	1	a	a	DET
chd-148	15	2	decline	decline	NOUN
chd-148	15	3	in	in	ADP
chd-148	15	4	overall	overall	ADJ
chd-148	15	5	cancer	cancer	NOUN
chd-148	15	6	mortality	mortality	NOUN
chd-148	15	7	rates	rate	NOUN
chd-148	15	8	in	in	ADP
chd-148	15	9	the	the	DET
chd-148	15	10	united	united	PROPN
chd-148	15	11	states	states	PROPN
chd-148	15	12	was	be	AUX
chd-148	15	13	evident	evident	ADJ
chd-148	15	14	in	in	ADP
chd-148	15	15	the	the	DET
chd-148	15	16	1990	1990	NUM
chd-148	15	17	’s	’s	NOUN
chd-148	15	18	,	,	PUNCT
chd-148	15	19	due	due	ADP
chd-148	15	20	to	to	ADP
chd-148	15	21	widespread	widespread	ADJ
chd-148	15	22	cancer	cancer	NOUN
chd-148	15	23	screening	screening	NOUN
chd-148	15	24	,	,	PUNCT
chd-148	15	25	improvements	improvement	NOUN
chd-148	15	26	in	in	ADP
chd-148	15	27	treatments	treatment	NOUN
chd-148	15	28	,	,	PUNCT
chd-148	15	29	and	and	CCONJ
chd-148	15	30	reductions	reduction	NOUN
chd-148	15	31	in	in	ADP
chd-148	15	32	cancer	cancer	NOUN
chd-148	15	33	risk	risk	NOUN
chd-148	15	34	factors	factor	NOUN
chd-148	15	35	such	such	ADJ
chd-148	15	36	as	as	ADP
chd-148	15	37	tobacco	tobacco	NOUN
chd-148	15	38	smoking	smoking	NOUN
chd-148	15	39	(	(	PUNCT
chd-148	15	40	jemal	jemal	PROPN
chd-148	15	41	et	et	PROPN
chd-148	15	42	al	al	PROPN
chd-148	15	43	.	.	PROPN
chd-148	15	44	,	,	PUNCT
chd-148	15	45	2017	2017	NUM
chd-148	15	46	;	;	PUNCT
chd-148	15	47	o'keefe	o'keefe	PROPN
chd-148	15	48	et	et	PROPN
chd-148	15	49	al	al	PROPN
chd-148	15	50	.	.	PROPN
chd-148	15	51	,	,	PUNCT
chd-148	15	52	2015	2015	NUM
chd-148	15	53	)	)	PUNCT
chd-148	15	54	.	.	PUNCT
chd-148	16	1	however	however	ADV
chd-148	16	2	,	,	PUNCT
chd-148	16	3	the	the	DET
chd-148	16	4	mortality	mortality	NOUN
chd-148	16	5	rate	rate	NOUN
chd-148	16	6	for	for	ADP
chd-148	16	7	lca	lca	PROPN
chd-148	16	8	increased	increase	VERB
chd-148	16	9	,	,	PUNCT
chd-148	16	10	with	with	ADP
chd-148	16	11	an	an	DET
chd-148	16	12	unequal	unequal	ADJ
chd-148	16	13	distribution	distribution	NOUN
chd-148	16	14	throughout	throughout	ADP
chd-148	16	15	the	the	DET
chd-148	16	16	population	population	NOUN
chd-148	16	17	.	.	PUNCT
chd-148	17	1	additionally	additionally	ADV
chd-148	17	2	,	,	PUNCT
chd-148	17	3	hepatocellular	hepatocellular	ADJ
chd-148	17	4	carcinoma	carcinoma	NOUN
chd-148	17	5	(	(	PUNCT
chd-148	17	6	hcc	hcc	PROPN
chd-148	17	7	)	)	PUNCT
chd-148	17	8	,	,	PUNCT
chd-148	17	9	reported	report	VERB
chd-148	17	10	more	more	ADV
chd-148	17	11	often	often	ADV
chd-148	17	12	in	in	ADP
chd-148	17	13	asia	asia	PROPN
chd-148	17	14	than	than	ADP
chd-148	17	15	in	in	ADP
chd-148	17	16	the	the	DET
chd-148	17	17	united	united	PROPN
chd-148	17	18	states	states	PROPN
chd-148	17	19	,	,	PUNCT
chd-148	17	20	is	be	AUX
chd-148	17	21	the	the	DET
chd-148	17	22	third	third	ADJ
chd-148	17	23	leading	lead	VERB
chd-148	17	24	cause	cause	NOUN
chd-148	17	25	of	of	ADP
chd-148	17	26	cancer	cancer	NOUN
chd-148	17	27	mortality	mortality	NOUN
chd-148	17	28	worldwide	worldwide	ADV
chd-148	17	29	(	(	PUNCT
chd-148	17	30	altekruse	altekruse	VERB
chd-148	17	31	et	et	PROPN
chd-148	17	32	al	al	PROPN
chd-148	17	33	.	.	PROPN
chd-148	17	34	,	,	PUNCT
chd-148	17	35	2009	2009	NUM
chd-148	17	36	)	)	PUNCT
chd-148	17	37	.	.	PUNCT
chd-148	18	1	thus	thus	ADV
chd-148	18	2	,	,	PUNCT
chd-148	18	3	hcc	hcc	PROPN
chd-148	18	4	is	be	AUX
chd-148	18	5	one	one	NUM
chd-148	18	6	of	of	ADP
chd-148	18	7	the	the	DET
chd-148	18	8	most	most	ADV
chd-148	18	9	fatal	fatal	ADJ
chd-148	18	10	cancers	cancer	NOUN
chd-148	18	11	,	,	PUNCT
chd-148	18	12	with	with	ADP
chd-148	18	13	only	only	ADV
chd-148	18	14	a	a	DET
chd-148	18	15	7	7	NUM
chd-148	18	16	%	%	NOUN
chd-148	18	17	5	5	NUM
chd-148	18	18	-	-	PUNCT
chd-148	18	19	year	year	NOUN
chd-148	18	20	survival	survival	NOUN
chd-148	18	21	(	(	PUNCT
chd-148	18	22	ruggieri	ruggieri	VERB
chd-148	18	23	et	et	PROPN
chd-148	18	24	al	al	PROPN
chd-148	18	25	.	.	PROPN
chd-148	18	26	,	,	PUNCT
chd-148	18	27	2010	2010	NUM
chd-148	18	28	)	)	PUNCT
chd-148	18	29	.	.	PUNCT
chd-148	19	1	moreover	moreover	ADV
chd-148	19	2	,	,	PUNCT
chd-148	19	3	in	in	ADP
chd-148	19	4	the	the	DET
chd-148	19	5	united	united	PROPN
chd-148	19	6	states	states	PROPN
chd-148	19	7	,	,	PUNCT
chd-148	19	8	geographical	geographical	ADJ
chd-148	19	9	and	and	CCONJ
chd-148	19	10	biological	biological	ADJ
chd-148	19	11	factors	factor	NOUN
chd-148	19	12	are	be	AUX
chd-148	19	13	associated	associate	VERB
chd-148	19	14	with	with	ADP
chd-148	19	15	racial	racial	ADJ
chd-148	19	16	disparities	disparity	NOUN
chd-148	19	17	.	.	PUNCT
chd-148	20	1	in	in	ADP
chd-148	20	2	the	the	DET
chd-148	20	3	development	development	NOUN
chd-148	20	4	of	of	ADP
chd-148	20	5	hcc	hcc	PROPN
chd-148	20	6	,	,	PUNCT
chd-148	20	7	exposure	exposure	NOUN
chd-148	20	8	to	to	ADP
chd-148	20	9	hepatitis	hepatitis	PROPN
chd-148	20	10	b	b	PROPN
chd-148	20	11	virus	virus	NOUN
chd-148	20	12	(	(	PUNCT
chd-148	20	13	hbv	hbv	NOUN
chd-148	20	14	)	)	PUNCT
chd-148	20	15	and	and	CCONJ
chd-148	20	16	hcv	hcv	NOUN
chd-148	20	17	infections	infection	NOUN
chd-148	20	18	,	,	PUNCT
chd-148	20	19	alcoholic	alcoholic	ADJ
chd-148	20	20	liver	liver	NOUN
chd-148	20	21	disease	disease	NOUN
chd-148	20	22	,	,	PUNCT
chd-148	20	23	hemochromatosis	hemochromatosis	NOUN
chd-148	20	24	,	,	PUNCT
chd-148	20	25	and	and	CCONJ
chd-148	20	26	non	non	ADJ
chd-148	20	27	-	-	ADJ
chd-148	20	28	alcoholic	alcoholic	ADJ
chd-148	20	29	steatohepatitis	steatohepatitis	NOUN
chd-148	20	30	are	be	AUX
chd-148	20	31	involved	involve	VERB
chd-148	20	32	;	;	PUNCT
chd-148	20	33	there	there	PRON
chd-148	20	34	are	be	VERB
chd-148	20	35	also	also	ADV
chd-148	20	36	genetic	genetic	ADJ
chd-148	20	37	and	and	CCONJ
chd-148	20	38	environmental	environmental	ADJ
chd-148	20	39	contributions	contribution	NOUN
chd-148	20	40	(	(	PUNCT
chd-148	20	41	ruggieri	ruggieri	NOUN
chd-148	20	42	et	et	PROPN
chd-148	20	43	al	al	PROPN
chd-148	20	44	.	.	PROPN
chd-148	20	45	,	,	PUNCT
chd-148	20	46	2010	2010	NUM
chd-148	20	47	)	)	PUNCT
chd-148	20	48	.	.	PUNCT
chd-148	21	1	furthermore	furthermore	ADV
chd-148	21	2	,	,	PUNCT
chd-148	21	3	some	some	DET
chd-148	21	4	racial	racial	ADJ
chd-148	21	5	groups	group	NOUN
chd-148	21	6	are	be	AUX
chd-148	21	7	more	more	ADV
chd-148	21	8	affected	affected	ADJ
chd-148	21	9	,	,	PUNCT
chd-148	21	10	as	as	SCONJ
chd-148	21	11	shown	show	VERB
chd-148	21	12	by	by	ADP
chd-148	21	13	data	datum	NOUN
chd-148	21	14	on	on	ADP
chd-148	21	15	cancer	cancer	NOUN
chd-148	21	16	incidence	incidence	NOUN
chd-148	21	17	and	and	CCONJ
chd-148	21	18	mortality	mortality	NOUN
chd-148	21	19	(	(	PUNCT
chd-148	21	20	deshmukh	deshmukh	PROPN
chd-148	21	21	et	et	PROPN
chd-148	21	22	al	al	PROPN
chd-148	21	23	.	.	PROPN
chd-148	21	24	,	,	PUNCT
chd-148	21	25	2017	2017	NUM
chd-148	21	26	)	)	PUNCT
chd-148	21	27	.	.	PUNCT
chd-148	22	1	in	in	ADP
chd-148	22	2	the	the	DET
chd-148	22	3	united	united	PROPN
chd-148	22	4	states	states	PROPN
chd-148	22	5	,	,	PUNCT
chd-148	22	6	the	the	DET
chd-148	22	7	mortality	mortality	NOUN
chd-148	22	8	for	for	ADP
chd-148	22	9	african	african	ADJ
chd-148	22	10	americans	americans	PROPN
chd-148	22	11	(	(	PUNCT
chd-148	22	12	aa	aa	NOUN
chd-148	22	13	)	)	PUNCT
chd-148	22	14	with	with	ADP
chd-148	22	15	hcc	hcc	PROPN
chd-148	22	16	is	be	AUX
chd-148	22	17	worse	bad	ADJ
chd-148	22	18	than	than	ADP
chd-148	22	19	for	for	ADP
chd-148	22	20	any	any	DET
chd-148	22	21	other	other	ADJ
chd-148	22	22	racial	racial	ADJ
chd-148	22	23	group	group	NOUN
chd-148	22	24	.	.	PUNCT
chd-148	23	1	in	in	ADP
chd-148	23	2	addition	addition	NOUN
chd-148	23	3	,	,	PUNCT
chd-148	23	4	in	in	ADP
chd-148	23	5	eastern	eastern	ADJ
chd-148	23	6	and	and	CCONJ
chd-148	23	7	southern	southern	ADJ
chd-148	23	8	asia	asia	PROPN
chd-148	23	9	,	,	PUNCT
chd-148	23	10	middle	middle	ADJ
chd-148	23	11	and	and	CCONJ
chd-148	23	12	western	western	PROPN
chd-148	23	13	africa	africa	PROPN
chd-148	23	14	,	,	PUNCT
chd-148	23	15	melanesia	melanesia	PROPN
chd-148	23	16	,	,	PUNCT
chd-148	23	17	and	and	CCONJ
chd-148	23	18	micronesia	micronesia	PROPN
chd-148	23	19	/	/	SYM
chd-148	23	20	polynesia	polynesia	PROPN
chd-148	23	21	,	,	PUNCT
chd-148	23	22	the	the	DET
chd-148	23	23	incidence	incidence	NOUN
chd-148	23	24	of	of	ADP
chd-148	23	25	hcc	hcc	PROPN
chd-148	23	26	is	be	AUX
chd-148	23	27	higher	high	ADJ
chd-148	23	28	for	for	ADP
chd-148	23	29	males	male	NOUN
chd-148	23	30	than	than	ADP
chd-148	23	31	females	female	NOUN
chd-148	23	32	(	(	PUNCT
chd-148	23	33	ferlay	ferlay	NOUN
chd-148	23	34	et	et	PROPN
chd-148	23	35	al	al	PROPN
chd-148	23	36	.	.	PROPN
chd-148	23	37	,	,	PUNCT
chd-148	23	38	2010	2010	NUM
chd-148	23	39	)	)	PUNCT
chd-148	23	40	.	.	PUNCT
chd-148	24	1	according	accord	VERB
chd-148	24	2	to	to	ADP
chd-148	24	3	the	the	DET
chd-148	24	4	nih	nih	PROPN
chd-148	24	5	surveillance	surveillance	PROPN
chd-148	24	6	,	,	PUNCT
chd-148	24	7	epidemiology	epidemiology	NOUN
chd-148	24	8	,	,	PUNCT
chd-148	24	9	and	and	CCONJ
chd-148	24	10	end	end	VERB
chd-148	24	11	results	result	NOUN
chd-148	24	12	(	(	PUNCT
chd-148	24	13	seer	seer	NOUN
chd-148	24	14	)	)	PUNCT
chd-148	24	15	database	database	NOUN
chd-148	24	16	,	,	PUNCT
chd-148	24	17	the	the	DET
chd-148	24	18	annual	annual	ADJ
chd-148	24	19	incidence	incidence	NOUN
chd-148	24	20	of	of	ADP
chd-148	24	21	hcc	hcc	PROPN
chd-148	24	22	has	have	AUX
chd-148	24	23	tripled	triple	VERB
chd-148	24	24	between	between	ADP
chd-148	24	25	1975	1975	NUM
chd-148	24	26	and	and	CCONJ
chd-148	24	27	2005	2005	NUM
chd-148	24	28	(	(	PUNCT
chd-148	24	29	altekruse	altekruse	VERB
chd-148	24	30	et	et	PROPN
chd-148	24	31	al	al	PROPN
chd-148	24	32	.	.	PROPN
chd-148	24	33	,	,	PUNCT
chd-148	24	34	2009	2009	NUM
chd-148	24	35	)	)	PUNCT
chd-148	24	36	.	.	PUNCT
chd-148	25	1	the	the	DET
chd-148	25	2	statistical	statistical	ADJ
chd-148	25	3	data	datum	NOUN
chd-148	25	4	of	of	ADP
chd-148	25	5	the	the	DET
chd-148	25	6	national	national	PROPN
chd-148	25	7	institutes	institutes	PROPN
chd-148	25	8	of	of	ADP
chd-148	25	9	health	health	PROPN
chd-148	25	10	(	(	PUNCT
chd-148	25	11	nih	nih	PROPN
chd-148	25	12	)	)	PUNCT
chd-148	25	13	and	and	CCONJ
chd-148	25	14	the	the	DET
chd-148	25	15	centers	center	NOUN
chd-148	25	16	for	for	ADP
chd-148	25	17	disease	disease	NOUN
chd-148	25	18	control	control	NOUN
chd-148	25	19	and	and	CCONJ
chd-148	25	20	prevention	prevention	NOUN
chd-148	25	21	(	(	PUNCT
chd-148	25	22	cdc	cdc	PROPN
chd-148	25	23	)	)	PUNCT
chd-148	25	24	show	show	VERB
chd-148	25	25	a	a	DET
chd-148	25	26	difference	difference	NOUN
chd-148	25	27	in	in	ADP
chd-148	25	28	the	the	DET
chd-148	25	29	lca	lca	PROPN
chd-148	25	30	-	-	PUNCT
chd-148	25	31	based	base	VERB
chd-148	25	32	mortality	mortality	NOUN
chd-148	25	33	rates	rate	NOUN
chd-148	25	34	by	by	ADP
chd-148	25	35	race	race	NOUN
chd-148	25	36	/	/	SYM
chd-148	25	37	ethnicity	ethnicity	NOUN
chd-148	25	38	.	.	PUNCT
chd-148	26	1	a	a	DET
chd-148	26	2	schematic	schematic	ADJ
chd-148	26	3	presentation	presentation	NOUN
chd-148	26	4	of	of	ADP
chd-148	26	5	liver	liver	NOUN
chd-148	26	6	cancer	cancer	NOUN
chd-148	26	7	disparity	disparity	NOUN
chd-148	26	8	associated	associate	VERB
chd-148	26	9	factors	factor	NOUN
chd-148	26	10	are	be	AUX
chd-148	26	11	shown	show	VERB
chd-148	26	12	in	in	ADP
chd-148	26	13	figure	figure	NOUN
chd-148	26	14	1	1	NUM
chd-148	26	15	.	.	PUNCT
chd-148	27	1	in	in	ADP
chd-148	27	2	the	the	DET
chd-148	27	3	present	present	ADJ
chd-148	27	4	review	review	NOUN
chd-148	27	5	,	,	PUNCT
chd-148	27	6	our	our	PRON
chd-148	27	7	focus	focus	NOUN
chd-148	27	8	was	be	AUX
chd-148	27	9	to	to	PART
chd-148	27	10	estimate	estimate	VERB
chd-148	27	11	the	the	DET
chd-148	27	12	worldwide	worldwide	ADJ
chd-148	27	13	burden	burden	NOUN
chd-148	27	14	of	of	ADP
chd-148	27	15	lca	lca	PROPN
chd-148	27	16	disparities	disparity	NOUN
chd-148	27	17	based	base	VERB
chd-148	27	18	on	on	ADP
chd-148	27	19	race	race	NOUN
chd-148	27	20	/	/	SYM
chd-148	27	21	ethnicity	ethnicity	NOUN
chd-148	27	22	,	,	PUNCT
chd-148	27	23	health	health	NOUN
chd-148	27	24	and	and	CCONJ
chd-148	27	25	nutrition	nutrition	NOUN
chd-148	27	26	,	,	PUNCT
chd-148	27	27	and	and	CCONJ
chd-148	27	28	molecular	molecular	ADJ
chd-148	27	29	and	and	CCONJ
chd-148	27	30	geographical	geographical	ADJ
chd-148	27	31	factors	factor	NOUN
chd-148	27	32	.	.	PUNCT
chd-148	28	1	figure	figure	VERB
chd-148	28	2	1	1	NUM
chd-148	28	3	.	.	PUNCT
chd-148	28	4	schematic	schematic	ADJ
chd-148	28	5	presentation	presentation	NOUN
chd-148	28	6	of	of	ADP
chd-148	28	7	liver	liver	NOUN
chd-148	28	8	cancer	cancer	NOUN
chd-148	28	9	disparity	disparity	NOUN
chd-148	28	10	associated	associate	VERB
chd-148	28	11	factors	factor	NOUN
chd-148	28	12	factors	factor	NOUN
chd-148	28	13	associated	associate	VERB
chd-148	28	14	with	with	ADP
chd-148	28	15	lca	lca	PROPN
chd-148	28	16	disparities	disparity	NOUN
chd-148	28	17	of	of	ADP
chd-148	28	18	lca	lca	PROPN
chd-148	28	19	occurrence	occurrence	NOUN
chd-148	28	20	by	by	ADP
chd-148	28	21	sex	sex	NOUN
chd-148	28	22	and	and	CCONJ
chd-148	28	23	race	race	NOUN
chd-148	28	24	/	/	SYM
chd-148	28	25	ethnicity	ethnicity	NOUN
chd-148	28	26	the	the	DET
chd-148	28	27	incidence	incidence	NOUN
chd-148	28	28	of	of	ADP
chd-148	28	29	lca	lca	PROPN
chd-148	28	30	varies	vary	VERB
chd-148	28	31	by	by	ADP
chd-148	28	32	race	race	NOUN
chd-148	28	33	/	/	SYM
chd-148	28	34	ethnicity	ethnicity	NOUN
chd-148	28	35	due	due	ADP
chd-148	28	36	to	to	ADP
chd-148	28	37	differences	difference	NOUN
chd-148	28	38	in	in	ADP
chd-148	28	39	the	the	DET
chd-148	28	40	prevalence	prevalence	NOUN
chd-148	28	41	of	of	ADP
chd-148	28	42	risk	risk	NOUN
chd-148	28	43	factors	factor	NOUN
chd-148	28	44	and	and	CCONJ
chd-148	28	45	,	,	PUNCT
chd-148	28	46	to	to	ADP
chd-148	28	47	some	some	DET
chd-148	28	48	extent	extent	NOUN
chd-148	28	49	,	,	PUNCT
chd-148	28	50	disparities	disparity	NOUN
chd-148	28	51	in	in	ADP
chd-148	28	52	access	access	NOUN
chd-148	28	53	to	to	ADP
chd-148	28	54	high	high	ADJ
chd-148	28	55	-	-	PUNCT
chd-148	28	56	quality	quality	NOUN
chd-148	28	57	care	care	NOUN
chd-148	28	58	.	.	PUNCT
chd-148	29	1	recently	recently	ADV
chd-148	29	2	,	,	PUNCT
chd-148	29	3	an	an	DET
chd-148	29	4	annual	annual	ADJ
chd-148	29	5	report	report	NOUN
chd-148	29	6	on	on	ADP
chd-148	29	7	cancer	cancer	NOUN
chd-148	29	8	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PART
chd-148	29	9	e3	e3	NOUN
chd-148	29	10	cancer	cancer	NOUN
chd-148	29	11	health	health	NOUN
chd-148	29	12	disparities	disparity	NOUN
chd-148	29	13	research	research	NOUN
chd-148	29	14	incidences	incidence	NOUN
chd-148	29	15	from	from	ADP
chd-148	29	16	1975	1975	NUM
chd-148	29	17	-	-	SYM
chd-148	29	18	2012	2012	NUM
chd-148	29	19	and/or	and/or	CCONJ
chd-148	29	20	2014	2014	NUM
chd-148	29	21	(	(	PUNCT
chd-148	29	22	islami	islami	PROPN
chd-148	29	23	et	et	PROPN
chd-148	29	24	al	al	PROPN
chd-148	29	25	.	.	PROPN
chd-148	29	26	,	,	PUNCT
chd-148	29	27	2017	2017	NUM
chd-148	29	28	;	;	PUNCT
chd-148	29	29	ryerson	ryerson	NOUN
chd-148	29	30	et	et	PROPN
chd-148	29	31	al	al	PROPN
chd-148	29	32	.	.	PROPN
chd-148	29	33	,	,	PUNCT
chd-148	29	34	2016	2016	NUM
chd-148	29	35	)	)	PUNCT
chd-148	29	36	,	,	PUNCT
chd-148	29	37	showed	show	VERB
chd-148	29	38	lower	low	ADJ
chd-148	29	39	rates	rate	NOUN
chd-148	29	40	of	of	ADP
chd-148	29	41	overall	overall	ADJ
chd-148	29	42	cancer	cancer	NOUN
chd-148	29	43	incidences	incidence	NOUN
chd-148	29	44	among	among	ADP
chd-148	29	45	both	both	DET
chd-148	29	46	men	man	NOUN
chd-148	29	47	and	and	CCONJ
chd-148	29	48	women	woman	NOUN
chd-148	29	49	but	but	CCONJ
chd-148	29	50	increased	increase	VERB
chd-148	29	51	rates	rate	NOUN
chd-148	29	52	of	of	ADP
chd-148	29	53	lca	lca	PROPN
chd-148	29	54	-	-	PUNCT
chd-148	29	55	related	relate	VERB
chd-148	29	56	deaths	death	NOUN
chd-148	29	57	for	for	ADP
chd-148	29	58	both	both	DET
chd-148	29	59	sexes	sex	NOUN
chd-148	29	60	.	.	PUNCT
chd-148	30	1	from	from	ADP
chd-148	30	2	2003	2003	NUM
chd-148	30	3	through	through	ADP
chd-148	30	4	2012	2012	NUM
chd-148	30	5	,	,	PUNCT
chd-148	30	6	the	the	DET
chd-148	30	7	mortality	mortality	NOUN
chd-148	30	8	rates	rate	NOUN
chd-148	30	9	were	be	AUX
chd-148	30	10	higher	high	ADJ
chd-148	30	11	among	among	ADP
chd-148	30	12	men	man	NOUN
chd-148	30	13	(	(	PUNCT
chd-148	30	14	ryerson	ryerson	NOUN
chd-148	30	15	et	et	PROPN
chd-148	30	16	al	al	PROPN
chd-148	30	17	.	.	PROPN
chd-148	30	18	,	,	PUNCT
chd-148	30	19	2016	2016	NUM
chd-148	30	20	)	)	PUNCT
chd-148	30	21	.	.	PUNCT
chd-148	31	1	early	early	ADJ
chd-148	31	2	2000	2000	NUM
chd-148	31	3	estimates	estimate	NOUN
chd-148	31	4	indicated	indicate	VERB
chd-148	31	5	that	that	SCONJ
chd-148	31	6	lca	lca	PROPN
chd-148	31	7	incidence	incidence	NOUN
chd-148	31	8	was	be	AUX
chd-148	31	9	the	the	DET
chd-148	31	10	fifth	fifth	ADJ
chd-148	31	11	most	most	ADV
chd-148	31	12	common	common	ADJ
chd-148	31	13	cancer	cancer	NOUN
chd-148	31	14	in	in	ADP
chd-148	31	15	men	man	NOUN
chd-148	31	16	and	and	CCONJ
chd-148	31	17	eighth	eighth	ADJ
chd-148	31	18	for	for	ADP
chd-148	31	19	women	woman	NOUN
chd-148	31	20	worldwide	worldwide	ADV
chd-148	31	21	,	,	PUNCT
chd-148	31	22	with	with	ADP
chd-148	31	23	male	male	ADJ
chd-148	31	24	/	/	SYM
chd-148	31	25	female	female	ADJ
chd-148	31	26	ratios	ratio	NOUN
chd-148	31	27	regularly	regularly	ADV
chd-148	31	28	averaging	average	VERB
chd-148	31	29	between	between	ADP
chd-148	31	30	2:1	2:1	NUM
chd-148	31	31	and	and	CCONJ
chd-148	31	32	4:1	4:1	NUM
chd-148	31	33	.	.	PUNCT
chd-148	32	1	(	(	PUNCT
chd-148	32	2	montalto	montalto	X
chd-148	32	3	et	et	PROPN
chd-148	32	4	al	al	PROPN
chd-148	32	5	.	.	PROPN
chd-148	32	6	,	,	PUNCT
chd-148	32	7	2002	2002	NUM
chd-148	32	8	)	)	PUNCT
chd-148	32	9	.	.	PUNCT
chd-148	33	1	however	however	ADV
chd-148	33	2	,	,	PUNCT
chd-148	33	3	for	for	ADP
chd-148	33	4	countries	country	NOUN
chd-148	33	5	with	with	ADP
chd-148	33	6	low	low	ADJ
chd-148	33	7	incidences	incidence	NOUN
chd-148	33	8	of	of	ADP
chd-148	33	9	lca	lca	PROPN
chd-148	33	10	,	,	PUNCT
chd-148	33	11	the	the	DET
chd-148	33	12	age	age	NOUN
chd-148	33	13	distribution	distribution	NOUN
chd-148	33	14	for	for	ADP
chd-148	33	15	males	male	NOUN
chd-148	33	16	and	and	CCONJ
chd-148	33	17	females	female	NOUN
chd-148	33	18	was	be	AUX
chd-148	33	19	rare	rare	ADJ
chd-148	33	20	before	before	ADP
chd-148	33	21	the	the	DET
chd-148	33	22	age	age	NOUN
chd-148	33	23	of	of	ADP
chd-148	33	24	50	50	NUM
chd-148	33	25	.	.	PUNCT
chd-148	34	1	among	among	ADP
chd-148	34	2	high	high	ADJ
chd-148	34	3	-	-	PUNCT
chd-148	34	4	risk	risk	NOUN
chd-148	34	5	countries	country	NOUN
chd-148	34	6	such	such	ADJ
chd-148	34	7	as	as	ADP
chd-148	34	8	those	those	PRON
chd-148	34	9	in	in	ADP
chd-148	34	10	southeast	southeast	PROPN
chd-148	34	11	asia	asia	PROPN
chd-148	34	12	and	and	CCONJ
chd-148	34	13	west	west	PROPN
chd-148	34	14	and	and	CCONJ
chd-148	34	15	coastal	coastal	PROPN
chd-148	34	16	africa	africa	PROPN
chd-148	34	17	,	,	PUNCT
chd-148	34	18	the	the	DET
chd-148	34	19	occurrence	occurrence	NOUN
chd-148	34	20	of	of	ADP
chd-148	34	21	lca	lca	PROPN
chd-148	34	22	was	be	AUX
chd-148	34	23	evident	evident	ADJ
chd-148	34	24	before	before	ADP
chd-148	34	25	the	the	DET
chd-148	34	26	age	age	NOUN
chd-148	34	27	of	of	ADP
chd-148	34	28	20	20	NUM
chd-148	34	29	;	;	PUNCT
chd-148	34	30	gender	gender	NOUN
chd-148	34	31	ratios	ratio	NOUN
chd-148	34	32	were	be	AUX
chd-148	34	33	higher	high	ADJ
chd-148	34	34	,	,	PUNCT
chd-148	34	35	and	and	CCONJ
chd-148	34	36	the	the	DET
chd-148	34	37	male	male	ADJ
chd-148	34	38	excess	excess	NOUN
chd-148	34	39	was	be	AUX
chd-148	34	40	greater	great	ADJ
chd-148	34	41	for	for	ADP
chd-148	34	42	those	those	DET
chd-148	34	43	less	less	ADJ
chd-148	34	44	than	than	ADP
chd-148	34	45	50	50	NUM
chd-148	34	46	years	year	NOUN
chd-148	34	47	of	of	ADP
chd-148	34	48	age	age	NOUN
chd-148	34	49	.	.	PUNCT
chd-148	35	1	in	in	ADP
chd-148	35	2	addition	addition	NOUN
chd-148	35	3	,	,	PUNCT
chd-148	35	4	clinical	clinical	ADJ
chd-148	35	5	observations	observation	NOUN
chd-148	35	6	and	and	CCONJ
chd-148	35	7	death	death	NOUN
chd-148	35	8	statistics	statistic	NOUN
chd-148	35	9	showed	show	VERB
chd-148	35	10	that	that	SCONJ
chd-148	35	11	lca	lca	PROPN
chd-148	35	12	due	due	ADP
chd-148	35	13	to	to	ADP
chd-148	35	14	hepatitis	hepatitis	NOUN
chd-148	35	15	infections	infection	NOUN
chd-148	35	16	appeared	appear	VERB
chd-148	35	17	to	to	PART
chd-148	35	18	progress	progress	VERB
chd-148	35	19	more	more	ADV
chd-148	35	20	in	in	ADP
chd-148	35	21	males	male	NOUN
chd-148	35	22	than	than	ADP
chd-148	35	23	females	female	NOUN
chd-148	35	24	and	and	CCONJ
chd-148	35	25	that	that	SCONJ
chd-148	35	26	cirrhosis	cirrhosis	NOUN
chd-148	35	27	was	be	AUX
chd-148	35	28	largely	largely	ADV
chd-148	35	29	a	a	DET
chd-148	35	30	disease	disease	NOUN
chd-148	35	31	of	of	ADP
chd-148	35	32	men	man	NOUN
chd-148	35	33	and	and	CCONJ
chd-148	35	34	postmenopausal	postmenopausal	ADJ
chd-148	35	35	women	woman	NOUN
chd-148	35	36	(	(	PUNCT
chd-148	35	37	giannitrapani	giannitrapani	NOUN
chd-148	35	38	et	et	PROPN
chd-148	35	39	al	al	PROPN
chd-148	35	40	.	.	PROPN
chd-148	35	41	,	,	PUNCT
chd-148	35	42	2006	2006	NUM
chd-148	35	43	;	;	PUNCT
chd-148	35	44	ruggieri	ruggieri	VERB
chd-148	35	45	et	et	PROPN
chd-148	35	46	al	al	PROPN
chd-148	35	47	.	.	PROPN
chd-148	35	48	,	,	PUNCT
chd-148	35	49	2010	2010	NUM
chd-148	35	50	)	)	PUNCT
chd-148	35	51	.	.	PUNCT
chd-148	36	1	in	in	ADP
chd-148	36	2	the	the	DET
chd-148	36	3	united	united	PROPN
chd-148	36	4	states	states	PROPN
chd-148	36	5	,	,	PUNCT
chd-148	36	6	there	there	PRON
chd-148	36	7	were	be	VERB
chd-148	36	8	disparities	disparity	NOUN
chd-148	36	9	in	in	ADP
chd-148	36	10	the	the	DET
chd-148	36	11	rates	rate	NOUN
chd-148	36	12	and	and	CCONJ
chd-148	36	13	survival	survival	NOUN
chd-148	36	14	for	for	ADP
chd-148	36	15	various	various	ADJ
chd-148	36	16	races	race	NOUN
chd-148	36	17	/	/	SYM
chd-148	36	18	ethnicities	ethnicity	NOUN
chd-148	36	19	and	and	CCONJ
chd-148	36	20	between	between	ADP
chd-148	36	21	states	state	NOUN
chd-148	36	22	;	;	PUNCT
chd-148	36	23	the	the	DET
chd-148	36	24	relative	relative	ADJ
chd-148	36	25	risk	risk	NOUN
chd-148	36	26	of	of	ADP
chd-148	36	27	death	death	NOUN
chd-148	36	28	for	for	ADP
chd-148	36	29	all	all	DET
chd-148	36	30	cancers	cancer	NOUN
chd-148	36	31	combined	combine	VERB
chd-148	36	32	was	be	AUX
chd-148	36	33	33	33	NUM
chd-148	36	34	%	%	NOUN
chd-148	36	35	higher	high	ADJ
chd-148	36	36	for	for	ADP
chd-148	36	37	nonhispanic	nonhispanic	ADJ
chd-148	36	38	(	(	PUNCT
chd-148	36	39	nh	nh	NOUN
chd-148	36	40	)	)	PUNCT
chd-148	36	41	blacks	black	NOUN
chd-148	36	42	and	and	CCONJ
chd-148	36	43	51	51	NUM
chd-148	36	44	%	%	NOUN
chd-148	36	45	higher	high	ADJ
chd-148	36	46	for	for	ADP
chd-148	36	47	nh	nh	PROPN
chd-148	36	48	indian	indian	PROPN
chd-148	36	49	/	/	SYM
chd-148	36	50	alaska	alaska	PROPN
chd-148	36	51	natives	native	NOUN
chd-148	36	52	compared	compare	VERB
chd-148	36	53	to	to	ADP
chd-148	36	54	nh	nh	PROPN
chd-148	36	55	whites	whites	PROPN
chd-148	36	56	(	(	PUNCT
chd-148	36	57	islami	islami	PROPN
chd-148	36	58	et	et	PROPN
chd-148	36	59	al	al	PROPN
chd-148	36	60	.	.	PROPN
chd-148	36	61	,	,	PUNCT
chd-148	36	62	2017	2017	NUM
chd-148	36	63	)	)	PUNCT
chd-148	36	64	.	.	PUNCT
chd-148	37	1	however	however	ADV
chd-148	37	2	,	,	PUNCT
chd-148	37	3	there	there	PRON
chd-148	37	4	was	be	VERB
chd-148	37	5	a	a	DET
chd-148	37	6	disparity	disparity	NOUN
chd-148	37	7	in	in	ADP
chd-148	37	8	lca	lca	PROPN
chd-148	37	9	incidence	incidence	NOUN
chd-148	37	10	in	in	ADP
chd-148	37	11	that	that	SCONJ
chd-148	37	12	it	it	PRON
chd-148	37	13	was	be	AUX
chd-148	37	14	higher	high	ADJ
chd-148	37	15	among	among	ADP
chd-148	37	16	nh	nh	PROPN
chd-148	37	17	whites	white	NOUN
chd-148	37	18	,	,	PUNCT
chd-148	37	19	nh	nh	PROPN
chd-148	37	20	blacks	black	NOUN
chd-148	37	21	,	,	PUNCT
chd-148	37	22	and	and	CCONJ
chd-148	37	23	hispanic	hispanic	ADJ
chd-148	37	24	men	man	NOUN
chd-148	37	25	and	and	CCONJ
chd-148	37	26	women	woman	NOUN
chd-148	37	27	born	bear	VERB
chd-148	37	28	after	after	ADP
chd-148	37	29	1938	1938	NUM
chd-148	37	30	-	-	SYM
chd-148	37	31	1947	1947	NUM
chd-148	37	32	;	;	PUNCT
chd-148	37	33	it	it	PRON
chd-148	37	34	was	be	AUX
chd-148	37	35	minimal	minimal	ADJ
chd-148	37	36	for	for	ADP
chd-148	37	37	nh	nh	PROPN
chd-148	37	38	asian	asian	ADJ
chd-148	37	39	and	and	CCONJ
chd-148	37	40	pacific	pacific	ADJ
chd-148	37	41	islanders	islander	NOUN
chd-148	37	42	(	(	PUNCT
chd-148	37	43	ryerson	ryerson	NOUN
chd-148	37	44	et	et	PROPN
chd-148	37	45	al	al	PROPN
chd-148	37	46	.	.	PROPN
chd-148	37	47	,	,	PUNCT
chd-148	37	48	2016	2016	NUM
chd-148	37	49	)	)	PUNCT
chd-148	37	50	.	.	PUNCT
chd-148	38	1	among	among	ADP
chd-148	38	2	hispanics	hispanic	NOUN
chd-148	38	3	,	,	PUNCT
chd-148	38	4	the	the	DET
chd-148	38	5	disparities	disparity	NOUN
chd-148	38	6	in	in	ADP
chd-148	38	7	lca	lca	PROPN
chd-148	38	8	incidence	incidence	NOUN
chd-148	38	9	and	and	CCONJ
chd-148	38	10	mortality	mortality	NOUN
chd-148	38	11	were	be	AUX
chd-148	38	12	related	relate	VERB
chd-148	38	13	to	to	ADP
chd-148	38	14	their	their	PRON
chd-148	38	15	nativity	nativity	NOUN
chd-148	38	16	.	.	PUNCT
chd-148	39	1	the	the	DET
chd-148	39	2	hcc	hcc	PROPN
chd-148	39	3	incidence	incidence	NOUN
chd-148	39	4	was	be	AUX
chd-148	39	5	twice	twice	ADV
chd-148	39	6	as	as	ADV
chd-148	39	7	high	high	ADJ
chd-148	39	8	for	for	ADP
chd-148	39	9	us	we	PRON
chd-148	39	10	-	-	PUNCT
chd-148	39	11	born	bear	VERB
chd-148	39	12	hispanic	hispanic	ADJ
chd-148	39	13	men	man	NOUN
chd-148	39	14	compared	compare	VERB
chd-148	39	15	to	to	ADP
chd-148	39	16	the	the	DET
chd-148	39	17	foreign	foreign	NOUN
chd-148	39	18	-	-	PUNCT
chd-148	39	19	born	bear	VERB
chd-148	39	20	hispanic	hispanic	ADJ
chd-148	39	21	men	man	NOUN
chd-148	39	22	(	(	PUNCT
chd-148	39	23	setiawan	setiawan	X
chd-148	39	24	et	et	PROPN
chd-148	39	25	al	al	PROPN
chd-148	39	26	.	.	PROPN
chd-148	39	27	,	,	PUNCT
chd-148	39	28	2016	2016	NUM
chd-148	39	29	)	)	PUNCT
chd-148	39	30	.	.	PUNCT
chd-148	40	1	the	the	DET
chd-148	40	2	risk	risk	NOUN
chd-148	40	3	factors	factor	NOUN
chd-148	40	4	of	of	ADP
chd-148	40	5	smoking	smoking	NOUN
chd-148	40	6	status	status	NOUN
chd-148	40	7	,	,	PUNCT
chd-148	40	8	hepatitis	hepatitis	PROPN
chd-148	40	9	b	b	PROPN
chd-148	40	10	/	/	SYM
chd-148	40	11	c	c	NOUN
chd-148	40	12	infection	infection	NOUN
chd-148	40	13	,	,	PUNCT
chd-148	40	14	and	and	CCONJ
chd-148	40	15	diabetes	diabetes	NOUN
chd-148	40	16	accounted	account	VERB
chd-148	40	17	for	for	ADP
chd-148	40	18	hcc	hcc	PROPN
chd-148	40	19	among	among	ADP
chd-148	40	20	us	us	PROPN
chd-148	40	21	-	-	PUNCT
chd-148	40	22	born	bear	VERB
chd-148	40	23	hispanics	hispanic	NOUN
chd-148	40	24	.	.	PUNCT
chd-148	41	1	an	an	DET
chd-148	41	2	overview	overview	NOUN
chd-148	41	3	of	of	ADP
chd-148	41	4	the	the	DET
chd-148	41	5	disparities	disparity	NOUN
chd-148	41	6	of	of	ADP
chd-148	41	7	lca	lca	PROPN
chd-148	41	8	incidence	incidence	NOUN
chd-148	41	9	according	accord	VERB
chd-148	41	10	to	to	ADP
chd-148	41	11	race	race	NOUN
chd-148	41	12	and	and	CCONJ
chd-148	41	13	ethnicity	ethnicity	NOUN
chd-148	41	14	is	be	AUX
chd-148	41	15	presented	present	VERB
chd-148	41	16	in	in	ADP
chd-148	41	17	table	table	NOUN
chd-148	41	18	1	1	NUM
chd-148	41	19	.	.	PUNCT
chd-148	41	20	table	table	NOUN
chd-148	41	21	1	1	NUM
chd-148	41	22	.	.	PUNCT
chd-148	42	1	disparities	disparity	NOUN
chd-148	42	2	of	of	ADP
chd-148	42	3	lca	lca	PROPN
chd-148	42	4	incidences	incidence	NOUN
chd-148	42	5	according	accord	VERB
chd-148	42	6	to	to	ADP
chd-148	42	7	race	race	NOUN
chd-148	42	8	and	and	CCONJ
chd-148	42	9	ethnicity	ethnicity	NOUN
chd-148	42	10	.	.	PUNCT
chd-148	43	1	region	region	NOUN
chd-148	43	2	born	bear	VERB
chd-148	43	3	ethnicity/	ethnicity/	NUM
chd-148	43	4	gender	gender	NOUN
chd-148	43	5	incidence	incidence	NOUN
chd-148	43	6	(	(	PUNCT
chd-148	43	7	per	per	ADP
chd-148	43	8	100,000	100,000	NUM
chd-148	43	9	)	)	PUNCT
chd-148	43	10	severity	severity	NOUN
chd-148	43	11	causes	cause	VERB
chd-148	43	12	mortality	mortality	NOUN
chd-148	43	13	(	(	PUNCT
chd-148	43	14	per	per	ADP
chd-148	43	15	100,000	100,000	NUM
chd-148	43	16	)	)	PUNCT
chd-148	43	17	reference	reference	NOUN
chd-148	43	18	us	we	PRON
chd-148	43	19	born	bear	VERB
chd-148	43	20	men	man	NOUN
chd-148	43	21	(	(	PUNCT
chd-148	43	22	overall	overall	ADJ
chd-148	43	23	)	)	PUNCT
chd-148	43	24	21	21	NUM
chd-148	43	25	-	-	SYM
chd-148	43	26	35	35	NUM
chd-148	43	27	---	---	PUNCT
chd-148	43	28	(	(	PUNCT
chd-148	43	29	altekruse	altekruse	VERB
chd-148	43	30	et	et	PROPN
chd-148	43	31	al	al	PROPN
chd-148	43	32	.	.	PROPN
chd-148	43	33	,	,	PUNCT
chd-148	43	34	2009	2009	NUM
chd-148	43	35	)	)	PUNCT
chd-148	44	1	women	woman	NOUN
chd-148	44	2	(	(	PUNCT
chd-148	44	3	overall	overall	ADJ
chd-148	44	4	)	)	PUNCT
chd-148	44	5	3.8	3.8	NUM
chd-148	44	6	-	-	SYM
chd-148	44	7	13.6	13.6	NUM
chd-148	44	8	---	---	PUNCT
chd-148	44	9	(	(	PUNCT
chd-148	44	10	altekruse	altekruse	VERB
chd-148	44	11	et	et	PROPN
chd-148	44	12	al	al	PROPN
chd-148	44	13	.	.	PROPN
chd-148	44	14	,	,	PUNCT
chd-148	44	15	2009	2009	NUM
chd-148	44	16	)	)	PUNCT
chd-148	44	17	hispanic	hispanic	NOUN
chd-148	44	18	(	(	PUNCT
chd-148	44	19	men	man	NOUN
chd-148	44	20	/	/	SYM
chd-148	44	21	women	woman	NOUN
chd-148	44	22	)	)	PUNCT
chd-148	44	23	1.8	1.8	NUM
chd-148	44	24	-	-	SYM
chd-148	44	25	60.2/1.248	60.2/1.248	NUM
chd-148	44	26	localized	localize	VERB
chd-148	44	27	to	to	ADP
chd-148	44	28	advanced	advanced	ADJ
chd-148	44	29	and	and	CCONJ
chd-148	44	30	unknown	unknown	ADJ
chd-148	44	31	chronic	chronic	ADJ
chd-148	44	32	hepatitis	hepatitis	NOUN
chd-148	44	33	/	/	SYM
chd-148	44	34	fibrosis/	fibrosis/	NUM
chd-148	44	35	alcohol	alcohol	NOUN
chd-148	44	36	-	-	PUNCT
chd-148	44	37	related	relate	VERB
chd-148	44	38	/	/	SYM
chd-148	44	39	other	other	ADJ
chd-148	44	40	63/42	63/42	NUM
chd-148	44	41	(	(	PUNCT
chd-148	44	42	setiawan	setiawan	X
chd-148	44	43	et	et	PROPN
chd-148	44	44	al	al	PROPN
chd-148	44	45	.	.	PROPN
chd-148	44	46	,	,	PUNCT
chd-148	44	47	2016	2016	NUM
chd-148	44	48	)	)	PUNCT
chd-148	44	49	asian	asian	NOUN
chd-148	44	50	(	(	PUNCT
chd-148	44	51	men	man	NOUN
chd-148	44	52	/	/	SYM
chd-148	44	53	women	woman	NOUN
chd-148	44	54	)	)	PUNCT
chd-148	44	55	35	35	NUM
chd-148	44	56	-	-	SYM
chd-148	44	57	83/5.937.9	83/5.937.9	NOUN
chd-148	44	58	localized	localize	VERB
chd-148	44	59	to	to	ADP
chd-148	44	60	advanced	advanced	ADJ
chd-148	44	61	hcv	hcv	PROPN
chd-148	44	62	/	/	SYM
chd-148	44	63	hbv	hbv	NOUN
chd-148	44	64	infection	infection	NOUN
chd-148	44	65	(	(	PUNCT
chd-148	44	66	altekruse	altekruse	VERB
chd-148	44	67	et	et	PROPN
chd-148	44	68	al	al	PROPN
chd-148	44	69	.	.	PROPN
chd-148	44	70	,	,	PUNCT
chd-148	44	71	2009	2009	NUM
chd-148	44	72	)	)	PUNCT
chd-148	44	73	african	african	ADJ
chd-148	44	74	(	(	PUNCT
chd-148	44	75	men	man	NOUN
chd-148	44	76	/	/	SYM
chd-148	44	77	women	woman	NOUN
chd-148	44	78	)	)	PUNCT
chd-148	44	79	37	37	NUM
chd-148	44	80	-	-	SYM
chd-148	44	81	40/6.913.6	40/6.913.6	NUM
chd-148	44	82	localized	localize	VERB
chd-148	44	83	to	to	ADP
chd-148	44	84	advanced	advanced	ADJ
chd-148	44	85	hcv	hcv	PROPN
chd-148	44	86	/	/	SYM
chd-148	44	87	hbv	hbv	NOUN
chd-148	44	88	infection	infection	NOUN
chd-148	44	89	/	/	SYM
chd-148	44	90	other	other	ADJ
chd-148	44	91	(	(	PUNCT
chd-148	44	92	altekruse	altekruse	PROPN
chd-148	44	93	et	et	PROPN
chd-148	44	94	al	al	PROPN
chd-148	44	95	.	.	PROPN
chd-148	44	96	,	,	PUNCT
chd-148	44	97	2009	2009	NUM
chd-148	44	98	)	)	PUNCT
chd-148	44	99	white	white	ADJ
chd-148	44	100	16.5	16.5	NUM
chd-148	44	101	-	-	PUNCT
chd-148	44	102	28/310.2	28/310.2	NUM
chd-148	44	103	localized	localize	VERB
chd-148	44	104	to	to	ADP
chd-148	44	105	advanced	advanced	ADJ
chd-148	44	106	hcv	hcv	PROPN
chd-148	44	107	/	/	SYM
chd-148	44	108	hbv	hbv	NOUN
chd-148	44	109	infection	infection	NOUN
chd-148	44	110	/	/	SYM
chd-148	44	111	obesity/0ther	obesity/0ther	PUNCT
chd-148	44	112	(	(	PUNCT
chd-148	44	113	altekruse	altekruse	VERB
chd-148	44	114	et	et	PROPN
chd-148	44	115	al	al	PROPN
chd-148	44	116	.	.	PROPN
chd-148	44	117	,	,	PUNCT
chd-148	44	118	2009	2009	NUM
chd-148	44	119	)	)	PUNCT
chd-148	44	120	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-148	44	121	e4	e4	PROPN
chd-148	44	122	cancer	cancer	NOUN
chd-148	44	123	health	health	NOUN
chd-148	44	124	disparities	disparity	NOUN
chd-148	44	125	research	research	VERB
chd-148	44	126	non	non	PROPN
chd-148	44	127	-	-	ADJ
chd-148	44	128	us	we	PRON
chd-148	44	129	born	bear	VERB
chd-148	44	130	men	man	NOUN
chd-148	44	131	75.9	75.9	NUM
chd-148	44	132	----	----	PUNCT
chd-148	44	133	(	(	PUNCT
chd-148	44	134	njei	njei	NOUN
chd-148	44	135	et	et	PROPN
chd-148	44	136	al	al	PROPN
chd-148	44	137	.	.	PROPN
chd-148	44	138	,	,	PUNCT
chd-148	44	139	2015	2015	NUM
chd-148	44	140	)	)	PUNCT
chd-148	44	141	women	woman	NOUN
chd-148	44	142	24.5	24.5	NUM
chd-148	44	143	----	----	PUNCT
chd-148	45	1	(	(	PUNCT
chd-148	45	2	njei	njei	NOUN
chd-148	45	3	et	et	PROPN
chd-148	45	4	al	al	PROPN
chd-148	45	5	.	.	PROPN
chd-148	45	6	,	,	PUNCT
chd-148	45	7	2015	2015	NUM
chd-148	45	8	)	)	PUNCT
chd-148	45	9	hispanic	hispanic	NOUN
chd-148	45	10	(	(	PUNCT
chd-148	45	11	men	man	NOUN
chd-148	45	12	/	/	SYM
chd-148	45	13	women	woman	NOUN
chd-148	45	14	)	)	PUNCT
chd-148	45	15	0	0	NUM
chd-148	45	16	-	-	PUNCT
chd-148	45	17	44/0	44/0	NUM
chd-148	45	18	-	-	PUNCT
chd-148	45	19	50	50	NUM
chd-148	45	20	localized	localize	VERB
chd-148	45	21	to	to	PART
chd-148	45	22	advance	advance	VERB
chd-148	45	23	and	and	CCONJ
chd-148	45	24	unknown	unknown	ADJ
chd-148	46	1	chronic	chronic	ADJ
chd-148	46	2	hepatitis	hepatitis	NOUN
chd-148	46	3	/	/	SYM
chd-148	46	4	fibrosis	fibrosis	NOUN
chd-148	46	5	/	/	SYM
chd-148	46	6	alco	alco	NOUN
chd-148	46	7	hol	hol	NOUN
chd-148	46	8	related	relate	VERB
chd-148	46	9	/	/	SYM
chd-148	46	10	other	other	ADJ
chd-148	46	11	35/19	35/19	NUM
chd-148	46	12	(	(	PUNCT
chd-148	46	13	setiawan	setiawan	X
chd-148	46	14	et	et	PROPN
chd-148	46	15	al	al	PROPN
chd-148	46	16	.	.	PROPN
chd-148	46	17	,	,	PUNCT
chd-148	46	18	2016	2016	NUM
chd-148	46	19	)	)	PUNCT
chd-148	46	20	asian	asian	ADJ
chd-148	46	21	18.9	18.9	NUM
chd-148	46	22	-	-	SYM
chd-148	46	23	24	24	NUM
chd-148	46	24	localized	localize	VERB
chd-148	46	25	to	to	ADP
chd-148	46	26	advanced	advanced	ADJ
chd-148	46	27	hcv	hcv	PROPN
chd-148	46	28	/	/	SYM
chd-148	46	29	hbv	hbv	NOUN
chd-148	46	30	infection	infection	NOUN
chd-148	46	31	(	(	PUNCT
chd-148	46	32	njei	njei	NOUN
chd-148	46	33	et	et	PROPN
chd-148	46	34	al	al	PROPN
chd-148	46	35	.	.	PROPN
chd-148	46	36	,	,	PUNCT
chd-148	46	37	2015	2015	NUM
chd-148	46	38	)	)	PUNCT
chd-148	46	39	african	african	ADJ
chd-148	46	40	10.9	10.9	NUM
chd-148	46	41	-	-	SYM
chd-148	46	42	12.5	12.5	NUM
chd-148	46	43	localized	localize	VERB
chd-148	46	44	to	to	ADP
chd-148	46	45	advanced	advanced	ADJ
chd-148	46	46	hcv	hcv	PROPN
chd-148	46	47	/	/	SYM
chd-148	46	48	hbv	hbv	NOUN
chd-148	46	49	infection	infection	NOUN
chd-148	46	50	/	/	SYM
chd-148	46	51	other	other	ADJ
chd-148	46	52	(	(	PUNCT
chd-148	46	53	njei	njei	NOUN
chd-148	46	54	et	et	PROPN
chd-148	46	55	al	al	PROPN
chd-148	46	56	.	.	PROPN
chd-148	46	57	,	,	PUNCT
chd-148	46	58	2015	2015	NUM
chd-148	46	59	)	)	PUNCT
chd-148	46	60	white	white	NOUN
chd-148	46	61	67	67	NUM
chd-148	46	62	localized	localize	VERB
chd-148	46	63	to	to	ADP
chd-148	46	64	advanced	advanced	ADJ
chd-148	46	65	hcv	hcv	PROPN
chd-148	46	66	/	/	SYM
chd-148	46	67	hbv	hbv	NOUN
chd-148	46	68	infection	infection	NOUN
chd-148	46	69	/	/	SYM
chd-148	46	70	obesity	obesity	NOUN
chd-148	46	71	/	/	SYM
chd-148	46	72	other	other	ADJ
chd-148	46	73	(	(	PUNCT
chd-148	46	74	njei	njei	NOUN
chd-148	46	75	et	et	PROPN
chd-148	46	76	al	al	PROPN
chd-148	46	77	.	.	PROPN
chd-148	46	78	,	,	PUNCT
chd-148	46	79	2015	2015	NUM
chd-148	46	80	)	)	PUNCT
chd-148	46	81	geographical	geographical	ADJ
chd-148	46	82	factors	factor	NOUN
chd-148	46	83	associated	associate	VERB
chd-148	46	84	with	with	ADP
chd-148	46	85	disparities	disparity	NOUN
chd-148	46	86	in	in	ADP
chd-148	46	87	lca	lca	PROPN
chd-148	46	88	hcc	hcc	PROPN
chd-148	46	89	is	be	AUX
chd-148	46	90	the	the	DET
chd-148	46	91	dominant	dominant	ADJ
chd-148	46	92	histologic	histologic	ADJ
chd-148	46	93	type	type	NOUN
chd-148	46	94	of	of	ADP
chd-148	46	95	lca	lca	PROPN
chd-148	46	96	,	,	PUNCT
chd-148	46	97	accounting	account	VERB
chd-148	46	98	for	for	ADP
chd-148	46	99	approximately	approximately	ADV
chd-148	46	100	80	80	NUM
chd-148	46	101	%	%	NOUN
chd-148	46	102	of	of	ADP
chd-148	46	103	total	total	ADJ
chd-148	46	104	cases	case	NOUN
chd-148	46	105	globally	globally	ADV
chd-148	46	106	(	(	PUNCT
chd-148	46	107	petrick	petrick	PROPN
chd-148	46	108	et	et	PROPN
chd-148	46	109	al	al	PROPN
chd-148	46	110	.	.	PROPN
chd-148	46	111	,	,	PUNCT
chd-148	46	112	2016	2016	NUM
chd-148	46	113	)	)	PUNCT
chd-148	46	114	.	.	PUNCT
chd-148	47	1	hcc	hcc	PROPN
chd-148	47	2	poses	pose	VERB
chd-148	47	3	a	a	DET
chd-148	47	4	prominent	prominent	ADJ
chd-148	47	5	disease	disease	NOUN
chd-148	47	6	burden	burden	NOUN
chd-148	47	7	throughout	throughout	ADP
chd-148	47	8	the	the	DET
chd-148	47	9	world	world	NOUN
chd-148	47	10	and	and	CCONJ
chd-148	47	11	particularly	particularly	ADV
chd-148	47	12	in	in	ADP
chd-148	47	13	africa	africa	PROPN
chd-148	47	14	and	and	CCONJ
chd-148	47	15	asia	asia	PROPN
chd-148	47	16	where	where	SCONJ
chd-148	47	17	hbv	hbv	NOUN
chd-148	47	18	is	be	AUX
chd-148	47	19	the	the	DET
chd-148	47	20	principal	principal	ADJ
chd-148	47	21	cause	cause	NOUN
chd-148	47	22	(	(	PUNCT
chd-148	47	23	bosch	bosch	PROPN
chd-148	47	24	et	et	PROPN
chd-148	47	25	al	al	PROPN
chd-148	47	26	.	.	PROPN
chd-148	47	27	,	,	PUNCT
chd-148	47	28	2005	2005	NUM
chd-148	47	29	)	)	PUNCT
chd-148	47	30	.	.	PUNCT
chd-148	48	1	in	in	ADP
chd-148	48	2	western	western	ADJ
chd-148	48	3	countries	country	NOUN
chd-148	48	4	,	,	PUNCT
chd-148	48	5	chronic	chronic	ADJ
chd-148	48	6	alcohol	alcohol	NOUN
chd-148	48	7	abuse	abuse	NOUN
chd-148	48	8	is	be	AUX
chd-148	48	9	the	the	DET
chd-148	48	10	primary	primary	ADJ
chd-148	48	11	factor	factor	NOUN
chd-148	48	12	associated	associate	VERB
chd-148	48	13	with	with	ADP
chd-148	48	14	hcc	hcc	PROPN
chd-148	48	15	.	.	PUNCT
chd-148	49	1	high	high	ADJ
chd-148	49	2	disease	disease	NOUN
chd-148	49	3	levels	level	NOUN
chd-148	49	4	in	in	ADP
chd-148	49	5	northern	northern	ADJ
chd-148	49	6	thailand	thailand	PROPN
chd-148	49	7	are	be	AUX
chd-148	49	8	due	due	ADJ
chd-148	49	9	to	to	ADP
chd-148	49	10	chronic	chronic	ADJ
chd-148	49	11	infections	infection	NOUN
chd-148	49	12	with	with	ADP
chd-148	49	13	the	the	DET
chd-148	49	14	liver	liver	NOUN
chd-148	49	15	fluke	fluke	NOUN
chd-148	49	16	,	,	PUNCT
chd-148	49	17	opisthorchis	opisthorchis	PRON
chd-148	49	18	viverrini	viverrini	NOUN
chd-148	49	19	,	,	PUNCT
chd-148	49	20	which	which	PRON
chd-148	49	21	is	be	AUX
chd-148	49	22	ingested	ingest	VERB
chd-148	49	23	through	through	ADP
chd-148	49	24	infected	infect	VERB
chd-148	49	25	raw	raw	ADJ
chd-148	49	26	fish	fish	NOUN
chd-148	49	27	(	(	PUNCT
chd-148	49	28	petrick	petrick	PROPN
chd-148	49	29	et	et	PROPN
chd-148	49	30	al	al	PROPN
chd-148	49	31	.	.	PROPN
chd-148	49	32	,	,	PUNCT
chd-148	49	33	2016	2016	NUM
chd-148	49	34	;	;	PUNCT
chd-148	49	35	sripa	sripa	VERB
chd-148	49	36	et	et	PROPN
chd-148	49	37	al	al	PROPN
chd-148	49	38	.	.	PROPN
chd-148	49	39	,	,	PUNCT
chd-148	49	40	2012	2012	NUM
chd-148	49	41	)	)	PUNCT
chd-148	49	42	.	.	PUNCT
chd-148	50	1	in	in	ADP
chd-148	50	2	countries	country	NOUN
chd-148	50	3	undergoing	undergo	VERB
chd-148	50	4	socio	socio	NOUN
chd-148	50	5	-	-	PUNCT
chd-148	50	6	economic	economic	ADJ
chd-148	50	7	development	development	NOUN
chd-148	50	8	,	,	PUNCT
chd-148	50	9	such	such	ADJ
chd-148	50	10	as	as	ADP
chd-148	50	11	some	some	PRON
chd-148	50	12	in	in	ADP
chd-148	50	13	asia	asia	PROPN
chd-148	50	14	,	,	PUNCT
chd-148	50	15	hcc	hcc	PROPN
chd-148	50	16	cases	case	NOUN
chd-148	50	17	account	account	VERB
chd-148	50	18	for	for	ADP
chd-148	50	19	nearly	nearly	ADV
chd-148	50	20	75	75	NUM
chd-148	50	21	%	%	NOUN
chd-148	50	22	of	of	ADP
chd-148	50	23	all	all	DET
chd-148	50	24	lcas	lcas	NOUN
chd-148	50	25	,	,	PUNCT
chd-148	50	26	and	and	CCONJ
chd-148	50	27	china	china	PROPN
chd-148	50	28	accounts	account	VERB
chd-148	50	29	for	for	ADP
chd-148	50	30	56	56	NUM
chd-148	50	31	%	%	NOUN
chd-148	50	32	of	of	ADP
chd-148	50	33	the	the	DET
chd-148	50	34	world	world	NOUN
chd-148	50	35	’s	’s	PART
chd-148	50	36	burden	burden	NOUN
chd-148	50	37	.	.	PUNCT
chd-148	51	1	the	the	DET
chd-148	51	2	highest	high	ADJ
chd-148	51	3	incidence	incidence	NOUN
chd-148	51	4	of	of	ADP
chd-148	51	5	hcc	hcc	PROPN
chd-148	51	6	occurs	occur	VERB
chd-148	51	7	in	in	ADP
chd-148	51	8	mongolia	mongolia	PROPN
chd-148	51	9	;	;	PUNCT
chd-148	51	10	the	the	DET
chd-148	51	11	lowest	low	ADJ
chd-148	51	12	incidence	incidence	NOUN
chd-148	51	13	is	be	AUX
chd-148	51	14	in	in	ADP
chd-148	51	15	nepal	nepal	ADJ
chd-148	51	16	(	(	PUNCT
chd-148	51	17	baatarkhuu	baatarkhuu	PROPN
chd-148	51	18	et	et	PROPN
chd-148	51	19	al	al	PROPN
chd-148	51	20	.	.	PROPN
chd-148	51	21	,	,	PUNCT
chd-148	51	22	2017	2017	NUM
chd-148	51	23	;	;	PUNCT
chd-148	51	24	shrestha	shrestha	NOUN
chd-148	51	25	,	,	PUNCT
chd-148	51	26	2018	2018	NUM
chd-148	51	27	)	)	PUNCT
chd-148	51	28	.	.	PUNCT
chd-148	52	1	however	however	ADV
chd-148	52	2	,	,	PUNCT
chd-148	52	3	hcc	hcc	PROPN
chd-148	52	4	incidence	incidence	NOUN
chd-148	52	5	has	have	AUX
chd-148	52	6	been	be	AUX
chd-148	52	7	increasing	increase	VERB
chd-148	52	8	in	in	ADP
chd-148	52	9	several	several	ADJ
chd-148	52	10	other	other	ADJ
chd-148	52	11	countries	country	NOUN
chd-148	52	12	,	,	PUNCT
chd-148	52	13	but	but	CCONJ
chd-148	52	14	there	there	PRON
chd-148	52	15	have	have	AUX
chd-148	52	16	been	be	AUX
chd-148	52	17	declines	decline	NOUN
chd-148	52	18	in	in	ADP
chd-148	52	19	some	some	DET
chd-148	52	20	asian	asian	ADJ
chd-148	52	21	countries	country	NOUN
chd-148	52	22	(	(	PUNCT
chd-148	52	23	mcglynn	mcglynn	PROPN
chd-148	52	24	and	and	CCONJ
chd-148	52	25	london	london	PROPN
chd-148	52	26	,	,	PUNCT
chd-148	52	27	2011	2011	NUM
chd-148	52	28	;	;	PUNCT
chd-148	52	29	mcglynn	mcglynn	PROPN
chd-148	52	30	et	et	PROPN
chd-148	52	31	al	al	PROPN
chd-148	52	32	.	.	PROPN
chd-148	52	33	,	,	PUNCT
chd-148	52	34	2015	2015	NUM
chd-148	52	35	;	;	PUNCT
chd-148	52	36	mcglynn	mcglynn	PROPN
chd-148	52	37	et	et	PROPN
chd-148	52	38	al	al	PROPN
chd-148	52	39	.	.	PROPN
chd-148	52	40	,	,	PUNCT
chd-148	52	41	2001	2001	NUM
chd-148	52	42	;	;	PUNCT
chd-148	52	43	zhang	zhang	PROPN
chd-148	52	44	et	et	PROPN
chd-148	52	45	al	al	PROPN
chd-148	52	46	.	.	PROPN
chd-148	52	47	,	,	PUNCT
chd-148	52	48	2015	2015	NUM
chd-148	52	49	)	)	PUNCT
chd-148	52	50	.	.	PUNCT
chd-148	53	1	however	however	ADV
chd-148	53	2	,	,	PUNCT
chd-148	53	3	the	the	DET
chd-148	53	4	rates	rate	NOUN
chd-148	53	5	of	of	ADP
chd-148	53	6	hcc	hcc	PROPN
chd-148	53	7	remain	remain	VERB
chd-148	53	8	highest	high	ADJ
chd-148	53	9	in	in	ADP
chd-148	53	10	asian	asian	ADJ
chd-148	53	11	counties	county	NOUN
chd-148	53	12	(	(	PUNCT
chd-148	53	13	petrick	petrick	PROPN
chd-148	53	14	et	et	PROPN
chd-148	53	15	al	al	PROPN
chd-148	53	16	.	.	PROPN
chd-148	53	17	,	,	PUNCT
chd-148	53	18	2016	2016	NUM
chd-148	53	19	)	)	PUNCT
chd-148	53	20	.	.	PUNCT
chd-148	54	1	although	although	SCONJ
chd-148	54	2	there	there	PRON
chd-148	54	3	was	be	VERB
chd-148	54	4	a	a	DET
chd-148	54	5	decrease	decrease	NOUN
chd-148	54	6	in	in	ADP
chd-148	54	7	hcc	hcc	PROPN
chd-148	54	8	burden	burden	NOUN
chd-148	54	9	in	in	ADP
chd-148	54	10	these	these	DET
chd-148	54	11	high	high	ADJ
chd-148	54	12	-	-	PUNCT
chd-148	54	13	risk	risk	NOUN
chd-148	54	14	countries	country	NOUN
chd-148	54	15	,	,	PUNCT
chd-148	54	16	there	there	PRON
chd-148	54	17	was	be	VERB
chd-148	54	18	a	a	DET
chd-148	54	19	rise	rise	NOUN
chd-148	54	20	in	in	ADP
chd-148	54	21	india	india	PROPN
chd-148	54	22	as	as	ADV
chd-148	54	23	well	well	ADV
chd-148	54	24	as	as	ADP
chd-148	54	25	in	in	ADP
chd-148	54	26	low	low	ADJ
chd-148	54	27	-	-	PUNCT
chd-148	54	28	risk	risk	NOUN
chd-148	54	29	countries	country	NOUN
chd-148	54	30	of	of	ADP
chd-148	54	31	africa	africa	PROPN
chd-148	54	32	,	,	PUNCT
chd-148	54	33	europe	europe	PROPN
chd-148	54	34	,	,	PUNCT
chd-148	54	35	the	the	DET
chd-148	54	36	americans	americans	PROPN
chd-148	54	37	,	,	PUNCT
chd-148	54	38	and	and	CCONJ
chd-148	54	39	oceania	oceania	PROPN
chd-148	54	40	;	;	PUNCT
chd-148	54	41	in	in	ADP
chd-148	54	42	thailand	thailand	PROPN
chd-148	54	43	,	,	PUNCT
chd-148	54	44	france	france	PROPN
chd-148	54	45	,	,	PUNCT
chd-148	54	46	and	and	CCONJ
chd-148	54	47	italy	italy	PROPN
chd-148	54	48	,	,	PUNCT
chd-148	54	49	there	there	PRON
chd-148	54	50	was	be	VERB
chd-148	54	51	a	a	DET
chd-148	54	52	decline	decline	NOUN
chd-148	54	53	.	.	PUNCT
chd-148	55	1	the	the	DET
chd-148	55	2	decreased	decrease	VERB
chd-148	55	3	incidence	incidence	NOUN
chd-148	55	4	in	in	ADP
chd-148	55	5	highrisk	highrisk	NOUN
chd-148	55	6	countries	country	NOUN
chd-148	55	7	was	be	AUX
chd-148	55	8	likely	likely	ADJ
chd-148	55	9	due	due	ADP
chd-148	55	10	to	to	ADP
chd-148	55	11	a	a	DET
chd-148	55	12	lower	low	ADJ
chd-148	55	13	prevalence	prevalence	NOUN
chd-148	55	14	of	of	ADP
chd-148	55	15	hbv	hbv	NOUN
chd-148	55	16	infections	infection	NOUN
chd-148	55	17	.	.	PUNCT
chd-148	56	1	particularly	particularly	ADV
chd-148	56	2	in	in	ADP
chd-148	56	3	low	low	ADJ
chd-148	56	4	-	-	PUNCT
chd-148	56	5	risk	risk	NOUN
chd-148	56	6	countries	country	NOUN
chd-148	56	7	,	,	PUNCT
chd-148	56	8	a	a	DET
chd-148	56	9	reduction	reduction	NOUN
chd-148	56	10	in	in	ADP
chd-148	56	11	hcc	hcc	PROPN
chd-148	56	12	burden	burden	NOUN
chd-148	56	13	will	will	AUX
chd-148	56	14	be	be	AUX
chd-148	56	15	seen	see	VERB
chd-148	56	16	when	when	SCONJ
chd-148	56	17	incidences	incidence	NOUN
chd-148	56	18	of	of	ADP
chd-148	56	19	hcv	hcv	NOUN
chd-148	56	20	,	,	PUNCT
chd-148	56	21	diabetes	diabetes	NOUN
chd-148	56	22	,	,	PUNCT
chd-148	56	23	and	and	CCONJ
chd-148	56	24	obesity	obesity	NOUN
chd-148	56	25	are	be	AUX
chd-148	56	26	lowered	lower	VERB
chd-148	56	27	.	.	PUNCT
chd-148	57	1	disparities	disparity	NOUN
chd-148	57	2	of	of	ADP
chd-148	57	3	lca	lca	PROPN
chd-148	57	4	from	from	ADP
chd-148	57	5	the	the	DET
chd-148	57	6	nutritional	nutritional	ADJ
chd-148	57	7	and	and	CCONJ
chd-148	57	8	health	health	NOUN
chd-148	57	9	perspective	perspective	NOUN
chd-148	57	10	“	"	PUNCT
chd-148	57	11	food	food	NOUN
chd-148	57	12	insecurity	insecurity	NOUN
chd-148	57	13	”	"	PUNCT
chd-148	57	14	refers	refer	VERB
chd-148	57	15	to	to	ADP
chd-148	57	16	a	a	DET
chd-148	57	17	lack	lack	NOUN
chd-148	57	18	of	of	ADP
chd-148	57	19	access	access	NOUN
chd-148	57	20	to	to	ADP
chd-148	57	21	sufficient	sufficient	ADJ
chd-148	57	22	,	,	PUNCT
chd-148	57	23	safe	safe	ADJ
chd-148	57	24	,	,	PUNCT
chd-148	57	25	and	and	CCONJ
chd-148	57	26	nutritious	nutritious	ADJ
chd-148	57	27	food	food	NOUN
chd-148	57	28	that	that	PRON
chd-148	57	29	fulfils	fulfil	VERB
chd-148	57	30	the	the	DET
chd-148	57	31	dietary	dietary	ADJ
chd-148	57	32	needs	need	NOUN
chd-148	57	33	and	and	CCONJ
chd-148	57	34	food	food	NOUN
chd-148	57	35	preferences	preference	NOUN
chd-148	57	36	for	for	ADP
chd-148	57	37	living	live	VERB
chd-148	57	38	a	a	DET
chd-148	57	39	healthy	healthy	ADJ
chd-148	57	40	life	life	NOUN
chd-148	57	41	.	.	PUNCT
chd-148	58	1	there	there	PRON
chd-148	58	2	is	be	VERB
chd-148	58	3	evidence	evidence	NOUN
chd-148	58	4	suggesting	suggest	VERB
chd-148	58	5	a	a	DET
chd-148	58	6	relationship	relationship	NOUN
chd-148	58	7	between	between	ADP
chd-148	58	8	specific	specific	ADJ
chd-148	58	9	dietary	dietary	ADJ
chd-148	58	10	components	component	NOUN
chd-148	58	11	and	and	CCONJ
chd-148	58	12	risk	risk	NOUN
chd-148	58	13	of	of	ADP
chd-148	58	14	cancers	cancer	NOUN
chd-148	58	15	at	at	ADP
chd-148	58	16	various	various	ADJ
chd-148	58	17	anatomic	anatomic	ADJ
chd-148	58	18	sites	site	NOUN
chd-148	58	19	(	(	PUNCT
chd-148	58	20	schutte	schutte	NOUN
chd-148	58	21	et	et	PROPN
chd-148	58	22	al	al	PROPN
chd-148	58	23	.	.	PROPN
chd-148	58	24	,	,	PUNCT
chd-148	58	25	2016	2016	NUM
chd-148	58	26	)	)	PUNCT
chd-148	58	27	.	.	PUNCT
chd-148	59	1	the	the	DET
chd-148	59	2	nutritional	nutritional	ADJ
chd-148	59	3	status	status	NOUN
chd-148	59	4	of	of	ADP
chd-148	59	5	patients	patient	NOUN
chd-148	59	6	is	be	AUX
chd-148	59	7	related	relate	VERB
chd-148	59	8	to	to	ADP
chd-148	59	9	their	their	PRON
chd-148	59	10	performance	performance	NOUN
chd-148	59	11	status	status	NOUN
chd-148	59	12	and	and	CCONJ
chd-148	59	13	to	to	ADP
chd-148	59	14	their	their	PRON
chd-148	59	15	tolerance	tolerance	NOUN
chd-148	59	16	for	for	ADP
chd-148	59	17	cancer	cancer	NOUN
chd-148	59	18	therapy	therapy	NOUN
chd-148	59	19	(	(	PUNCT
chd-148	59	20	schutte	schutte	NOUN
chd-148	59	21	et	et	PROPN
chd-148	59	22	al	al	PROPN
chd-148	59	23	.	.	PROPN
chd-148	59	24	,	,	PUNCT
chd-148	59	25	2016	2016	NUM
chd-148	59	26	)	)	PUNCT
chd-148	59	27	.	.	PUNCT
chd-148	60	1	few	few	ADJ
chd-148	60	2	studies	study	NOUN
chd-148	60	3	are	be	AUX
chd-148	60	4	investigating	investigate	VERB
chd-148	60	5	the	the	DET
chd-148	60	6	role	role	NOUN
chd-148	60	7	of	of	ADP
chd-148	60	8	diet	diet	NOUN
chd-148	60	9	in	in	ADP
chd-148	60	10	hepatocarcinogenesis	hepatocarcinogenesis	NOUN
chd-148	60	11	.	.	PUNCT
chd-148	61	1	risk	risk	NOUN
chd-148	61	2	factors	factor	NOUN
chd-148	61	3	for	for	ADP
chd-148	61	4	the	the	DET
chd-148	61	5	occurrence	occurrence	NOUN
chd-148	61	6	of	of	ADP
chd-148	61	7	lca	lca	PROPN
chd-148	61	8	include	include	VERB
chd-148	61	9	chronic	chronic	ADJ
chd-148	61	10	viral	viral	ADJ
chd-148	61	11	infections	infection	NOUN
chd-148	61	12	(	(	PUNCT
chd-148	61	13	hepatitis	hepatitis	NOUN
chd-148	61	14	b	b	PROPN
chd-148	61	15	and	and	CCONJ
chd-148	61	16	c	c	NOUN
chd-148	61	17	)	)	PUNCT
chd-148	61	18	,	,	PUNCT
chd-148	61	19	excess	excess	ADJ
chd-148	61	20	alcohol	alcohol	NOUN
chd-148	61	21	consumption	consumption	NOUN
chd-148	61	22	,	,	PUNCT
chd-148	61	23	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PUNCT
chd-148	61	24	e5	e5	PROPN
chd-148	61	25	cancer	cancer	NOUN
chd-148	61	26	health	health	NOUN
chd-148	61	27	disparities	disparity	NOUN
chd-148	61	28	research	research	VERB
chd-148	61	29	non	non	ADJ
chd-148	61	30	-	-	ADJ
chd-148	61	31	alcoholic	alcoholic	ADJ
chd-148	61	32	fatty	fatty	NOUN
chd-148	61	33	liver	liver	NOUN
chd-148	61	34	disease	disease	NOUN
chd-148	61	35	,	,	PUNCT
chd-148	61	36	dietary	dietary	ADJ
chd-148	61	37	exposure	exposure	NOUN
chd-148	61	38	to	to	ADP
chd-148	61	39	aflatoxin	aflatoxin	NOUN
chd-148	61	40	,	,	PUNCT
chd-148	61	41	obesity	obesity	NOUN
chd-148	61	42	,	,	PUNCT
chd-148	61	43	smoking	smoking	NOUN
chd-148	61	44	,	,	PUNCT
chd-148	61	45	and	and	CCONJ
chd-148	61	46	diabetes	diabetes	NOUN
chd-148	61	47	mellitus	mellitus	NOUN
chd-148	61	48	(	(	PUNCT
chd-148	61	49	el	el	NOUN
chd-148	61	50	-	-	PUNCT
chd-148	61	51	serag	serag	NOUN
chd-148	61	52	and	and	CCONJ
chd-148	61	53	rudolph	rudolph	NOUN
chd-148	61	54	,	,	PUNCT
chd-148	61	55	2007	2007	NUM
chd-148	61	56	)	)	PUNCT
chd-148	61	57	.	.	PUNCT
chd-148	62	1	however	however	ADV
chd-148	62	2	,	,	PUNCT
chd-148	62	3	a	a	DET
chd-148	62	4	substantial	substantial	ADJ
chd-148	62	5	portion	portion	NOUN
chd-148	62	6	of	of	ADP
chd-148	62	7	lca	lca	PROPN
chd-148	62	8	occurs	occur	VERB
chd-148	62	9	in	in	ADP
chd-148	62	10	patients	patient	NOUN
chd-148	62	11	without	without	ADP
chd-148	62	12	exposure	exposure	NOUN
chd-148	62	13	to	to	ADP
chd-148	62	14	these	these	DET
chd-148	62	15	risk	risk	NOUN
chd-148	62	16	factors	factor	NOUN
chd-148	62	17	,	,	PUNCT
chd-148	62	18	suggesting	suggest	VERB
chd-148	62	19	a	a	DET
chd-148	62	20	role	role	NOUN
chd-148	62	21	of	of	ADP
chd-148	62	22	additional	additional	ADJ
chd-148	62	23	factors	factor	NOUN
chd-148	62	24	.	.	PUNCT
chd-148	63	1	observational	observational	ADJ
chd-148	63	2	studies	study	NOUN
chd-148	63	3	indicate	indicate	VERB
chd-148	63	4	a	a	DET
chd-148	63	5	protective	protective	ADJ
chd-148	63	6	role	role	NOUN
chd-148	63	7	of	of	ADP
chd-148	63	8	a	a	DET
chd-148	63	9	diet	diet	NOUN
chd-148	63	10	containing	contain	VERB
chd-148	63	11	vegetables	vegetable	NOUN
chd-148	63	12	,	,	PUNCT
chd-148	63	13	fruits	fruit	NOUN
chd-148	63	14	,	,	PUNCT
chd-148	63	15	and	and	CCONJ
chd-148	63	16	cereals	cereal	NOUN
chd-148	63	17	(	(	PUNCT
chd-148	63	18	koumbi	koumbi	PROPN
chd-148	63	19	,	,	PUNCT
chd-148	63	20	2017	2017	NUM
chd-148	63	21	)	)	PUNCT
chd-148	63	22	in	in	ADP
chd-148	63	23	preventing	prevent	VERB
chd-148	63	24	cancer	cancer	NOUN
chd-148	63	25	.	.	PUNCT
chd-148	64	1	although	although	SCONJ
chd-148	64	2	various	various	ADJ
chd-148	64	3	studies	study	NOUN
chd-148	64	4	have	have	AUX
chd-148	64	5	presented	present	VERB
chd-148	64	6	conflicting	conflicting	ADJ
chd-148	64	7	results	result	NOUN
chd-148	64	8	,	,	PUNCT
chd-148	64	9	high	high	ADJ
chd-148	64	10	intakes	intake	NOUN
chd-148	64	11	of	of	ADP
chd-148	64	12	red	red	ADJ
chd-148	64	13	meat	meat	NOUN
chd-148	64	14	,	,	PUNCT
chd-148	64	15	fish	fish	NOUN
chd-148	64	16	,	,	PUNCT
chd-148	64	17	and	and	CCONJ
chd-148	64	18	dietary	dietary	ADJ
chd-148	64	19	sugars	sugar	NOUN
chd-148	64	20	are	be	AUX
chd-148	64	21	associated	associate	VERB
chd-148	64	22	with	with	ADP
chd-148	64	23	a	a	DET
chd-148	64	24	high	high	ADJ
chd-148	64	25	risk	risk	NOUN
chd-148	64	26	for	for	ADP
chd-148	64	27	western	western	ADJ
chd-148	64	28	europeans	european	NOUN
chd-148	64	29	(	(	PUNCT
chd-148	64	30	fedirko	fedirko	PROPN
chd-148	64	31	et	et	PROPN
chd-148	64	32	al	al	PROPN
chd-148	64	33	.	.	PROPN
chd-148	64	34	,	,	PUNCT
chd-148	64	35	2013	2013	NUM
chd-148	64	36	)	)	PUNCT
chd-148	64	37	.	.	PUNCT
chd-148	65	1	among	among	ADP
chd-148	65	2	japanese	japanese	PROPN
chd-148	65	3	,	,	PUNCT
chd-148	65	4	italians	italians	PROPN
chd-148	65	5	,	,	PUNCT
chd-148	65	6	and	and	CCONJ
chd-148	65	7	europeans	european	NOUN
chd-148	65	8	,	,	PUNCT
chd-148	65	9	high	high	ADJ
chd-148	65	10	intakes	intake	NOUN
chd-148	65	11	of	of	ADP
chd-148	65	12	vegetables	vegetable	NOUN
chd-148	65	13	,	,	PUNCT
chd-148	65	14	fruits	fruit	NOUN
chd-148	65	15	,	,	PUNCT
chd-148	65	16	cereals	cereal	NOUN
chd-148	65	17	,	,	PUNCT
chd-148	65	18	eggs	egg	NOUN
chd-148	65	19	,	,	PUNCT
chd-148	65	20	milk	milk	NOUN
chd-148	65	21	,	,	PUNCT
chd-148	65	22	and	and	CCONJ
chd-148	65	23	yogurt	yogurt	PROPN
chd-148	65	24	are	be	AUX
chd-148	65	25	associated	associate	VERB
chd-148	65	26	with	with	ADP
chd-148	65	27	a	a	DET
chd-148	65	28	lower	low	ADJ
chd-148	65	29	occurrence	occurrence	NOUN
chd-148	65	30	of	of	ADP
chd-148	65	31	lca	lca	PROPN
chd-148	65	32	(	(	PUNCT
chd-148	65	33	kurozawa	kurozawa	PROPN
chd-148	65	34	et	et	PROPN
chd-148	65	35	al	al	PROPN
chd-148	65	36	.	.	PROPN
chd-148	65	37	,	,	PUNCT
chd-148	65	38	2004	2004	NUM
chd-148	65	39	;	;	PUNCT
chd-148	65	40	negri	negri	PROPN
chd-148	65	41	et	et	PROPN
chd-148	65	42	al	al	PROPN
chd-148	65	43	.	.	PROPN
chd-148	65	44	,	,	PUNCT
chd-148	65	45	1991	1991	NUM
chd-148	65	46	;	;	PUNCT
chd-148	65	47	talamini	talamini	PROPN
chd-148	65	48	et	et	PROPN
chd-148	65	49	al	al	PROPN
chd-148	65	50	.	.	PROPN
chd-148	65	51	,	,	PUNCT
chd-148	65	52	2006	2006	NUM
chd-148	65	53	)	)	PUNCT
chd-148	65	54	.	.	PUNCT
chd-148	66	1	these	these	DET
chd-148	66	2	results	result	NOUN
chd-148	66	3	are	be	AUX
chd-148	66	4	supported	support	VERB
chd-148	66	5	by	by	ADP
chd-148	66	6	findings	finding	NOUN
chd-148	66	7	of	of	ADP
chd-148	66	8	a	a	DET
chd-148	66	9	study	study	NOUN
chd-148	66	10	of	of	ADP
chd-148	66	11	chinese	chinese	ADJ
chd-148	66	12	men	man	NOUN
chd-148	66	13	and	and	CCONJ
chd-148	66	14	women	woman	NOUN
chd-148	66	15	,	,	PUNCT
chd-148	66	16	which	which	PRON
chd-148	66	17	showed	show	VERB
chd-148	66	18	that	that	SCONJ
chd-148	66	19	a	a	DET
chd-148	66	20	vegetablebased	vegetablebased	ADJ
chd-148	66	21	diet	diet	NOUN
chd-148	66	22	is	be	AUX
chd-148	66	23	associated	associate	VERB
chd-148	66	24	with	with	ADP
chd-148	66	25	reduced	reduced	ADJ
chd-148	66	26	risk	risk	NOUN
chd-148	66	27	of	of	ADP
chd-148	66	28	lca	lca	PROPN
chd-148	66	29	(	(	PUNCT
chd-148	66	30	zhang	zhang	PROPN
chd-148	66	31	et	et	PROPN
chd-148	66	32	al	al	PROPN
chd-148	66	33	.	.	PROPN
chd-148	66	34	,	,	PUNCT
chd-148	66	35	2013	2013	NUM
chd-148	66	36	)	)	PUNCT
chd-148	66	37	.	.	PUNCT
chd-148	67	1	for	for	ADP
chd-148	67	2	japanese	japanese	ADJ
chd-148	67	3	individuals	individual	NOUN
chd-148	67	4	,	,	PUNCT
chd-148	67	5	overweight	overweight	ADJ
chd-148	67	6	or	or	CCONJ
chd-148	67	7	obesity	obesity	NOUN
chd-148	67	8	moderately	moderately	ADV
chd-148	67	9	increases	increase	VERB
chd-148	67	10	the	the	DET
chd-148	67	11	risk	risk	NOUN
chd-148	67	12	of	of	ADP
chd-148	67	13	lca	lca	PROPN
chd-148	67	14	(	(	PUNCT
chd-148	67	15	tanaka	tanaka	PROPN
chd-148	67	16	et	et	PROPN
chd-148	67	17	al	al	PROPN
chd-148	67	18	.	.	PROPN
chd-148	67	19	,	,	PUNCT
chd-148	67	20	2014	2014	NUM
chd-148	67	21	)	)	PUNCT
chd-148	67	22	.	.	PUNCT
chd-148	68	1	obesity	obesity	NOUN
chd-148	68	2	among	among	ADP
chd-148	68	3	americans	americans	PROPN
chd-148	68	4	has	have	AUX
chd-148	68	5	reached	reach	VERB
chd-148	68	6	an	an	DET
chd-148	68	7	epidemic	epidemic	NOUN
chd-148	68	8	proportion	proportion	NOUN
chd-148	68	9	(	(	PUNCT
chd-148	68	10	vastag	vastag	INTJ
chd-148	68	11	,	,	PUNCT
chd-148	68	12	2004	2004	NUM
chd-148	68	13	)	)	PUNCT
chd-148	68	14	,	,	PUNCT
chd-148	68	15	and	and	CCONJ
chd-148	68	16	64	64	NUM
chd-148	68	17	%	%	NOUN
chd-148	68	18	of	of	ADP
chd-148	68	19	the	the	DET
chd-148	68	20	adult	adult	NOUN
chd-148	68	21	population	population	NOUN
chd-148	68	22	is	be	AUX
chd-148	68	23	overweight	overweight	ADJ
chd-148	68	24	or	or	CCONJ
chd-148	68	25	obese	obese	ADJ
chd-148	68	26	.	.	PUNCT
chd-148	69	1	there	there	PRON
chd-148	69	2	is	be	VERB
chd-148	69	3	a	a	DET
chd-148	69	4	positive	positive	ADJ
chd-148	69	5	association	association	NOUN
chd-148	69	6	between	between	ADP
chd-148	69	7	obesity	obesity	NOUN
chd-148	69	8	and	and	CCONJ
chd-148	69	9	high	high	ADJ
chd-148	69	10	death	death	NOUN
chd-148	69	11	rates	rate	NOUN
chd-148	69	12	for	for	ADP
chd-148	69	13	liver	liver	NOUN
chd-148	69	14	and	and	CCONJ
chd-148	69	15	other	other	ADJ
chd-148	69	16	cancers	cancer	NOUN
chd-148	69	17	(	(	PUNCT
chd-148	69	18	calle	calle	X
chd-148	69	19	et	et	PROPN
chd-148	69	20	al	al	PROPN
chd-148	69	21	.	.	PROPN
chd-148	69	22	,	,	PUNCT
chd-148	69	23	2003	2003	NUM
chd-148	69	24	)	)	PUNCT
chd-148	69	25	.	.	PUNCT
chd-148	70	1	it	it	PRON
chd-148	70	2	was	be	AUX
chd-148	70	3	estimated	estimate	VERB
chd-148	70	4	that	that	SCONJ
chd-148	70	5	more	more	ADJ
chd-148	70	6	than	than	ADP
chd-148	70	7	90,000	90,000	NUM
chd-148	70	8	cancer	cancer	NOUN
chd-148	70	9	deaths	death	NOUN
chd-148	70	10	per	per	ADP
chd-148	70	11	year	year	NOUN
chd-148	70	12	could	could	AUX
chd-148	70	13	be	be	AUX
chd-148	70	14	avoided	avoid	VERB
chd-148	70	15	with	with	ADP
chd-148	70	16	the	the	DET
chd-148	70	17	maintenance	maintenance	NOUN
chd-148	70	18	of	of	ADP
chd-148	70	19	normal	normal	ADJ
chd-148	70	20	weight	weight	NOUN
chd-148	70	21	,	,	PUNCT
chd-148	70	22	and	and	CCONJ
chd-148	70	23	obesity	obesity	NOUN
chd-148	70	24	was	be	AUX
chd-148	70	25	a	a	DET
chd-148	70	26	major	major	ADJ
chd-148	70	27	risk	risk	NOUN
chd-148	70	28	factor	factor	NOUN
chd-148	70	29	for	for	ADP
chd-148	70	30	cancer	cancer	NOUN
chd-148	70	31	(	(	PUNCT
chd-148	70	32	donaldson	donaldson	PROPN
chd-148	70	33	,	,	PUNCT
chd-148	70	34	2004	2004	NUM
chd-148	70	35	)	)	PUNCT
chd-148	70	36	.	.	PUNCT
chd-148	71	1	among	among	ADP
chd-148	71	2	americans	americans	PROPN
chd-148	71	3	,	,	PUNCT
chd-148	71	4	obesity	obesity	NOUN
chd-148	71	5	,	,	PUNCT
chd-148	71	6	nutrient	nutrient	NOUN
chd-148	71	7	-	-	PUNCT
chd-148	71	8	sparse	sparse	ADJ
chd-148	71	9	foods	food	NOUN
chd-148	71	10	such	such	ADJ
chd-148	71	11	as	as	ADP
chd-148	71	12	concentrated	concentrated	ADJ
chd-148	71	13	sugars	sugar	NOUN
chd-148	71	14	and	and	CCONJ
chd-148	71	15	refined	refined	ADJ
chd-148	71	16	flour	flour	NOUN
chd-148	71	17	products	product	NOUN
chd-148	71	18	that	that	PRON
chd-148	71	19	contribute	contribute	VERB
chd-148	71	20	to	to	ADP
chd-148	71	21	reduced	reduce	VERB
chd-148	71	22	glucose	glucose	NOUN
chd-148	71	23	metabolism	metabolism	NOUN
chd-148	71	24	,	,	PUNCT
chd-148	71	25	low	low	ADJ
chd-148	71	26	fiber	fiber	NOUN
chd-148	71	27	intake	intake	NOUN
chd-148	71	28	,	,	PUNCT
chd-148	71	29	consumption	consumption	NOUN
chd-148	71	30	of	of	ADP
chd-148	71	31	red	red	ADJ
chd-148	71	32	meat	meat	NOUN
chd-148	71	33	,	,	PUNCT
chd-148	71	34	and	and	CCONJ
chd-148	71	35	an	an	DET
chd-148	71	36	imbalance	imbalance	NOUN
chd-148	71	37	of	of	ADP
chd-148	71	38	omega	omega	NOUN
chd-148	71	39	3	3	NUM
chd-148	71	40	and	and	CCONJ
chd-148	71	41	omega	omega	NOUN
chd-148	71	42	6	6	NUM
chd-148	71	43	fats	fat	NOUN
chd-148	71	44	contribute	contribute	VERB
chd-148	71	45	to	to	ADP
chd-148	71	46	excess	excess	ADJ
chd-148	71	47	risk	risk	NOUN
chd-148	71	48	of	of	ADP
chd-148	71	49	lca	lca	PROPN
chd-148	71	50	(	(	PUNCT
chd-148	71	51	donaldson	donaldson	PROPN
chd-148	71	52	,	,	PUNCT
chd-148	71	53	2004	2004	NUM
chd-148	71	54	)	)	PUNCT
chd-148	71	55	.	.	PUNCT
chd-148	72	1	a	a	DET
chd-148	72	2	study	study	NOUN
chd-148	72	3	focused	focus	VERB
chd-148	72	4	on	on	ADP
chd-148	72	5	the	the	DET
chd-148	72	6	type	type	NOUN
chd-148	72	7	of	of	ADP
chd-148	72	8	therapy	therapy	NOUN
chd-148	72	9	and	and	CCONJ
chd-148	72	10	patients	patient	NOUN
chd-148	72	11	with	with	ADP
chd-148	72	12	diagnosed	diagnose	VERB
chd-148	72	13	stages	stage	NOUN
chd-148	72	14	shows	show	VERB
chd-148	72	15	that	that	SCONJ
chd-148	72	16	for	for	SCONJ
chd-148	72	17	lca	lca	PROPN
chd-148	72	18	stage	stage	VERB
chd-148	72	19	a	a	DET
chd-148	72	20	patients	patient	NOUN
chd-148	72	21	,	,	PUNCT
chd-148	72	22	liver	liver	NOUN
chd-148	72	23	transplants	transplant	NOUN
chd-148	72	24	,	,	PUNCT
chd-148	72	25	radiofrequency	radiofrequency	NOUN
chd-148	72	26	ablation	ablation	NOUN
chd-148	72	27	(	(	PUNCT
chd-148	72	28	rfa	rfa	NOUN
chd-148	72	29	)	)	PUNCT
chd-148	72	30	,	,	PUNCT
chd-148	72	31	and	and	CCONJ
chd-148	72	32	embolization	embolization	NOUN
chd-148	72	33	were	be	AUX
chd-148	72	34	utilized	utilize	VERB
chd-148	72	35	less	less	ADV
chd-148	72	36	often	often	ADV
chd-148	72	37	for	for	ADP
chd-148	72	38	hispanics	hispanic	NOUN
chd-148	72	39	,	,	PUNCT
chd-148	72	40	nh	nh	PROPN
chd-148	72	41	blacks	black	NOUN
chd-148	72	42	,	,	PUNCT
chd-148	72	43	patients	patient	NOUN
chd-148	72	44	with	with	ADP
chd-148	72	45	medicaid	medicaid	PROPN
chd-148	72	46	,	,	PUNCT
chd-148	72	47	and	and	CCONJ
chd-148	72	48	patients	patient	NOUN
chd-148	72	49	in	in	ADP
chd-148	72	50	the	the	DET
chd-148	72	51	highest	high	ADJ
chd-148	72	52	income	income	NOUN
chd-148	72	53	quartile	quartile	NOUN
chd-148	72	54	.	.	PUNCT
chd-148	73	1	stage	stage	NOUN
chd-148	73	2	d	d	PROPN
chd-148	73	3	patients	patient	NOUN
chd-148	73	4	were	be	AUX
chd-148	73	5	less	less	ADV
chd-148	73	6	likely	likely	ADJ
chd-148	73	7	to	to	PART
chd-148	73	8	receive	receive	VERB
chd-148	73	9	cancer	cancer	NOUN
chd-148	73	10	therapy	therapy	NOUN
chd-148	73	11	if	if	SCONJ
chd-148	73	12	they	they	PRON
chd-148	73	13	had	have	VERB
chd-148	73	14	medicaid	medicaid	PROPN
chd-148	73	15	insurance	insurance	NOUN
chd-148	73	16	(	(	PUNCT
chd-148	73	17	harlan	harlan	PROPN
chd-148	73	18	et	et	PROPN
chd-148	73	19	al	al	PROPN
chd-148	73	20	.	.	PROPN
chd-148	73	21	,	,	PUNCT
chd-148	73	22	2015	2015	NUM
chd-148	73	23	)	)	PUNCT
chd-148	73	24	.	.	PUNCT
chd-148	74	1	additionally	additionally	ADV
chd-148	74	2	,	,	PUNCT
chd-148	74	3	26.8	26.8	NUM
chd-148	74	4	%	%	NOUN
chd-148	74	5	of	of	ADP
chd-148	74	6	patients	patient	NOUN
chd-148	74	7	diagnosed	diagnose	VERB
chd-148	74	8	with	with	ADP
chd-148	74	9	stage	stage	NOUN
chd-148	74	10	b	b	PROPN
chd-148	74	11	received	receive	VERB
chd-148	74	12	surgery	surgery	NOUN
chd-148	74	13	,	,	PUNCT
chd-148	74	14	followed	follow	VERB
chd-148	74	15	by	by	ADP
chd-148	74	16	12.4	12.4	NUM
chd-148	74	17	%	%	NOUN
chd-148	74	18	of	of	ADP
chd-148	74	19	those	those	PRON
chd-148	74	20	with	with	ADP
chd-148	74	21	stage	stage	NOUN
chd-148	74	22	0	0	NUM
chd-148	74	23	.	.	PUNCT
chd-148	75	1	for	for	ADP
chd-148	75	2	younger	young	ADJ
chd-148	75	3	patients	patient	NOUN
chd-148	75	4	,	,	PUNCT
chd-148	75	5	those	those	PRON
chd-148	75	6	diagnosed	diagnose	VERB
chd-148	75	7	and	and	CCONJ
chd-148	75	8	treated	treat	VERB
chd-148	75	9	at	at	ADP
chd-148	75	10	earlier	early	ADJ
chd-148	75	11	stages	stage	NOUN
chd-148	75	12	were	be	AUX
chd-148	75	13	more	more	ADV
chd-148	75	14	likely	likely	ADJ
chd-148	75	15	to	to	PART
chd-148	75	16	receive	receive	VERB
chd-148	75	17	surgery	surgery	NOUN
chd-148	75	18	than	than	ADP
chd-148	75	19	nh	nh	PROPN
chd-148	75	20	black	black	ADJ
chd-148	75	21	medicaid	medicaid	PROPN
chd-148	75	22	patients	patient	NOUN
chd-148	75	23	.	.	PUNCT
chd-148	76	1	furthermore	furthermore	ADV
chd-148	76	2	,	,	PUNCT
chd-148	76	3	transplants	transplant	NOUN
chd-148	76	4	were	be	AUX
chd-148	76	5	more	more	ADV
chd-148	76	6	frequent	frequent	ADJ
chd-148	76	7	for	for	ADP
chd-148	76	8	stage	stage	NOUN
chd-148	76	9	0	0	NUM
chd-148	76	10	(	(	PUNCT
chd-148	76	11	36.5	36.5	NUM
chd-148	76	12	%	%	NOUN
chd-148	76	13	)	)	PUNCT
chd-148	76	14	and	and	CCONJ
chd-148	76	15	stage	stage	VERB
chd-148	76	16	a	a	DET
chd-148	76	17	disease	disease	NOUN
chd-148	76	18	(	(	PUNCT
chd-148	76	19	48.1	48.1	NUM
chd-148	76	20	%	%	NOUN
chd-148	76	21	)	)	PUNCT
chd-148	76	22	than	than	ADP
chd-148	76	23	for	for	ADP
chd-148	76	24	patients	patient	NOUN
chd-148	76	25	aged	age	VERB
chd-148	76	26	50	50	NUM
chd-148	76	27	or	or	CCONJ
chd-148	76	28	older	old	ADJ
chd-148	76	29	,	,	PUNCT
chd-148	76	30	nh	nh	PROPN
chd-148	76	31	blacks	black	NOUN
chd-148	76	32	,	,	PUNCT
chd-148	76	33	hispanic	hispanic	ADJ
chd-148	76	34	patients	patient	NOUN
chd-148	76	35	,	,	PUNCT
chd-148	76	36	and	and	CCONJ
chd-148	76	37	stage	stage	NOUN
chd-148	76	38	b	b	X
chd-148	76	39	-	-	PUNCT
chd-148	76	40	d	d	PROPN
chd-148	76	41	medicaid	medicaid	PROPN
chd-148	76	42	patients	patient	NOUN
chd-148	76	43	(	(	PUNCT
chd-148	76	44	harlan	harlan	PROPN
chd-148	76	45	et	et	PROPN
chd-148	76	46	al	al	PROPN
chd-148	76	47	.	.	PROPN
chd-148	76	48	,	,	PUNCT
chd-148	76	49	2015	2015	NUM
chd-148	76	50	)	)	PUNCT
chd-148	76	51	.	.	PUNCT
chd-148	77	1	in	in	ADP
chd-148	77	2	addition	addition	NOUN
chd-148	77	3	to	to	ADP
chd-148	77	4	surgery	surgery	NOUN
chd-148	77	5	and	and	CCONJ
chd-148	77	6	transplantation	transplantation	NOUN
chd-148	77	7	,	,	PUNCT
chd-148	77	8	rfa	rfa	NOUN
chd-148	77	9	was	be	AUX
chd-148	77	10	more	more	ADV
chd-148	77	11	often	often	ADV
chd-148	77	12	used	use	VERB
chd-148	77	13	for	for	ADP
chd-148	77	14	stage	stage	NOUN
chd-148	77	15	0	0	NUM
chd-148	77	16	(	(	PUNCT
chd-148	77	17	3.7	3.7	NUM
chd-148	77	18	%	%	NOUN
chd-148	77	19	)	)	PUNCT
chd-148	77	20	and	and	CCONJ
chd-148	77	21	stage	stage	VERB
chd-148	77	22	a	a	DET
chd-148	77	23	(	(	PUNCT
chd-148	77	24	3.9	3.9	NUM
chd-148	77	25	%	%	NOUN
chd-148	77	26	)	)	PUNCT
chd-148	77	27	;	;	PUNCT
chd-148	77	28	for	for	ADP
chd-148	77	29	stage	stage	NOUN
chd-148	77	30	b	b	PROPN
chd-148	77	31	disease	disease	NOUN
chd-148	77	32	,	,	PUNCT
chd-148	77	33	tumor	tumor	NOUN
chd-148	77	34	embolization	embolization	NOUN
chd-148	77	35	was	be	AUX
chd-148	77	36	most	most	ADV
chd-148	77	37	often	often	ADV
chd-148	77	38	performed	perform	VERB
chd-148	77	39	in	in	ADP
chd-148	77	40	combination	combination	NOUN
chd-148	77	41	with	with	ADP
chd-148	77	42	systemic	systemic	ADJ
chd-148	77	43	chemotherapy	chemotherapy	NOUN
chd-148	77	44	(	(	PUNCT
chd-148	77	45	15.3	15.3	NUM
chd-148	77	46	%	%	NOUN
chd-148	77	47	)	)	PUNCT
chd-148	77	48	(	(	PUNCT
chd-148	77	49	harlan	harlan	PROPN
chd-148	77	50	et	et	PROPN
chd-148	77	51	al	al	PROPN
chd-148	77	52	.	.	PROPN
chd-148	77	53	,	,	PUNCT
chd-148	77	54	2015	2015	NUM
chd-148	77	55	)	)	PUNCT
chd-148	77	56	.	.	PUNCT
chd-148	78	1	molecular	molecular	ADJ
chd-148	78	2	perspectives	perspective	NOUN
chd-148	78	3	related	relate	VERB
chd-148	78	4	to	to	ADP
chd-148	78	5	disparities	disparity	NOUN
chd-148	78	6	in	in	ADP
chd-148	78	7	lca	lca	PROPN
chd-148	78	8	morphologically	morphologically	ADV
chd-148	78	9	,	,	PUNCT
chd-148	78	10	liver	liver	NOUN
chd-148	78	11	tumors	tumor	NOUN
chd-148	78	12	are	be	AUX
chd-148	78	13	heterogeneous	heterogeneous	ADJ
chd-148	78	14	within	within	ADP
chd-148	78	15	the	the	DET
chd-148	78	16	same	same	ADJ
chd-148	78	17	tumor	tumor	NOUN
chd-148	78	18	and	and	CCONJ
chd-148	78	19	for	for	ADP
chd-148	78	20	different	different	ADJ
chd-148	78	21	tumors	tumor	NOUN
chd-148	78	22	.	.	PUNCT
chd-148	79	1	some	some	DET
chd-148	79	2	subtypes	subtype	NOUN
chd-148	79	3	of	of	ADP
chd-148	79	4	lca	lca	PROPN
chd-148	79	5	have	have	AUX
chd-148	79	6	stem	stem	NOUN
chd-148	79	7	cell	cell	NOUN
chd-148	79	8	features	feature	NOUN
chd-148	79	9	;	;	PUNCT
chd-148	79	10	others	other	NOUN
chd-148	79	11	have	have	VERB
chd-148	79	12	a	a	DET
chd-148	79	13	phenotype	phenotype	NOUN
chd-148	79	14	intermediate	intermediate	ADJ
chd-148	79	15	between	between	ADP
chd-148	79	16	hepatocytes	hepatocyte	NOUN
chd-148	79	17	and	and	CCONJ
chd-148	79	18	cholangiocytes	cholangiocyte	NOUN
chd-148	79	19	(	(	PUNCT
chd-148	79	20	sia	sia	PROPN
chd-148	79	21	et	et	PROPN
chd-148	79	22	al	al	PROPN
chd-148	79	23	.	.	PROPN
chd-148	79	24	,	,	PUNCT
chd-148	79	25	2017	2017	NUM
chd-148	79	26	)	)	PUNCT
chd-148	79	27	.	.	PUNCT
chd-148	80	1	these	these	DET
chd-148	80	2	observations	observation	NOUN
chd-148	80	3	have	have	AUX
chd-148	80	4	raised	raise	VERB
chd-148	80	5	the	the	DET
chd-148	80	6	possibility	possibility	NOUN
chd-148	80	7	of	of	ADP
chd-148	80	8	disparities	disparity	NOUN
chd-148	80	9	in	in	ADP
chd-148	80	10	the	the	DET
chd-148	80	11	origin	origin	NOUN
chd-148	80	12	of	of	ADP
chd-148	80	13	lca	lca	PROPN
chd-148	80	14	.	.	PUNCT
chd-148	81	1	hepatic	hepatic	ADJ
chd-148	81	2	precursor	precursor	NOUN
chd-148	81	3	cells	cell	NOUN
chd-148	81	4	might	might	AUX
chd-148	81	5	generate	generate	VERB
chd-148	81	6	primary	primary	ADJ
chd-148	81	7	liver	liver	NOUN
chd-148	81	8	tumors	tumor	NOUN
chd-148	81	9	as	as	ADP
chd-148	81	10	,	,	PUNCT
chd-148	81	11	during	during	ADP
chd-148	81	12	development	development	NOUN
chd-148	81	13	,	,	PUNCT
chd-148	81	14	hepatocytes	hepatocyte	NOUN
chd-148	81	15	and	and	CCONJ
chd-148	81	16	cholangiocytes	cholangiocyte	NOUN
chd-148	81	17	can	can	AUX
chd-148	81	18	arise	arise	VERB
chd-148	81	19	from	from	ADP
chd-148	81	20	a	a	DET
chd-148	81	21	common	common	ADJ
chd-148	81	22	precursor	precursor	NOUN
chd-148	81	23	cell	cell	NOUN
chd-148	81	24	.	.	PUNCT
chd-148	82	1	however	however	ADV
chd-148	82	2	,	,	PUNCT
chd-148	82	3	tumors	tumor	NOUN
chd-148	82	4	developing	develop	VERB
chd-148	82	5	from	from	ADP
chd-148	82	6	mature	mature	ADJ
chd-148	82	7	hepatocytes	hepatocyte	NOUN
chd-148	82	8	and	and	CCONJ
chd-148	82	9	cholangiocytes	cholangiocyte	NOUN
chd-148	82	10	could	could	AUX
chd-148	82	11	be	be	AUX
chd-148	82	12	different	different	ADJ
chd-148	82	13	.	.	PUNCT
chd-148	83	1	moreover	moreover	ADV
chd-148	83	2	,	,	PUNCT
chd-148	83	3	hepatocytes	hepatocyte	NOUN
chd-148	83	4	could	could	AUX
chd-148	83	5	be	be	AUX
chd-148	83	6	a	a	DET
chd-148	83	7	source	source	NOUN
chd-148	83	8	of	of	ADP
chd-148	83	9	lca	lca	PROPN
chd-148	83	10	as	as	SCONJ
chd-148	83	11	these	these	DET
chd-148	83	12	cells	cell	NOUN
chd-148	83	13	can	can	AUX
chd-148	83	14	undergo	undergo	VERB
chd-148	83	15	mutations	mutation	NOUN
chd-148	83	16	in	in	ADP
chd-148	83	17	their	their	PRON
chd-148	83	18	genes	gene	NOUN
chd-148	83	19	,	,	PUNCT
chd-148	83	20	dedifferentiate	dedifferentiate	VERB
chd-148	83	21	into	into	ADP
chd-148	83	22	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PUNCT
chd-148	83	23	e6	e6	NOUN
chd-148	83	24	cancer	cancer	NOUN
chd-148	83	25	health	health	NOUN
chd-148	83	26	disparities	disparity	NOUN
chd-148	83	27	research	research	NOUN
chd-148	83	28	precursor	precursor	NOUN
chd-148	83	29	cells	cell	NOUN
chd-148	83	30	,	,	PUNCT
chd-148	83	31	and	and	CCONJ
chd-148	83	32	ultimately	ultimately	ADV
chd-148	83	33	transform	transform	VERB
chd-148	83	34	into	into	ADP
chd-148	83	35	lca	lca	PROPN
chd-148	83	36	cells	cell	NOUN
chd-148	83	37	with	with	ADP
chd-148	83	38	precursor	precursor	NOUN
chd-148	83	39	cell	cell	NOUN
chd-148	83	40	markers	marker	NOUN
chd-148	83	41	(	(	PUNCT
chd-148	83	42	chen	chen	PROPN
chd-148	83	43	et	et	PROPN
chd-148	83	44	al	al	PROPN
chd-148	83	45	.	.	PROPN
chd-148	83	46	,	,	PUNCT
chd-148	83	47	2012	2012	NUM
chd-148	83	48	;	;	PUNCT
chd-148	83	49	sia	sia	PROPN
chd-148	83	50	et	et	PROPN
chd-148	83	51	al	al	PROPN
chd-148	83	52	.	.	PROPN
chd-148	83	53	,	,	PUNCT
chd-148	83	54	2017	2017	NUM
chd-148	83	55	;	;	PUNCT
chd-148	83	56	tanimizu	tanimizu	PROPN
chd-148	83	57	et	et	PROPN
chd-148	83	58	al	al	PROPN
chd-148	83	59	.	.	PROPN
chd-148	83	60	,	,	PUNCT
chd-148	83	61	2013	2013	NUM
chd-148	83	62	)	)	PUNCT
chd-148	83	63	.	.	PUNCT
chd-148	84	1	the	the	DET
chd-148	84	2	liver	liver	NOUN
chd-148	84	3	is	be	AUX
chd-148	84	4	a	a	DET
chd-148	84	5	sexually	sexually	ADV
chd-148	84	6	dimorphic	dimorphic	ADJ
chd-148	84	7	organ	organ	NOUN
chd-148	84	8	.	.	PUNCT
chd-148	85	1	for	for	ADP
chd-148	85	2	males	male	NOUN
chd-148	85	3	and	and	CCONJ
chd-148	85	4	females	female	NOUN
chd-148	85	5	,	,	PUNCT
chd-148	85	6	there	there	PRON
chd-148	85	7	are	be	VERB
chd-148	85	8	differences	difference	NOUN
chd-148	85	9	in	in	ADP
chd-148	85	10	gene	gene	NOUN
chd-148	85	11	expression	expression	NOUN
chd-148	85	12	,	,	PUNCT
chd-148	85	13	mitochondrial	mitochondrial	ADJ
chd-148	85	14	function	function	NOUN
chd-148	85	15	and	and	CCONJ
chd-148	85	16	enzyme	enzyme	NOUN
chd-148	85	17	activity	activity	NOUN
chd-148	85	18	,	,	PUNCT
chd-148	85	19	lipids	lipids	ADP
chd-148	85	20	composition	composition	NOUN
chd-148	85	21	of	of	ADP
chd-148	85	22	cell	cell	NOUN
chd-148	85	23	membranes	membrane	NOUN
chd-148	85	24	,	,	PUNCT
chd-148	85	25	and	and	CCONJ
chd-148	85	26	immune	immune	ADJ
chd-148	85	27	responses	response	NOUN
chd-148	85	28	(	(	PUNCT
chd-148	85	29	dhir	dhir	PROPN
chd-148	85	30	et	et	PROPN
chd-148	85	31	al	al	PROPN
chd-148	85	32	.	.	PROPN
chd-148	85	33	,	,	PUNCT
chd-148	85	34	2006	2006	NUM
chd-148	85	35	)	)	PUNCT
chd-148	85	36	.	.	PUNCT
chd-148	86	1	the	the	DET
chd-148	86	2	differentiation	differentiation	NOUN
chd-148	86	3	of	of	ADP
chd-148	86	4	liver	liver	NOUN
chd-148	86	5	gender	gender	NOUN
chd-148	86	6	is	be	AUX
chd-148	86	7	maximum	maximum	ADJ
chd-148	86	8	at	at	ADP
chd-148	86	9	puberty	puberty	NOUN
chd-148	86	10	,	,	PUNCT
chd-148	86	11	with	with	ADP
chd-148	86	12	the	the	DET
chd-148	86	13	elevation	elevation	NOUN
chd-148	86	14	of	of	ADP
chd-148	86	15	testosterone	testosterone	NOUN
chd-148	86	16	in	in	ADP
chd-148	86	17	males	male	NOUN
chd-148	86	18	associated	associate	VERB
chd-148	86	19	with	with	ADP
chd-148	86	20	the	the	DET
chd-148	86	21	tyrosine	tyrosine	NOUN
chd-148	86	22	phosphorylation	phosphorylation	NOUN
chd-148	86	23	cascade	cascade	NOUN
chd-148	86	24	of	of	ADP
chd-148	86	25	jak2	jak2	PROPN
chd-148	86	26	/	/	SYM
chd-148	86	27	stat5	stat5	PROPN
chd-148	86	28	,	,	PUNCT
chd-148	86	29	which	which	PRON
chd-148	86	30	is	be	AUX
chd-148	86	31	involved	involve	VERB
chd-148	86	32	in	in	ADP
chd-148	86	33	the	the	DET
chd-148	86	34	transcription	transcription	NOUN
chd-148	86	35	of	of	ADP
chd-148	86	36	masculine	masculine	ADJ
chd-148	86	37	genes	gene	NOUN
chd-148	86	38	that	that	PRON
chd-148	86	39	repress	repress	VERB
chd-148	86	40	feminine	feminine	ADJ
chd-148	86	41	genes	gene	NOUN
chd-148	86	42	.	.	PUNCT
chd-148	87	1	however	however	ADV
chd-148	87	2	,	,	PUNCT
chd-148	87	3	for	for	ADP
chd-148	87	4	females	female	NOUN
chd-148	87	5	,	,	PUNCT
chd-148	87	6	secretion	secretion	NOUN
chd-148	87	7	of	of	ADP
chd-148	87	8	growth	growth	NOUN
chd-148	87	9	hormone	hormone	NOUN
chd-148	87	10	continues	continue	VERB
chd-148	87	11	,	,	PUNCT
chd-148	87	12	but	but	CCONJ
chd-148	87	13	at	at	ADP
chd-148	87	14	a	a	DET
chd-148	87	15	lower	low	ADJ
chd-148	87	16	rate	rate	NOUN
chd-148	87	17	,	,	PUNCT
chd-148	87	18	with	with	ADP
chd-148	87	19	unphosphorylated	unphosphorylated	ADJ
chd-148	87	20	stat5	stat5	NOUN
chd-148	87	21	associated	associate	VERB
chd-148	87	22	with	with	ADP
chd-148	87	23	gene	gene	NOUN
chd-148	87	24	transcription	transcription	NOUN
chd-148	87	25	.	.	PUNCT
chd-148	88	1	such	such	ADJ
chd-148	88	2	differences	difference	NOUN
chd-148	88	3	could	could	AUX
chd-148	88	4	account	account	VERB
chd-148	88	5	for	for	ADP
chd-148	88	6	the	the	DET
chd-148	88	7	disparity	disparity	NOUN
chd-148	88	8	in	in	ADP
chd-148	88	9	the	the	DET
chd-148	88	10	development	development	NOUN
chd-148	88	11	of	of	ADP
chd-148	88	12	lca	lca	PROPN
chd-148	88	13	between	between	ADP
chd-148	88	14	the	the	DET
chd-148	88	15	two	two	NUM
chd-148	88	16	sexes	sex	NOUN
chd-148	88	17	(	(	PUNCT
chd-148	88	18	dhir	dhir	PROPN
chd-148	88	19	et	et	PROPN
chd-148	88	20	al	al	PROPN
chd-148	88	21	.	.	PROPN
chd-148	88	22	,	,	PUNCT
chd-148	88	23	2006	2006	NUM
chd-148	88	24	;	;	PUNCT
chd-148	88	25	waxman	waxman	NOUN
chd-148	88	26	and	and	CCONJ
chd-148	88	27	holloway	holloway	PROPN
chd-148	88	28	,	,	PUNCT
chd-148	88	29	2009	2009	NUM
chd-148	88	30	)	)	PUNCT
chd-148	88	31	.	.	PUNCT
chd-148	89	1	molecular	molecular	ADJ
chd-148	89	2	factors	factor	NOUN
chd-148	89	3	involved	involve	VERB
chd-148	89	4	in	in	ADP
chd-148	89	5	the	the	DET
chd-148	89	6	disparities	disparity	NOUN
chd-148	89	7	of	of	ADP
chd-148	89	8	incidence	incidence	NOUN
chd-148	89	9	and	and	CCONJ
chd-148	89	10	mortality	mortality	NOUN
chd-148	89	11	of	of	ADP
chd-148	89	12	lca	lca	PROPN
chd-148	89	13	are	be	AUX
chd-148	89	14	shown	show	VERB
chd-148	89	15	in	in	ADP
chd-148	89	16	table	table	NOUN
chd-148	89	17	2	2	NUM
chd-148	89	18	.	.	PUNCT
chd-148	90	1	a	a	DET
chd-148	90	2	separate	separate	ADJ
chd-148	90	3	study	study	NOUN
chd-148	90	4	of	of	ADP
chd-148	90	5	hcc	hcc	PROPN
chd-148	90	6	showed	show	VERB
chd-148	90	7	that	that	SCONJ
chd-148	90	8	inhabitants	inhabitant	NOUN
chd-148	90	9	of	of	ADP
chd-148	90	10	asian	asian	ADJ
chd-148	90	11	and	and	CCONJ
chd-148	90	12	african	african	ADJ
chd-148	90	13	countries	country	NOUN
chd-148	90	14	were	be	AUX
chd-148	90	15	more	more	ADV
chd-148	90	16	likely	likely	ADJ
chd-148	90	17	to	to	PART
chd-148	90	18	have	have	VERB
chd-148	90	19	chronic	chronic	ADJ
chd-148	90	20	hbv	hbv	NOUN
chd-148	90	21	infections	infection	NOUN
chd-148	90	22	,	,	PUNCT
chd-148	90	23	whereas	whereas	SCONJ
chd-148	90	24	those	those	PRON
chd-148	90	25	in	in	ADP
chd-148	90	26	japan	japan	PROPN
chd-148	90	27	and	and	CCONJ
chd-148	90	28	the	the	DET
chd-148	90	29	united	united	PROPN
chd-148	90	30	states	states	PROPN
chd-148	90	31	were	be	AUX
chd-148	90	32	more	more	ADV
chd-148	90	33	likely	likely	ADJ
chd-148	90	34	to	to	PART
chd-148	90	35	have	have	VERB
chd-148	90	36	hcv	hcv	NOUN
chd-148	90	37	infections	infection	NOUN
chd-148	90	38	(	(	PUNCT
chd-148	90	39	el	el	NOUN
chd-148	90	40	-	-	PUNCT
chd-148	90	41	serag	serag	NOUN
chd-148	90	42	and	and	CCONJ
chd-148	90	43	rudolph	rudolph	NOUN
chd-148	90	44	,	,	PUNCT
chd-148	90	45	2007	2007	NUM
chd-148	90	46	)	)	PUNCT
chd-148	90	47	.	.	PUNCT
chd-148	91	1	in	in	ADP
chd-148	91	2	addition	addition	NOUN
chd-148	91	3	,	,	PUNCT
chd-148	91	4	about	about	ADP
chd-148	91	5	half	half	NOUN
chd-148	91	6	of	of	ADP
chd-148	91	7	the	the	DET
chd-148	91	8	cancers	cancer	NOUN
chd-148	91	9	are	be	AUX
chd-148	91	10	activated	activate	VERB
chd-148	91	11	due	due	ADP
chd-148	91	12	to	to	ADP
chd-148	91	13	tp53	tp53	PROPN
chd-148	91	14	mutations	mutation	NOUN
chd-148	91	15	;	;	PUNCT
chd-148	91	16	in	in	ADP
chd-148	91	17	a	a	DET
chd-148	91	18	clinical	clinical	ADJ
chd-148	91	19	study	study	NOUN
chd-148	91	20	of	of	ADP
chd-148	91	21	chinese	chinese	ADJ
chd-148	91	22	patients	patient	NOUN
chd-148	91	23	,	,	PUNCT
chd-148	91	24	nearly	nearly	ADV
chd-148	91	25	half	half	NOUN
chd-148	91	26	had	have	VERB
chd-148	91	27	a	a	DET
chd-148	91	28	point	point	NOUN
chd-148	91	29	mutation	mutation	NOUN
chd-148	91	30	at	at	ADP
chd-148	91	31	codon	codon	PROPN
chd-148	91	32	249	249	NUM
chd-148	91	33	(	(	PUNCT
chd-148	91	34	aravalli	aravalli	PROPN
chd-148	91	35	et	et	PROPN
chd-148	91	36	al	al	PROPN
chd-148	91	37	.	.	PROPN
chd-148	91	38	,	,	PUNCT
chd-148	91	39	2008	2008	NUM
chd-148	91	40	)	)	PUNCT
chd-148	91	41	.	.	PUNCT
chd-148	92	1	thus	thus	ADV
chd-148	92	2	,	,	PUNCT
chd-148	92	3	understanding	understand	VERB
chd-148	92	4	the	the	DET
chd-148	92	5	molecular	molecular	ADJ
chd-148	92	6	mechanism	mechanism	NOUN
chd-148	92	7	of	of	ADP
chd-148	92	8	hcc	hcc	PROPN
chd-148	92	9	is	be	AUX
chd-148	92	10	a	a	DET
chd-148	92	11	promising	promising	ADJ
chd-148	92	12	strategy	strategy	NOUN
chd-148	92	13	for	for	ADP
chd-148	92	14	dealing	deal	VERB
chd-148	92	15	with	with	ADP
chd-148	92	16	cancer	cancer	NOUN
chd-148	92	17	disparities	disparity	NOUN
chd-148	92	18	.	.	PUNCT
chd-148	93	1	table	table	NOUN
chd-148	93	2	2	2	NUM
chd-148	93	3	.	.	PUNCT
chd-148	94	1	molecular	molecular	ADJ
chd-148	94	2	factors	factor	NOUN
chd-148	94	3	involved	involve	VERB
chd-148	94	4	in	in	ADP
chd-148	94	5	disparities	disparity	NOUN
chd-148	94	6	in	in	ADP
chd-148	94	7	incidence	incidence	NOUN
chd-148	94	8	and	and	CCONJ
chd-148	94	9	mortality	mortality	NOUN
chd-148	94	10	of	of	ADP
chd-148	94	11	lca	lca	PROPN
chd-148	94	12	.	.	PUNCT
chd-148	95	1	cellular	cellular	ADJ
chd-148	95	2	and	and	CCONJ
chd-148	95	3	molecular	molecular	ADJ
chd-148	95	4	factors	factor	NOUN
chd-148	95	5	/	/	SYM
chd-148	95	6	mechanisms	mechanism	NOUN
chd-148	95	7	dysregulation	dysregulation	NOUN
chd-148	95	8	associated	associate	VERB
chd-148	95	9	with	with	ADP
chd-148	95	10	reference	reference	NOUN
chd-148	95	11	cytokines	cytokine	VERB
chd-148	95	12	il-6	il-6	PRON
chd-148	95	13	overexpression	overexpression	NOUN
chd-148	95	14	hcv	hcv	X
chd-148	95	15	(	(	PUNCT
chd-148	95	16	rogers	rogers	PROPN
chd-148	95	17	et	et	PROPN
chd-148	95	18	al	al	PROPN
chd-148	95	19	.	.	PROPN
chd-148	95	20	,	,	PUNCT
chd-148	95	21	2007	2007	NUM
chd-148	95	22	)	)	PUNCT
chd-148	95	23	;	;	PUNCT
chd-148	95	24	(	(	PUNCT
chd-148	95	25	nakagawa	nakagawa	PROPN
chd-148	95	26	et	et	PROPN
chd-148	95	27	al	al	PROPN
chd-148	95	28	.	.	PROPN
chd-148	95	29	,	,	PUNCT
chd-148	95	30	2009	2009	NUM
chd-148	95	31	)	)	PUNCT
chd-148	95	32	;	;	PUNCT
chd-148	95	33	(	(	PUNCT
chd-148	95	34	wong	wong	PROPN
chd-148	95	35	et	et	PROPN
chd-148	95	36	al	al	PROPN
chd-148	95	37	.	.	PROPN
chd-148	95	38	,	,	PUNCT
chd-148	95	39	2009	2009	NUM
chd-148	95	40	)	)	PUNCT
chd-148	95	41	il-10	il-10	DET
chd-148	95	42	polymorphism	polymorphism	NOUN
chd-148	95	43	in	in	ADP
chd-148	95	44	promoter	promoter	NOUN
chd-148	95	45	hcv	hcv	PROPN
chd-148	95	46	(	(	PUNCT
chd-148	95	47	paladino	paladino	PROPN
chd-148	95	48	et	et	PROPN
chd-148	95	49	al	al	PROPN
chd-148	95	50	.	.	PROPN
chd-148	95	51	,	,	PUNCT
chd-148	95	52	2006	2006	NUM
chd-148	95	53	)	)	PUNCT
chd-148	95	54	;	;	PUNCT
chd-148	95	55	(	(	PUNCT
chd-148	95	56	persico	persico	X
chd-148	95	57	et	et	PROPN
chd-148	95	58	al	al	PROPN
chd-148	95	59	.	.	PROPN
chd-148	95	60	,	,	PUNCT
chd-148	95	61	2006	2006	NUM
chd-148	95	62	)	)	PUNCT
chd-148	95	63	interferon	interferon	ADJ
chd-148	95	64	overexpression	overexpression	NOUN
chd-148	95	65	hcv	hcv	NOUN
chd-148	95	66	(	(	PUNCT
chd-148	95	67	rogers	rogers	PROPN
chd-148	95	68	et	et	PROPN
chd-148	95	69	al	al	PROPN
chd-148	95	70	.	.	PROPN
chd-148	95	71	,	,	PUNCT
chd-148	95	72	2007	2007	NUM
chd-148	95	73	)	)	PUNCT
chd-148	95	74	sex	sex	NOUN
chd-148	95	75	hormones	hormone	NOUN
chd-148	95	76	androgen	androgen	NOUN
chd-148	95	77	,	,	PUNCT
chd-148	95	78	estrogen	estrogen	NOUN
chd-148	95	79	,	,	PUNCT
chd-148	95	80	and	and	CCONJ
chd-148	95	81	progesterone	progesterone	NOUN
chd-148	95	82	differential	differential	NOUN
chd-148	95	83	expression	expression	NOUN
chd-148	95	84	regulation	regulation	NOUN
chd-148	95	85	of	of	ADP
chd-148	95	86	transcriptional	transcriptional	ADJ
chd-148	95	87	factors	factor	NOUN
chd-148	95	88	nfkb	nfkb	PROPN
chd-148	95	89	and	and	CCONJ
chd-148	95	90	c	c	X
chd-148	95	91	/	/	SYM
chd-148	95	92	ebpβ	ebpβ	ADJ
chd-148	95	93	,	,	PUNCT
chd-148	95	94	immune	immune	ADJ
chd-148	95	95	response	response	NOUN
chd-148	95	96	,	,	PUNCT
chd-148	95	97	and	and	CCONJ
chd-148	95	98	cell	cell	NOUN
chd-148	95	99	proliferation	proliferation	NOUN
chd-148	95	100	(	(	PUNCT
chd-148	95	101	naugler	naugler	NOUN
chd-148	95	102	et	et	PROPN
chd-148	95	103	al	al	PROPN
chd-148	95	104	.	.	PROPN
chd-148	95	105	,	,	PUNCT
chd-148	95	106	2007	2007	NUM
chd-148	95	107	)	)	PUNCT
chd-148	95	108	;	;	PUNCT
chd-148	95	109	(	(	PUNCT
chd-148	95	110	ohnishi	ohnishi	PROPN
chd-148	95	111	et	et	PROPN
chd-148	95	112	al	al	PROPN
chd-148	95	113	.	.	PROPN
chd-148	95	114	,	,	PUNCT
chd-148	95	115	1986	1986	NUM
chd-148	95	116	)	)	PUNCT
chd-148	95	117	reactive	reactive	ADJ
chd-148	95	118	oxygen	oxygen	NOUN
chd-148	95	119	species	species	NOUN
chd-148	95	120	production	production	NOUN
chd-148	95	121	depletion	depletion	NOUN
chd-148	95	122	of	of	ADP
chd-148	95	123	antioxidant	antioxidant	ADJ
chd-148	95	124	defences	defence	NOUN
chd-148	95	125	;	;	PUNCT
chd-148	95	126	changes	change	NOUN
chd-148	95	127	in	in	ADP
chd-148	95	128	key	key	ADJ
chd-148	95	129	organelles	organelle	NOUN
chd-148	95	130	,	,	PUNCT
chd-148	95	131	including	include	VERB
chd-148	95	132	mitochondria	mitochondria	PROPN
chd-148	95	133	(	(	PUNCT
chd-148	95	134	tien	tien	PROPN
chd-148	95	135	kuo	kuo	PROPN
chd-148	95	136	and	and	CCONJ
chd-148	95	137	savaraj	savaraj	VERB
chd-148	95	138	,	,	PUNCT
chd-148	95	139	2006	2006	NUM
chd-148	95	140	)	)	PUNCT
chd-148	95	141	mutations	mutation	NOUN
chd-148	95	142	hypermethylation	hypermethylation	NOUN
chd-148	95	143	of	of	ADP
chd-148	95	144	genes	gene	NOUN
chd-148	95	145	lztr1	lztr1	PROPN
chd-148	95	146	,	,	PUNCT
chd-148	95	147	eef1a1	eef1a1	NOUN
chd-148	95	148	,	,	PUNCT
chd-148	95	149	sf3b1	sf3b1	ADP
chd-148	95	150	,	,	PUNCT
chd-148	95	151	and	and	CCONJ
chd-148	95	152	smarca4	smarca4	NOUN
chd-148	95	153	,	,	PUNCT
chd-148	95	154	ccr5	ccr5	NOUN
chd-148	95	155	32	32	NUM
chd-148	95	156	delta	delta	NOUN
chd-148	95	157	(	(	PUNCT
chd-148	95	158	et.al	et.al	PROPN
chd-148	95	159	.	.	PROPN
chd-148	95	160	,	,	PUNCT
chd-148	95	161	2017	2017	NUM
chd-148	95	162	)	)	PUNCT
chd-148	95	163	chemokines	chemokine	NOUN
chd-148	95	164	are	be	AUX
chd-148	95	165	the	the	DET
chd-148	95	166	low	low	ADJ
chd-148	95	167	molecular	molecular	ADJ
chd-148	95	168	weight	weight	NOUN
chd-148	95	169	proteins	protein	NOUN
chd-148	95	170	that	that	PRON
chd-148	95	171	function	function	VERB
chd-148	95	172	in	in	ADP
chd-148	95	173	leukocyte	leukocyte	NOUN
chd-148	95	174	trafficking	trafficking	NOUN
chd-148	95	175	and	and	CCONJ
chd-148	95	176	other	other	ADJ
chd-148	95	177	biological	biological	ADJ
chd-148	95	178	activities	activity	NOUN
chd-148	95	179	.	.	PUNCT
chd-148	96	1	they	they	PRON
chd-148	96	2	belong	belong	VERB
chd-148	96	3	to	to	ADP
chd-148	96	4	the	the	DET
chd-148	96	5	g	g	NOUN
chd-148	96	6	-	-	PUNCT
chd-148	96	7	protein	protein	NOUN
chd-148	96	8	coupled	couple	VERB
chd-148	96	9	receptor	receptor	NOUN
chd-148	96	10	family	family	NOUN
chd-148	96	11	,	,	PUNCT
chd-148	96	12	bind	bind	VERB
chd-148	96	13	to	to	ADP
chd-148	96	14	their	their	PRON
chd-148	96	15	cognate	cognate	NOUN
chd-148	96	16	receptors	receptor	NOUN
chd-148	96	17	,	,	PUNCT
chd-148	96	18	and	and	CCONJ
chd-148	96	19	determine	determine	VERB
chd-148	96	20	the	the	DET
chd-148	96	21	metastatic	metastatic	ADJ
chd-148	96	22	destination	destination	NOUN
chd-148	96	23	of	of	ADP
chd-148	96	24	tumor	tumor	NOUN
chd-148	96	25	cells	cell	NOUN
chd-148	96	26	(	(	PUNCT
chd-148	96	27	singh	singh	PROPN
chd-148	96	28	et	et	PROPN
chd-148	96	29	al	al	PROPN
chd-148	96	30	.	.	PROPN
chd-148	96	31	,	,	PUNCT
chd-148	96	32	2018	2018	NUM
chd-148	96	33	)	)	PUNCT
chd-148	96	34	.	.	PUNCT
chd-148	97	1	chemokines	chemokine	NOUN
chd-148	97	2	are	be	AUX
chd-148	97	3	involved	involve	VERB
chd-148	97	4	in	in	ADP
chd-148	97	5	liver	liver	NOUN
chd-148	97	6	inflammation	inflammation	NOUN
chd-148	97	7	,	,	PUNCT
chd-148	97	8	which	which	PRON
chd-148	97	9	regulates	regulate	VERB
chd-148	97	10	activities	activity	NOUN
chd-148	97	11	of	of	ADP
chd-148	97	12	circulating	circulate	VERB
chd-148	97	13	immune	immune	ADJ
chd-148	97	14	cells	cell	NOUN
chd-148	97	15	,	,	PUNCT
chd-148	97	16	endothelial	endothelial	ADJ
chd-148	97	17	cells	cell	NOUN
chd-148	97	18	,	,	PUNCT
chd-148	97	19	and	and	CCONJ
chd-148	97	20	hepatocytes	hepatocyte	NOUN
chd-148	97	21	.	.	PUNCT
chd-148	98	1	moreover	moreover	ADV
chd-148	98	2	,	,	PUNCT
chd-148	98	3	they	they	PRON
chd-148	98	4	contribute	contribute	VERB
chd-148	98	5	to	to	ADP
chd-148	98	6	cell	cell	NOUN
chd-148	98	7	proliferation	proliferation	NOUN
chd-148	98	8	,	,	PUNCT
chd-148	98	9	pathogenesis	pathogenesis	NOUN
chd-148	98	10	,	,	PUNCT
chd-148	98	11	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-148	98	12	e7	e7	PROPN
chd-148	98	13	cancer	cancer	NOUN
chd-148	98	14	health	health	NOUN
chd-148	98	15	disparities	disparity	NOUN
chd-148	98	16	research	research	NOUN
chd-148	98	17	angiogenesis	angiogenesis	NOUN
chd-148	98	18	,	,	PUNCT
chd-148	98	19	and	and	CCONJ
chd-148	98	20	the	the	DET
chd-148	98	21	inflammatory	inflammatory	ADJ
chd-148	98	22	microenvironment	microenvironment	NOUN
chd-148	98	23	of	of	ADP
chd-148	98	24	hccs	hccs	NOUN
chd-148	98	25	(	(	PUNCT
chd-148	98	26	abdolmohammadi	abdolmohammadi	NOUN
chd-148	98	27	et	et	PROPN
chd-148	98	28	al	al	PROPN
chd-148	98	29	.	.	PROPN
chd-148	98	30	,	,	PUNCT
chd-148	98	31	2016	2016	NUM
chd-148	98	32	)	)	PUNCT
chd-148	98	33	.	.	PUNCT
chd-148	99	1	therefore	therefore	ADV
chd-148	99	2	,	,	PUNCT
chd-148	99	3	we	we	PRON
chd-148	99	4	reviewed	review	VERB
chd-148	99	5	the	the	DET
chd-148	99	6	role	role	NOUN
chd-148	99	7	of	of	ADP
chd-148	99	8	chemokines	chemokine	NOUN
chd-148	99	9	and	and	CCONJ
chd-148	99	10	their	their	PRON
chd-148	99	11	receptors	receptor	NOUN
chd-148	99	12	in	in	ADP
chd-148	99	13	the	the	DET
chd-148	99	14	regulation	regulation	NOUN
chd-148	99	15	of	of	ADP
chd-148	99	16	lca	lca	PROPN
chd-148	99	17	disparities	disparity	NOUN
chd-148	99	18	.	.	PUNCT
chd-148	100	1	chemokine	chemokine	ADJ
chd-148	100	2	receptor	receptor	NOUN
chd-148	100	3	5	5	NUM
chd-148	100	4	(	(	PUNCT
chd-148	100	5	ccr5	ccr5	NOUN
chd-148	100	6	)	)	PUNCT
chd-148	100	7	delta	delta	NOUN
chd-148	100	8	32	32	NUM
chd-148	100	9	alleles	allele	NOUN
chd-148	100	10	may	may	AUX
chd-148	100	11	predispose	predispose	VERB
chd-148	100	12	patients	patient	NOUN
chd-148	100	13	to	to	PART
chd-148	100	14	chronic	chronic	ADJ
chd-148	100	15	hbv	hbv	NOUN
chd-148	100	16	infections	infection	NOUN
chd-148	100	17	.	.	PUNCT
chd-148	101	1	a	a	DET
chd-148	101	2	total	total	NOUN
chd-148	101	3	of	of	ADP
chd-148	101	4	812	812	NUM
chd-148	101	5	iranian	iranian	ADJ
chd-148	101	6	individuals	individual	NOUN
chd-148	101	7	,	,	PUNCT
chd-148	101	8	grouped	group	VERB
chd-148	101	9	into	into	ADP
chd-148	101	10	hbv	hbv	NOUN
chd-148	101	11	-	-	PUNCT
chd-148	101	12	infected	infect	VERB
chd-148	101	13	and	and	CCONJ
chd-148	101	14	healthy	healthy	ADJ
chd-148	101	15	controls	control	NOUN
chd-148	101	16	,	,	PUNCT
chd-148	101	17	demonstrated	demonstrate	VERB
chd-148	101	18	that	that	SCONJ
chd-148	101	19	ccr5	ccr5	PROPN
chd-148	101	20	delta	delta	NOUN
chd-148	101	21	32	32	NUM
chd-148	101	22	was	be	AUX
chd-148	101	23	more	more	ADV
chd-148	101	24	frequent	frequent	ADJ
chd-148	101	25	in	in	ADP
chd-148	101	26	healthy	healthy	ADJ
chd-148	101	27	controls	control	NOUN
chd-148	101	28	than	than	ADP
chd-148	101	29	in	in	ADP
chd-148	101	30	hbv	hbv	NOUN
chd-148	101	31	-	-	PUNCT
chd-148	101	32	infected	infect	VERB
chd-148	101	33	individuals	individual	NOUN
chd-148	101	34	(	(	PUNCT
chd-148	101	35	abdolmohammadi	abdolmohammadi	NOUN
chd-148	101	36	et	et	PROPN
chd-148	101	37	al	al	PROPN
chd-148	101	38	.	.	PROPN
chd-148	101	39	,	,	PUNCT
chd-148	101	40	2016	2016	NUM
chd-148	101	41	)	)	PUNCT
chd-148	101	42	.	.	PUNCT
chd-148	102	1	in	in	ADP
chd-148	102	2	addition	addition	NOUN
chd-148	102	3	,	,	PUNCT
chd-148	102	4	the	the	DET
chd-148	102	5	ccr5	ccr5	NOUN
chd-148	102	6	receptor	receptor	NOUN
chd-148	102	7	is	be	AUX
chd-148	102	8	a	a	DET
chd-148	102	9	coreceptor	coreceptor	NOUN
chd-148	102	10	for	for	ADP
chd-148	102	11	the	the	DET
chd-148	102	12	hiv	hiv	PROPN
chd-148	102	13	gp120	gp120	PROPN
chd-148	102	14	protein	protein	NOUN
chd-148	102	15	(	(	PUNCT
chd-148	102	16	wilkin	wilkin	PROPN
chd-148	102	17	et	et	PROPN
chd-148	102	18	al	al	PROPN
chd-148	102	19	.	.	PROPN
chd-148	102	20	,	,	PUNCT
chd-148	102	21	2010	2010	NUM
chd-148	102	22	)	)	PUNCT
chd-148	102	23	.	.	PUNCT
chd-148	103	1	a	a	DET
chd-148	103	2	ccr5	ccr5	NOUN
chd-148	103	3	delta	delta	NOUN
chd-148	103	4	32	32	NUM
chd-148	103	5	mutation	mutation	NOUN
chd-148	103	6	is	be	AUX
chd-148	103	7	present	present	ADJ
chd-148	103	8	in	in	ADP
chd-148	103	9	10	10	NUM
chd-148	103	10	-	-	SYM
chd-148	103	11	15	15	NUM
chd-148	103	12	%	%	NOUN
chd-148	103	13	of	of	ADP
chd-148	103	14	caucasians	caucasian	NOUN
chd-148	103	15	.	.	PUNCT
chd-148	104	1	those	those	PRON
chd-148	104	2	who	who	PRON
chd-148	104	3	have	have	VERB
chd-148	104	4	a	a	DET
chd-148	104	5	copy	copy	NOUN
chd-148	104	6	of	of	ADP
chd-148	104	7	the	the	DET
chd-148	104	8	gene	gene	NOUN
chd-148	104	9	encoding	encode	VERB
chd-148	104	10	ccr5	ccr5	PROPN
chd-148	104	11	delta	delta	PROPN
chd-148	104	12	32	32	NUM
chd-148	104	13	have	have	VERB
chd-148	104	14	a	a	DET
chd-148	104	15	greater	great	ADJ
chd-148	104	16	probability	probability	NOUN
chd-148	104	17	of	of	ADP
chd-148	104	18	recovery	recovery	NOUN
chd-148	104	19	from	from	ADP
chd-148	104	20	hbv	hbv	NOUN
chd-148	104	21	infection	infection	NOUN
chd-148	104	22	(	(	PUNCT
chd-148	104	23	thio	thio	NOUN
chd-148	104	24	et	et	NOUN
chd-148	104	25	al	al	PROPN
chd-148	104	26	.	.	PROPN
chd-148	104	27	,	,	PUNCT
chd-148	104	28	2007	2007	NUM
chd-148	104	29	)	)	PUNCT
chd-148	104	30	.	.	PUNCT
chd-148	105	1	indians	indians	PROPN
chd-148	105	2	having	have	VERB
chd-148	105	3	ccr5	ccr5	NOUN
chd-148	105	4	delta	delta	NOUN
chd-148	105	5	32	32	NUM
chd-148	105	6	heterozygosity	heterozygosity	NOUN
chd-148	105	7	are	be	AUX
chd-148	105	8	more	more	ADV
chd-148	105	9	susceptible	susceptible	ADJ
chd-148	105	10	to	to	ADP
chd-148	105	11	hbv	hbv	NOUN
chd-148	105	12	-	-	PUNCT
chd-148	105	13	related	relate	VERB
chd-148	105	14	liver	liver	NOUN
chd-148	105	15	disease	disease	NOUN
chd-148	105	16	(	(	PUNCT
chd-148	105	17	suneetha	suneetha	PROPN
chd-148	105	18	et	et	PROPN
chd-148	105	19	al	al	PROPN
chd-148	105	20	.	.	PROPN
chd-148	105	21	,	,	PUNCT
chd-148	105	22	2006	2006	NUM
chd-148	105	23	)	)	PUNCT
chd-148	105	24	.	.	PUNCT
chd-148	106	1	this	this	PRON
chd-148	106	2	shows	show	VERB
chd-148	106	3	that	that	SCONJ
chd-148	106	4	,	,	PUNCT
chd-148	106	5	due	due	ADP
chd-148	106	6	to	to	ADP
chd-148	106	7	differences	difference	NOUN
chd-148	106	8	in	in	ADP
chd-148	106	9	genetic	genetic	ADJ
chd-148	106	10	background	background	NOUN
chd-148	106	11	,	,	PUNCT
chd-148	106	12	those	those	PRON
chd-148	106	13	with	with	ADP
chd-148	106	14	ccr5	ccr5	NOUN
chd-148	106	15	delta	delta	NOUN
chd-148	106	16	32	32	NUM
chd-148	106	17	are	be	AUX
chd-148	106	18	resistant	resistant	ADJ
chd-148	106	19	to	to	ADP
chd-148	106	20	hbv	hbv	NOUN
chd-148	106	21	infection	infection	NOUN
chd-148	106	22	.	.	PUNCT
chd-148	107	1	the	the	DET
chd-148	107	2	ccr5	ccr5	PROPN
chd-148	107	3	delta	delta	PROPN
chd-148	107	4	32	32	NUM
chd-148	107	5	allele	allele	NOUN
chd-148	107	6	is	be	AUX
chd-148	107	7	not	not	PART
chd-148	107	8	present	present	ADJ
chd-148	107	9	in	in	ADP
chd-148	107	10	residents	resident	NOUN
chd-148	107	11	of	of	ADP
chd-148	107	12	southeast	southeast	ADJ
chd-148	107	13	asian	asian	ADJ
chd-148	107	14	countries	country	NOUN
chd-148	107	15	,	,	PUNCT
chd-148	107	16	and	and	CCONJ
chd-148	107	17	,	,	PUNCT
chd-148	107	18	in	in	ADP
chd-148	107	19	a	a	DET
chd-148	107	20	study	study	NOUN
chd-148	107	21	of	of	ADP
chd-148	107	22	ccr5	ccr5	PROPN
chd-148	107	23	delta	delta	PROPN
chd-148	107	24	32	32	NUM
chd-148	107	25	polymorphism	polymorphism	NOUN
chd-148	107	26	in	in	ADP
chd-148	107	27	china	china	PROPN
chd-148	107	28	,	,	PUNCT
chd-148	107	29	no	no	DET
chd-148	107	30	mutated	mutate	VERB
chd-148	107	31	allele	allele	NOUN
chd-148	107	32	was	be	AUX
chd-148	107	33	detected	detect	VERB
chd-148	107	34	.	.	PUNCT
chd-148	108	1	conclusions	conclusion	NOUN
chd-148	108	2	in	in	ADP
chd-148	108	3	the	the	DET
chd-148	108	4	future	future	NOUN
chd-148	108	5	,	,	PUNCT
chd-148	108	6	the	the	DET
chd-148	108	7	burden	burden	NOUN
chd-148	108	8	of	of	ADP
chd-148	108	9	lca	lca	PROPN
chd-148	108	10	in	in	ADP
chd-148	108	11	the	the	DET
chd-148	108	12	united	united	PROPN
chd-148	108	13	states	states	PROPN
chd-148	108	14	and	and	CCONJ
chd-148	108	15	worldwide	worldwide	ADV
chd-148	108	16	is	be	AUX
chd-148	108	17	expected	expect	VERB
chd-148	108	18	to	to	PART
chd-148	108	19	increase	increase	VERB
chd-148	108	20	.	.	PUNCT
chd-148	109	1	despite	despite	SCONJ
chd-148	109	2	improvements	improvement	NOUN
chd-148	109	3	in	in	ADP
chd-148	109	4	lca	lca	PROPN
chd-148	109	5	treatments	treatments	PROPN
chd-148	109	6	and	and	CCONJ
chd-148	109	7	survival	survival	NOUN
chd-148	109	8	rates	rate	NOUN
chd-148	109	9	,	,	PUNCT
chd-148	109	10	the	the	DET
chd-148	109	11	overall	overall	ADJ
chd-148	109	12	prognosis	prognosis	NOUN
chd-148	109	13	for	for	ADP
chd-148	109	14	lca	lca	PROPN
chd-148	109	15	remains	remain	VERB
chd-148	109	16	poor	poor	ADJ
chd-148	109	17	.	.	PUNCT
chd-148	110	1	wide	wide	ADJ
chd-148	110	2	disparities	disparity	NOUN
chd-148	110	3	in	in	ADP
chd-148	110	4	lca	lca	PROPN
chd-148	110	5	rates	rate	NOUN
chd-148	110	6	by	by	ADP
chd-148	110	7	sex	sex	NOUN
chd-148	110	8	,	,	PUNCT
chd-148	110	9	age	age	NOUN
chd-148	110	10	,	,	PUNCT
chd-148	110	11	gender	gender	NOUN
chd-148	110	12	,	,	PUNCT
chd-148	110	13	and	and	CCONJ
chd-148	110	14	ethnicity	ethnicity	NOUN
chd-148	110	15	reflect	reflect	VERB
chd-148	110	16	differences	difference	NOUN
chd-148	110	17	in	in	ADP
chd-148	110	18	the	the	DET
chd-148	110	19	major	major	ADJ
chd-148	110	20	risk	risk	NOUN
chd-148	110	21	factors	factor	NOUN
chd-148	110	22	and	and	CCONJ
chd-148	110	23	inequalities	inequality	NOUN
chd-148	110	24	in	in	ADP
chd-148	110	25	access	access	NOUN
chd-148	110	26	to	to	ADP
chd-148	110	27	high	high	ADJ
chd-148	110	28	-	-	PUNCT
chd-148	110	29	quality	quality	NOUN
chd-148	110	30	care	care	NOUN
chd-148	110	31	.	.	PUNCT
chd-148	111	1	the	the	DET
chd-148	111	2	increase	increase	NOUN
chd-148	111	3	in	in	ADP
chd-148	111	4	obesity	obesity	NOUN
chd-148	111	5	in	in	ADP
chd-148	111	6	the	the	DET
chd-148	111	7	general	general	ADJ
chd-148	111	8	population	population	NOUN
chd-148	111	9	,	,	PUNCT
chd-148	111	10	lack	lack	NOUN
chd-148	111	11	of	of	ADP
chd-148	111	12	healthy	healthy	ADJ
chd-148	111	13	nutrition	nutrition	NOUN
chd-148	111	14	,	,	PUNCT
chd-148	111	15	inappropriate	inappropriate	ADJ
chd-148	111	16	lifestyles	lifestyle	NOUN
chd-148	111	17	,	,	PUNCT
chd-148	111	18	and	and	CCONJ
chd-148	111	19	limited	limited	ADJ
chd-148	111	20	understanding	understanding	NOUN
chd-148	111	21	of	of	ADP
chd-148	111	22	the	the	DET
chd-148	111	23	molecular	molecular	ADJ
chd-148	111	24	aspects	aspect	NOUN
chd-148	111	25	and	and	CCONJ
chd-148	111	26	origin	origin	NOUN
chd-148	111	27	of	of	ADP
chd-148	111	28	lca	lca	PROPN
chd-148	111	29	are	be	AUX
chd-148	111	30	impediments	impediment	NOUN
chd-148	111	31	in	in	ADP
chd-148	111	32	preventing	prevent	VERB
chd-148	111	33	and	and	CCONJ
chd-148	111	34	treating	treat	VERB
chd-148	111	35	these	these	DET
chd-148	111	36	cancers	cancer	NOUN
chd-148	111	37	.	.	PUNCT
chd-148	112	1	to	to	PART
chd-148	112	2	curb	curb	VERB
chd-148	112	3	the	the	DET
chd-148	112	4	rising	rise	VERB
chd-148	112	5	problem	problem	NOUN
chd-148	112	6	of	of	ADP
chd-148	112	7	lca	lca	PROPN
chd-148	112	8	and	and	CCONJ
chd-148	112	9	its	its	PRON
chd-148	112	10	disparities	disparity	NOUN
chd-148	112	11	,	,	PUNCT
chd-148	112	12	interventions	intervention	NOUN
chd-148	112	13	should	should	AUX
chd-148	112	14	include	include	VERB
chd-148	112	15	the	the	DET
chd-148	112	16	application	application	NOUN
chd-148	112	17	of	of	ADP
chd-148	112	18	existing	exist	VERB
chd-148	112	19	knowledge	knowledge	NOUN
chd-148	112	20	in	in	ADP
chd-148	112	21	prevention	prevention	NOUN
chd-148	112	22	,	,	PUNCT
chd-148	112	23	early	early	ADJ
chd-148	112	24	detection	detection	NOUN
chd-148	112	25	,	,	PUNCT
chd-148	112	26	and	and	CCONJ
chd-148	112	27	treatment	treatment	NOUN
chd-148	112	28	,	,	PUNCT
chd-148	112	29	maintaining	maintain	VERB
chd-148	112	30	healthy	healthy	ADJ
chd-148	112	31	body	body	NOUN
chd-148	112	32	weight	weight	NOUN
chd-148	112	33	,	,	PUNCT
chd-148	112	34	providing	provide	VERB
chd-148	112	35	access	access	NOUN
chd-148	112	36	to	to	ADP
chd-148	112	37	highquality	highquality	NOUN
chd-148	112	38	diabetes	diabetes	NOUN
chd-148	112	39	care	care	NOUN
chd-148	112	40	,	,	PUNCT
chd-148	112	41	preventing	prevent	VERB
chd-148	112	42	excessive	excessive	ADJ
chd-148	112	43	alcohol	alcohol	NOUN
chd-148	112	44	drinking	drinking	NOUN
chd-148	112	45	,	,	PUNCT
chd-148	112	46	and	and	CCONJ
chd-148	112	47	controlling	control	VERB
chd-148	112	48	tobacco	tobacco	NOUN
chd-148	112	49	consumption	consumption	NOUN
chd-148	112	50	.	.	PUNCT
chd-148	113	1	acknowledgements	acknowledgement	NOUN
chd-148	113	2	this	this	DET
chd-148	113	3	study	study	NOUN
chd-148	113	4	was	be	AUX
chd-148	113	5	supported	support	VERB
chd-148	113	6	in	in	ADP
chd-148	113	7	part	part	NOUN
chd-148	113	8	by	by	ADP
chd-148	113	9	the	the	DET
chd-148	113	10	national	national	PROPN
chd-148	113	11	institutes	institutes	PROPN
chd-148	113	12	of	of	ADP
chd-148	113	13	health	health	PROPN
chd-148	113	14	under	under	ADP
chd-148	113	15	award	award	NOUN
chd-148	113	16	number	number	NOUN
chd-148	113	17	sc1ca193758	sc1ca193758	ADJ
chd-148	113	18	and	and	CCONJ
chd-148	113	19	u54ca118638	u54ca118638	NOUN
chd-148	113	20	,	,	PUNCT
chd-148	113	21	and	and	CCONJ
chd-148	113	22	by	by	ADP
chd-148	113	23	the	the	DET
chd-148	113	24	department	department	PROPN
chd-148	113	25	of	of	ADP
chd-148	113	26	defence	defence	PROPN
chd-148	113	27	,	,	PUNCT
chd-148	113	28	award	award	NOUN
chd-148	113	29	number	number	NOUN
chd-148	113	30	w81xwh1810429	w81xwh1810429	PROPN
chd-148	113	31	.	.	PUNCT
chd-148	114	1	conflict	conflict	NOUN
chd-148	114	2	of	of	ADP
chd-148	114	3	interest	interest	NOUN
chd-148	114	4	all	all	DET
chd-148	114	5	authors	author	NOUN
chd-148	114	6	declare	declare	VERB
chd-148	114	7	no	no	DET
chd-148	114	8	potential	potential	ADJ
chd-148	114	9	conflicts	conflict	NOUN
chd-148	114	10	of	of	ADP
chd-148	114	11	interest	interest	NOUN
chd-148	114	12	.	.	PUNCT
chd-148	115	1	authors	author	NOUN
chd-148	115	2	’	’	PART
chd-148	115	3	contributions	contribution	NOUN
chd-148	115	4	sks	sk	NOUN
chd-148	115	5	was	be	AUX
chd-148	115	6	involved	involve	VERB
chd-148	115	7	in	in	ADP
chd-148	115	8	data	datum	NOUN
chd-148	115	9	collection	collection	NOUN
chd-148	115	10	and	and	CCONJ
chd-148	115	11	drafting	drafting	NOUN
chd-148	115	12	of	of	ADP
chd-148	115	13	the	the	DET
chd-148	115	14	article	article	NOUN
chd-148	115	15	.	.	PUNCT
chd-148	116	1	rs	rs	PROPN
chd-148	116	2	designed	design	VERB
chd-148	116	3	the	the	DET
chd-148	116	4	concept	concept	NOUN
chd-148	116	5	,	,	PUNCT
chd-148	116	6	critically	critically	ADV
chd-148	116	7	reviewed	review	VERB
chd-148	116	8	and	and	CCONJ
chd-148	116	9	editing	editing	NOUN
chd-148	116	10	of	of	ADP
chd-148	116	11	the	the	DET
chd-148	116	12	final	final	ADJ
chd-148	116	13	version	version	NOUN
chd-148	116	14	of	of	ADP
chd-148	116	15	the	the	DET
chd-148	116	16	manuscript	manuscript	NOUN
chd-148	116	17	.	.	PUNCT
chd-148	117	1	all	all	DET
chd-148	117	2	authors	author	NOUN
chd-148	117	3	read	read	VERB
chd-148	117	4	and	and	CCONJ
chd-148	117	5	approved	approve	VERB
chd-148	117	6	the	the	DET
chd-148	117	7	final	final	ADJ
chd-148	117	8	manuscript	manuscript	NOUN
chd-148	117	9	.	.	PUNCT
chd-148	118	1	references	reference	NOUN
chd-148	118	2	abdolmohammadi	abdolmohammadi	PROPN
chd-148	118	3	,	,	PUNCT
chd-148	118	4	r.	r.	PROPN
chd-148	118	5	,	,	PUNCT
chd-148	118	6	azar	azar	PROPN
chd-148	118	7	,	,	PUNCT
chd-148	118	8	s.s	s.s	PROPN
chd-148	118	9	.	.	PROPN
chd-148	118	10	,	,	PUNCT
chd-148	118	11	khosravi	khosravi	NOUN
chd-148	118	12	,	,	PUNCT
chd-148	118	13	a.	a.	NOUN
chd-148	118	14	,	,	PUNCT
chd-148	118	15	and	and	CCONJ
chd-148	118	16	shahbazi	shahbazi	NOUN
chd-148	118	17	,	,	PUNCT
chd-148	118	18	m.	m.	NOUN
chd-148	118	19	(	(	PUNCT
chd-148	118	20	2016	2016	NUM
chd-148	118	21	)	)	PUNCT
chd-148	118	22	.	.	PUNCT
chd-148	119	1	ccr5	ccr5	NOUN
chd-148	119	2	polymorphism	polymorphism	NOUN
chd-148	119	3	as	as	ADP
chd-148	119	4	a	a	DET
chd-148	119	5	protective	protective	ADJ
chd-148	119	6	factor	factor	NOUN
chd-148	119	7	for	for	ADP
chd-148	119	8	hepatocellular	hepatocellular	ADJ
chd-148	119	9	carcinoma	carcinoma	NOUN
chd-148	119	10	in	in	ADP
chd-148	119	11	hepatitis	hepatitis	PROPN
chd-148	119	12	b	b	PROPN
chd-148	119	13	virus	virus	NOUN
chd-148	119	14	-	-	PUNCT
chd-148	119	15	infected	infect	VERB
chd-148	119	16	iranian	iranian	ADJ
chd-148	119	17	patients	patient	NOUN
chd-148	119	18	.	.	PUNCT
chd-148	120	1	asian	asian	PROPN
chd-148	120	2	pacific	pacific	PROPN
chd-148	120	3	journal	journal	PROPN
chd-148	120	4	of	of	ADP
chd-148	120	5	cancer	cancer	NOUN
chd-148	120	6	prevention	prevention	NOUN
chd-148	120	7	17	17	NUM
chd-148	120	8	,	,	PUNCT
chd-148	120	9	4643	4643	NUM
chd-148	120	10	-	-	SYM
chd-148	120	11	4646	4646	NUM
chd-148	120	12	.	.	PUNCT
chd-148	121	1	altekruse	altekruse	PROPN
chd-148	121	2	,	,	PUNCT
chd-148	121	3	s.f	s.f	PROPN
chd-148	121	4	.	.	PROPN
chd-148	121	5	,	,	PUNCT
chd-148	121	6	mcglynn	mcglynn	PROPN
chd-148	121	7	,	,	PUNCT
chd-148	121	8	k.a	k.a	PROPN
chd-148	121	9	.	.	PROPN
chd-148	121	10	,	,	PUNCT
chd-148	121	11	and	and	CCONJ
chd-148	121	12	reichman	reichman	NOUN
chd-148	121	13	,	,	PUNCT
chd-148	121	14	m.e	m.e	PROPN
chd-148	121	15	.	.	PROPN
chd-148	121	16	(	(	PUNCT
chd-148	121	17	2009	2009	NUM
chd-148	121	18	)	)	PUNCT
chd-148	121	19	.	.	PUNCT
chd-148	122	1	hepatocellular	hepatocellular	ADJ
chd-148	122	2	carcinoma	carcinoma	NOUN
chd-148	122	3	incidence	incidence	NOUN
chd-148	122	4	,	,	PUNCT
chd-148	122	5	mortality	mortality	NOUN
chd-148	122	6	,	,	PUNCT
chd-148	122	7	and	and	CCONJ
chd-148	122	8	survival	survival	NOUN
chd-148	122	9	trends	trend	NOUN
chd-148	122	10	in	in	ADP
chd-148	122	11	the	the	DET
chd-148	122	12	united	united	PROPN
chd-148	122	13	states	states	PROPN
chd-148	122	14	from	from	ADP
chd-148	122	15	1975	1975	NUM
chd-148	122	16	to	to	ADP
chd-148	122	17	2005	2005	NUM
chd-148	122	18	.	.	PUNCT
chd-148	123	1	j	j	PROPN
chd-148	123	2	clin	clin	PROPN
chd-148	123	3	oncol	oncol	PROPN
chd-148	123	4	27	27	NUM
chd-148	123	5	,	,	PUNCT
chd-148	123	6	1485	1485	NUM
chd-148	123	7	-	-	SYM
chd-148	123	8	1491	1491	NUM
chd-148	123	9	.	.	PUNCT
chd-148	124	1	aravalli	aravalli	PROPN
chd-148	124	2	,	,	PUNCT
chd-148	124	3	r.n	r.n	PROPN
chd-148	124	4	.	.	PROPN
chd-148	124	5	,	,	PUNCT
chd-148	124	6	steer	steer	NOUN
chd-148	124	7	,	,	PUNCT
chd-148	124	8	c.j	c.j	PROPN
chd-148	124	9	.	.	PROPN
chd-148	124	10	,	,	PUNCT
chd-148	124	11	and	and	CCONJ
chd-148	124	12	cressman	cressman	ADJ
chd-148	124	13	,	,	PUNCT
chd-148	124	14	e.n	e.n	PROPN
chd-148	124	15	.	.	PROPN
chd-148	124	16	(	(	PUNCT
chd-148	124	17	2008	2008	NUM
chd-148	124	18	)	)	PUNCT
chd-148	124	19	.	.	PUNCT
chd-148	125	1	molecular	molecular	ADJ
chd-148	125	2	mechanisms	mechanism	NOUN
chd-148	125	3	of	of	ADP
chd-148	125	4	hepatocellular	hepatocellular	ADJ
chd-148	125	5	carcinoma	carcinoma	NOUN
chd-148	125	6	.	.	PUNCT
chd-148	126	1	hepatology	hepatology	NOUN
chd-148	126	2	48	48	NUM
chd-148	126	3	,	,	PUNCT
chd-148	126	4	2047	2047	NUM
chd-148	126	5	-	-	SYM
chd-148	126	6	2063	2063	NUM
chd-148	126	7	.	.	PUNCT
chd-148	127	1	baatarkhuu	baatarkhuu	ADV
chd-148	127	2	,	,	PUNCT
chd-148	127	3	o.	o.	INTJ
chd-148	127	4	,	,	PUNCT
chd-148	127	5	uugantsetseg	uugantsetseg	PROPN
chd-148	127	6	,	,	PUNCT
chd-148	127	7	g.	g.	PROPN
chd-148	127	8	,	,	PUNCT
chd-148	127	9	munkh	munkh	ADJ
chd-148	127	10	-	-	NOUN
chd-148	127	11	orshikh	orshikh	ADJ
chd-148	127	12	,	,	PUNCT
chd-148	127	13	d.	d.	PROPN
chd-148	127	14	,	,	PUNCT
chd-148	127	15	naranzul	naranzul	ADJ
chd-148	127	16	,	,	PUNCT
chd-148	127	17	n.	n.	NOUN
chd-148	127	18	,	,	PUNCT
chd-148	127	19	badamjav	badamjav	NOUN
chd-148	127	20	,	,	PUNCT
chd-148	127	21	s.	s.	PROPN
chd-148	127	22	,	,	PUNCT
chd-148	127	23	tserendagva	tserendagva	PROPN
chd-148	127	24	,	,	PUNCT
chd-148	127	25	d.	d.	PROPN
chd-148	127	26	,	,	PUNCT
chd-148	127	27	amarsanaa	amarsanaa	PROPN
chd-148	127	28	,	,	PUNCT
chd-148	127	29	j.	j.	PROPN
chd-148	127	30	,	,	PUNCT
chd-148	127	31	and	and	CCONJ
chd-148	127	32	do	do	VERB
chd-148	127	33	young	young	PROPN
chd-148	127	34	,	,	PUNCT
chd-148	127	35	k.	k.	PROPN
chd-148	127	36	(	(	PUNCT
chd-148	127	37	2017	2017	NUM
chd-148	127	38	)	)	PUNCT
chd-148	127	39	.	.	PUNCT
chd-148	128	1	viral	viral	ADJ
chd-148	128	2	hepatitis	hepatitis	NOUN
chd-148	128	3	and	and	CCONJ
chd-148	128	4	liver	liver	NOUN
chd-148	128	5	diseases	disease	NOUN
chd-148	128	6	in	in	ADP
chd-148	128	7	mongolia	mongolia	PROPN
chd-148	128	8	.	.	PUNCT
chd-148	129	1	euroasian	euroasian	PROPN
chd-148	129	2	j	j	PROPN
chd-148	129	3	hepatogastroenterol	hepatogastroenterol	PROPN
chd-148	129	4	7	7	NUM
chd-148	129	5	,	,	PUNCT
chd-148	129	6	68	68	NUM
chd-148	129	7	-	-	SYM
chd-148	129	8	72	72	NUM
chd-148	129	9	.	.	PUNCT
chd-148	130	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-148	130	2	e8	e8	PROPN
chd-148	130	3	cancer	cancer	PROPN
chd-148	130	4	health	health	NOUN
chd-148	130	5	disparities	disparity	NOUN
chd-148	130	6	research	research	PROPN
chd-148	130	7	bosch	bosch	PROPN
chd-148	130	8	,	,	PUNCT
chd-148	130	9	f.x	f.x	PROPN
chd-148	130	10	.	.	PROPN
chd-148	130	11	,	,	PUNCT
chd-148	130	12	ribes	ribe	NOUN
chd-148	130	13	,	,	PUNCT
chd-148	130	14	j.	j.	PROPN
chd-148	130	15	,	,	PUNCT
chd-148	130	16	cleries	clerie	NOUN
chd-148	130	17	,	,	PUNCT
chd-148	130	18	r.	r.	PROPN
chd-148	130	19	,	,	PUNCT
chd-148	130	20	and	and	CCONJ
chd-148	130	21	diaz	diaz	PROPN
chd-148	130	22	,	,	PUNCT
chd-148	130	23	m.	m.	NOUN
chd-148	130	24	(	(	PUNCT
chd-148	130	25	2005	2005	NUM
chd-148	130	26	)	)	PUNCT
chd-148	130	27	.	.	PUNCT
chd-148	131	1	epidemiology	epidemiology	NOUN
chd-148	131	2	of	of	ADP
chd-148	131	3	hepatocellular	hepatocellular	ADJ
chd-148	131	4	carcinoma	carcinoma	NOUN
chd-148	131	5	.	.	PUNCT
chd-148	132	1	clin	clin	PROPN
chd-148	132	2	liver	liver	NOUN
chd-148	132	3	dis	dis	PROPN
chd-148	132	4	9	9	NUM
chd-148	132	5	,	,	PUNCT
chd-148	132	6	191	191	NUM
chd-148	132	7	-	-	SYM
chd-148	132	8	211	211	NUM
chd-148	132	9	,	,	PUNCT
chd-148	132	10	v.	v.	PROPN
chd-148	132	11	calle	calle	PROPN
chd-148	132	12	,	,	PUNCT
chd-148	132	13	e.e	e.e	PROPN
chd-148	132	14	.	.	PROPN
chd-148	132	15	,	,	PUNCT
chd-148	132	16	rodriguez	rodriguez	PROPN
chd-148	132	17	,	,	PUNCT
chd-148	132	18	c.	c.	PROPN
chd-148	132	19	,	,	PUNCT
chd-148	132	20	walker	walker	PROPN
chd-148	132	21	-	-	PUNCT
chd-148	132	22	thurmond	thurmond	PROPN
chd-148	132	23	,	,	PUNCT
chd-148	132	24	k.	k.	PROPN
chd-148	132	25	,	,	PUNCT
chd-148	132	26	and	and	CCONJ
chd-148	132	27	thun	thun	PROPN
chd-148	132	28	,	,	PUNCT
chd-148	132	29	m.j	m.j	PROPN
chd-148	132	30	.	.	PROPN
chd-148	132	31	(	(	PUNCT
chd-148	132	32	2003	2003	NUM
chd-148	132	33	)	)	PUNCT
chd-148	132	34	.	.	PUNCT
chd-148	133	1	overweight	overweight	ADJ
chd-148	133	2	,	,	PUNCT
chd-148	133	3	obesity	obesity	NOUN
chd-148	133	4	,	,	PUNCT
chd-148	133	5	and	and	CCONJ
chd-148	133	6	mortality	mortality	NOUN
chd-148	133	7	from	from	ADP
chd-148	133	8	cancer	cancer	NOUN
chd-148	133	9	in	in	ADP
chd-148	133	10	a	a	DET
chd-148	133	11	prospectively	prospectively	ADV
chd-148	133	12	studied	study	VERB
chd-148	133	13	cohort	cohort	NOUN
chd-148	133	14	of	of	ADP
chd-148	133	15	u.s	u.s	PROPN
chd-148	133	16	.	.	PROPN
chd-148	133	17	adults	adult	NOUN
chd-148	133	18	.	.	PUNCT
chd-148	134	1	n	n	X
chd-148	134	2	engl	engl	PROPN
chd-148	134	3	j	j	PROPN
chd-148	134	4	med	me	VERB
chd-148	134	5	348	348	NUM
chd-148	134	6	,	,	PUNCT
chd-148	134	7	1625	1625	NUM
chd-148	134	8	-	-	SYM
chd-148	134	9	1638	1638	NUM
chd-148	134	10	.	.	PUNCT
chd-148	135	1	chen	chen	PROPN
chd-148	135	2	,	,	PUNCT
chd-148	135	3	j.	j.	PROPN
chd-148	135	4	(	(	PUNCT
chd-148	135	5	2018	2018	NUM
chd-148	135	6	)	)	PUNCT
chd-148	135	7	.	.	PUNCT
chd-148	136	1	the	the	DET
chd-148	136	2	prognostic	prognostic	ADJ
chd-148	136	3	analysis	analysis	NOUN
chd-148	136	4	of	of	ADP
chd-148	136	5	different	different	ADJ
chd-148	136	6	metastatic	metastatic	ADJ
chd-148	136	7	patterns	pattern	NOUN
chd-148	136	8	in	in	ADP
chd-148	136	9	advanced	advanced	ADJ
chd-148	136	10	liver	liver	NOUN
chd-148	136	11	cancer	cancer	NOUN
chd-148	136	12	patients	patient	NOUN
chd-148	136	13	:	:	PUNCT
chd-148	136	14	a	a	DET
chd-148	136	15	population	population	NOUN
chd-148	136	16	based	base	VERB
chd-148	136	17	analysis	analysis	NOUN
chd-148	136	18	.	.	PUNCT
chd-148	137	1	plos	plos	PROPN
chd-148	137	2	one	one	NUM
chd-148	137	3	13	13	NUM
chd-148	137	4	,	,	PUNCT
chd-148	137	5	e0200909	e0200909	PROPN
chd-148	137	6	.	.	PUNCT
chd-148	138	1	chen	chen	PROPN
chd-148	138	2	,	,	PUNCT
chd-148	138	3	y.	y.	PROPN
chd-148	138	4	,	,	PUNCT
chd-148	138	5	wong	wong	PROPN
chd-148	138	6	,	,	PUNCT
chd-148	138	7	p.p	p.p	PROPN
chd-148	138	8	.	.	PROPN
chd-148	138	9	,	,	PUNCT
chd-148	138	10	sjeklocha	sjeklocha	PROPN
chd-148	138	11	,	,	PUNCT
chd-148	138	12	l.	l.	PROPN
chd-148	138	13	,	,	PUNCT
chd-148	138	14	steer	steer	NOUN
chd-148	138	15	,	,	PUNCT
chd-148	138	16	c.j	c.j	PROPN
chd-148	138	17	.	.	PROPN
chd-148	138	18	,	,	PUNCT
chd-148	138	19	and	and	CCONJ
chd-148	138	20	sahin	sahin	PROPN
chd-148	138	21	,	,	PUNCT
chd-148	138	22	m.b	m.b	PROPN
chd-148	138	23	.	.	PROPN
chd-148	138	24	(	(	PUNCT
chd-148	138	25	2012	2012	NUM
chd-148	138	26	)	)	PUNCT
chd-148	138	27	.	.	PUNCT
chd-148	139	1	mature	mature	ADJ
chd-148	139	2	hepatocytes	hepatocyte	NOUN
chd-148	139	3	exhibit	exhibit	VERB
chd-148	139	4	unexpected	unexpected	ADJ
chd-148	139	5	plasticity	plasticity	NOUN
chd-148	139	6	by	by	ADP
chd-148	139	7	direct	direct	ADJ
chd-148	139	8	dedifferentiation	dedifferentiation	NOUN
chd-148	139	9	into	into	ADP
chd-148	139	10	liver	liver	NOUN
chd-148	139	11	progenitor	progenitor	NOUN
chd-148	139	12	cells	cell	NOUN
chd-148	139	13	in	in	ADP
chd-148	139	14	culture	culture	NOUN
chd-148	139	15	.	.	PUNCT
chd-148	140	1	hepatology	hepatology	NOUN
chd-148	140	2	55	55	NUM
chd-148	140	3	,	,	PUNCT
chd-148	140	4	563	563	NUM
chd-148	140	5	-	-	SYM
chd-148	140	6	574	574	NUM
chd-148	140	7	.	.	PUNCT
chd-148	141	1	deshmukh	deshmukh	PROPN
chd-148	141	2	,	,	PUNCT
chd-148	141	3	s.k	s.k	PROPN
chd-148	141	4	.	.	PROPN
chd-148	141	5	,	,	PUNCT
chd-148	141	6	azim	azim	PROPN
chd-148	141	7	,	,	PUNCT
chd-148	141	8	s.	s.	PROPN
chd-148	141	9	,	,	PUNCT
chd-148	141	10	ahmad	ahmad	PROPN
chd-148	141	11	,	,	PUNCT
chd-148	141	12	a.	a.	PROPN
chd-148	141	13	,	,	PUNCT
chd-148	141	14	zubair	zubair	PROPN
chd-148	141	15	,	,	PUNCT
chd-148	141	16	h.	h.	PROPN
chd-148	141	17	,	,	PUNCT
chd-148	141	18	tyagi	tyagi	PROPN
chd-148	141	19	,	,	PUNCT
chd-148	141	20	n.	n.	PROPN
chd-148	141	21	,	,	PUNCT
chd-148	141	22	srivastava	srivastava	PROPN
chd-148	141	23	,	,	PUNCT
chd-148	141	24	s.k	s.k	PROPN
chd-148	141	25	.	.	PROPN
chd-148	141	26	,	,	PUNCT
chd-148	141	27	bhardwaj	bhardwaj	PROPN
chd-148	141	28	,	,	PUNCT
chd-148	141	29	a.	a.	PROPN
chd-148	141	30	,	,	PUNCT
chd-148	141	31	singh	singh	PROPN
chd-148	141	32	,	,	PUNCT
chd-148	141	33	s.	s.	PROPN
chd-148	141	34	,	,	PUNCT
chd-148	141	35	rocconi	rocconi	PROPN
chd-148	141	36	,	,	PUNCT
chd-148	141	37	r.p	r.p	PROPN
chd-148	141	38	.	.	PROPN
chd-148	141	39	,	,	PUNCT
chd-148	141	40	and	and	CCONJ
chd-148	141	41	singh	singh	PROPN
chd-148	141	42	,	,	PUNCT
chd-148	141	43	a.p	a.p	PROPN
chd-148	141	44	.	.	PROPN
chd-148	141	45	(	(	PUNCT
chd-148	141	46	2017	2017	NUM
chd-148	141	47	)	)	PUNCT
chd-148	141	48	.	.	PUNCT
chd-148	142	1	biological	biological	ADJ
chd-148	142	2	basis	basis	NOUN
chd-148	142	3	of	of	ADP
chd-148	142	4	cancer	cancer	NOUN
chd-148	142	5	health	health	NOUN
chd-148	142	6	disparities	disparity	NOUN
chd-148	142	7	:	:	PUNCT
chd-148	142	8	resources	resource	NOUN
chd-148	142	9	and	and	CCONJ
chd-148	142	10	challenges	challenge	NOUN
chd-148	142	11	for	for	ADP
chd-148	142	12	research	research	NOUN
chd-148	142	13	.	.	PUNCT
chd-148	143	1	am	be	AUX
chd-148	143	2	j	j	PROPN
chd-148	143	3	cancer	cancer	NOUN
chd-148	143	4	res	re	NOUN
chd-148	143	5	7	7	NUM
chd-148	143	6	,	,	PUNCT
chd-148	143	7	1	1	NUM
chd-148	143	8	-	-	SYM
chd-148	143	9	12	12	NUM
chd-148	143	10	.	.	PUNCT
chd-148	144	1	dhir	dhir	PROPN
chd-148	144	2	,	,	PUNCT
chd-148	144	3	r.n	r.n	PROPN
chd-148	144	4	.	.	PROPN
chd-148	144	5	,	,	PUNCT
chd-148	144	6	dworakowski	dworakowski	PROPN
chd-148	144	7	,	,	PUNCT
chd-148	144	8	w.	w.	NOUN
chd-148	144	9	,	,	PUNCT
chd-148	144	10	thangavel	thangavel	NOUN
chd-148	144	11	,	,	PUNCT
chd-148	144	12	c.	c.	NOUN
chd-148	144	13	,	,	PUNCT
chd-148	144	14	and	and	CCONJ
chd-148	144	15	shapiro	shapiro	PROPN
chd-148	144	16	,	,	PUNCT
chd-148	144	17	b.h	b.h	PROPN
chd-148	144	18	.	.	PUNCT
chd-148	144	19	(	(	PUNCT
chd-148	144	20	2006	2006	NUM
chd-148	144	21	)	)	PUNCT
chd-148	144	22	.	.	PUNCT
chd-148	145	1	sexually	sexually	ADV
chd-148	145	2	dimorphic	dimorphic	ADJ
chd-148	145	3	regulation	regulation	NOUN
chd-148	145	4	of	of	ADP
chd-148	145	5	hepatic	hepatic	ADJ
chd-148	145	6	isoforms	isoform	NOUN
chd-148	145	7	of	of	ADP
chd-148	145	8	human	human	ADJ
chd-148	145	9	cytochrome	cytochrome	NOUN
chd-148	145	10	p450	p450	NUM
chd-148	145	11	by	by	ADP
chd-148	145	12	growth	growth	NOUN
chd-148	145	13	hormone	hormone	NOUN
chd-148	145	14	.	.	PUNCT
chd-148	146	1	j	j	PROPN
chd-148	146	2	pharmacol	pharmacol	PROPN
chd-148	146	3	exp	exp	NOUN
chd-148	146	4	ther	ther	ADV
chd-148	146	5	316	316	NUM
chd-148	146	6	,	,	PUNCT
chd-148	146	7	87	87	NUM
chd-148	146	8	-	-	SYM
chd-148	146	9	94	94	NUM
chd-148	146	10	.	.	PUNCT
chd-148	147	1	donaldson	donaldson	PROPN
chd-148	147	2	,	,	PUNCT
chd-148	147	3	m.s	m.s	PROPN
chd-148	147	4	.	.	PROPN
chd-148	147	5	(	(	PUNCT
chd-148	147	6	2004	2004	NUM
chd-148	147	7	)	)	PUNCT
chd-148	147	8	.	.	PUNCT
chd-148	148	1	nutrition	nutrition	NOUN
chd-148	148	2	and	and	CCONJ
chd-148	148	3	cancer	cancer	NOUN
chd-148	148	4	:	:	PUNCT
chd-148	148	5	a	a	DET
chd-148	148	6	review	review	NOUN
chd-148	148	7	of	of	ADP
chd-148	148	8	the	the	DET
chd-148	148	9	evidence	evidence	NOUN
chd-148	148	10	for	for	ADP
chd-148	148	11	an	an	DET
chd-148	148	12	anti	anti	ADJ
chd-148	148	13	-	-	ADJ
chd-148	148	14	cancer	cancer	ADJ
chd-148	148	15	diet	diet	NOUN
chd-148	148	16	.	.	PUNCT
chd-148	149	1	nutr	nutr	PROPN
chd-148	149	2	j	j	PROPN
chd-148	149	3	3	3	NUM
chd-148	149	4	,	,	PUNCT
chd-148	149	5	19	19	NUM
chd-148	149	6	.	.	PUNCT
chd-148	150	1	el	el	PROPN
chd-148	150	2	-	-	PUNCT
chd-148	150	3	serag	serag	NOUN
chd-148	150	4	,	,	PUNCT
chd-148	150	5	h.b	h.b	PROPN
chd-148	150	6	.	.	PROPN
chd-148	150	7	,	,	PUNCT
chd-148	150	8	and	and	CCONJ
chd-148	150	9	rudolph	rudolph	PROPN
chd-148	150	10	,	,	PUNCT
chd-148	150	11	k.l	k.l	PROPN
chd-148	150	12	.	.	PROPN
chd-148	150	13	(	(	PUNCT
chd-148	150	14	2007	2007	NUM
chd-148	150	15	)	)	PUNCT
chd-148	150	16	.	.	PUNCT
chd-148	151	1	hepatocellular	hepatocellular	ADJ
chd-148	151	2	carcinoma	carcinoma	NOUN
chd-148	151	3	:	:	PUNCT
chd-148	151	4	epidemiology	epidemiology	NOUN
chd-148	151	5	and	and	CCONJ
chd-148	151	6	molecular	molecular	ADJ
chd-148	151	7	carcinogenesis	carcinogenesis	NOUN
chd-148	151	8	.	.	PUNCT
chd-148	152	1	gastroenterology	gastroenterology	NOUN
chd-148	152	2	132	132	NUM
chd-148	152	3	,	,	PUNCT
chd-148	152	4	2557	2557	NUM
chd-148	152	5	-	-	SYM
chd-148	152	6	2576	2576	NUM
chd-148	152	7	.	.	PUNCT
chd-148	153	1	et.al	et.al	PROPN
chd-148	153	2	.	.	PROPN
chd-148	153	3	,	,	PUNCT
chd-148	153	4	a.a	a.a	PROPN
chd-148	153	5	.	.	PROPN
chd-148	153	6	(	(	PUNCT
chd-148	153	7	2017	2017	NUM
chd-148	153	8	)	)	PUNCT
chd-148	153	9	.	.	PUNCT
chd-148	154	1	comprehensive	comprehensive	ADJ
chd-148	154	2	and	and	CCONJ
chd-148	154	3	integrative	integrative	ADJ
chd-148	154	4	genomic	genomic	ADJ
chd-148	154	5	characterization	characterization	NOUN
chd-148	154	6	of	of	ADP
chd-148	154	7	hepatocellular	hepatocellular	ADJ
chd-148	154	8	carcinoma	carcinoma	NOUN
chd-148	154	9	.	.	PUNCT
chd-148	155	1	cell	cell	NOUN
chd-148	155	2	169	169	NUM
chd-148	155	3	,	,	PUNCT
chd-148	155	4	1327	1327	NUM
chd-148	155	5	-	-	SYM
chd-148	155	6	1341.e1323	1341.e1323	NOUN
chd-148	155	7	.	.	PUNCT
chd-148	156	1	fedirko	fedirko	PROPN
chd-148	156	2	,	,	PUNCT
chd-148	156	3	v.	v.	ADV
chd-148	156	4	,	,	PUNCT
chd-148	156	5	lukanova	lukanova	PROPN
chd-148	156	6	,	,	PUNCT
chd-148	156	7	a.	a.	NOUN
chd-148	156	8	,	,	PUNCT
chd-148	156	9	bamia	bamia	NOUN
chd-148	156	10	,	,	PUNCT
chd-148	156	11	c.	c.	PROPN
chd-148	156	12	,	,	PUNCT
chd-148	156	13	trichopolou	trichopolou	PROPN
chd-148	156	14	,	,	PUNCT
chd-148	156	15	a.	a.	NOUN
chd-148	156	16	,	,	PUNCT
chd-148	156	17	trepo	trepo	NOUN
chd-148	156	18	,	,	PUNCT
chd-148	156	19	e.	e.	PROPN
chd-148	156	20	,	,	PUNCT
chd-148	156	21	nothlings	nothling	NOUN
chd-148	156	22	,	,	PUNCT
chd-148	156	23	u.	u.	PROPN
chd-148	156	24	,	,	PUNCT
chd-148	156	25	schlesinger	schlesinger	PROPN
chd-148	156	26	,	,	PUNCT
chd-148	156	27	s.	s.	PROPN
chd-148	156	28	,	,	PUNCT
chd-148	156	29	aleksandrova	aleksandrova	PROPN
chd-148	156	30	,	,	PUNCT
chd-148	156	31	k.	k.	PROPN
chd-148	156	32	,	,	PUNCT
chd-148	156	33	boffetta	boffetta	PROPN
chd-148	156	34	,	,	PUNCT
chd-148	156	35	p.	p.	NOUN
chd-148	156	36	,	,	PUNCT
chd-148	156	37	tjonneland	tjonneland	NOUN
chd-148	156	38	,	,	PUNCT
chd-148	156	39	a.	a.	NOUN
chd-148	156	40	,	,	PUNCT
chd-148	156	41	et	et	PROPN
chd-148	156	42	al	al	PROPN
chd-148	156	43	.	.	PROPN
chd-148	156	44	(	(	PUNCT
chd-148	156	45	2013	2013	NUM
chd-148	156	46	)	)	PUNCT
chd-148	156	47	.	.	PUNCT
chd-148	157	1	glycemic	glycemic	ADJ
chd-148	157	2	index	index	NOUN
chd-148	157	3	,	,	PUNCT
chd-148	157	4	glycemic	glycemic	ADJ
chd-148	157	5	load	load	NOUN
chd-148	157	6	,	,	PUNCT
chd-148	157	7	dietary	dietary	ADJ
chd-148	157	8	carbohydrate	carbohydrate	NOUN
chd-148	157	9	,	,	PUNCT
chd-148	157	10	and	and	CCONJ
chd-148	157	11	dietary	dietary	ADJ
chd-148	157	12	fiber	fiber	NOUN
chd-148	157	13	intake	intake	NOUN
chd-148	157	14	and	and	CCONJ
chd-148	157	15	risk	risk	NOUN
chd-148	157	16	of	of	ADP
chd-148	157	17	liver	liver	NOUN
chd-148	157	18	and	and	CCONJ
chd-148	157	19	biliary	biliary	ADJ
chd-148	157	20	tract	tract	NOUN
chd-148	157	21	cancers	cancer	NOUN
chd-148	157	22	in	in	ADP
chd-148	157	23	western	western	ADJ
chd-148	157	24	europeans	europeans	PROPN
chd-148	157	25	.	.	PUNCT
chd-148	158	1	ann	ann	PROPN
chd-148	158	2	oncol	oncol	PROPN
chd-148	158	3	24	24	NUM
chd-148	158	4	,	,	PUNCT
chd-148	158	5	543	543	NUM
chd-148	158	6	-	-	SYM
chd-148	158	7	553	553	NUM
chd-148	158	8	.	.	PUNCT
chd-148	159	1	ferlay	ferlay	NOUN
chd-148	159	2	,	,	PUNCT
chd-148	159	3	j.	j.	PROPN
chd-148	159	4	,	,	PUNCT
chd-148	159	5	shin	shin	PROPN
chd-148	159	6	,	,	PUNCT
chd-148	159	7	h.r	h.r	PROPN
chd-148	159	8	.	.	PROPN
chd-148	159	9	,	,	PUNCT
chd-148	159	10	bray	bray	PROPN
chd-148	159	11	,	,	PUNCT
chd-148	159	12	f.	f.	PROPN
chd-148	159	13	,	,	PUNCT
chd-148	159	14	forman	forman	PROPN
chd-148	159	15	,	,	PUNCT
chd-148	159	16	d.	d.	PROPN
chd-148	159	17	,	,	PUNCT
chd-148	159	18	mathers	mathers	PROPN
chd-148	159	19	,	,	PUNCT
chd-148	159	20	c.	c.	NOUN
chd-148	159	21	,	,	PUNCT
chd-148	159	22	and	and	CCONJ
chd-148	159	23	parkin	parkin	NOUN
chd-148	159	24	,	,	PUNCT
chd-148	159	25	d.m	d.m	PROPN
chd-148	159	26	.	.	PUNCT
chd-148	159	27	(	(	PUNCT
chd-148	159	28	2010	2010	NUM
chd-148	159	29	)	)	PUNCT
chd-148	159	30	.	.	PUNCT
chd-148	160	1	estimates	estimate	NOUN
chd-148	160	2	of	of	ADP
chd-148	160	3	worldwide	worldwide	ADJ
chd-148	160	4	burden	burden	NOUN
chd-148	160	5	of	of	ADP
chd-148	160	6	cancer	cancer	NOUN
chd-148	160	7	in	in	ADP
chd-148	160	8	2008	2008	NUM
chd-148	160	9	:	:	PUNCT
chd-148	160	10	globocan	globocan	PROPN
chd-148	160	11	2008	2008	NUM
chd-148	160	12	.	.	PUNCT
chd-148	161	1	int	int	PROPN
chd-148	161	2	j	j	PROPN
chd-148	161	3	cancer	cancer	NOUN
chd-148	161	4	127	127	NUM
chd-148	161	5	,	,	PUNCT
chd-148	161	6	2893	2893	NUM
chd-148	161	7	-	-	SYM
chd-148	161	8	2917	2917	NUM
chd-148	161	9	.	.	PUNCT
chd-148	162	1	geboy	geboy	NOUN
chd-148	162	2	,	,	PUNCT
chd-148	162	3	a.g	a.g	PROPN
chd-148	162	4	.	.	PROPN
chd-148	162	5	,	,	PUNCT
chd-148	162	6	mahajan	mahajan	PROPN
chd-148	162	7	,	,	PUNCT
chd-148	162	8	s.	s.	PROPN
chd-148	162	9	,	,	PUNCT
chd-148	162	10	daly	daly	PROPN
chd-148	162	11	,	,	PUNCT
chd-148	162	12	a.p	a.p	PROPN
chd-148	162	13	.	.	PROPN
chd-148	162	14	,	,	PUNCT
chd-148	162	15	sewell	sewell	PROPN
chd-148	162	16	,	,	PUNCT
chd-148	162	17	c.f	c.f	PROPN
chd-148	162	18	.	.	PROPN
chd-148	162	19	,	,	PUNCT
chd-148	162	20	fleming	fleming	PROPN
chd-148	162	21	,	,	PUNCT
chd-148	162	22	i.c	i.c	PROPN
chd-148	162	23	.	.	PROPN
chd-148	162	24	,	,	PUNCT
chd-148	162	25	cha	cha	PROPN
chd-148	162	26	,	,	PUNCT
chd-148	162	27	h.a	h.a	PROPN
chd-148	162	28	.	.	PROPN
chd-148	162	29	,	,	PUNCT
chd-148	162	30	perez	perez	PROPN
chd-148	162	31	,	,	PUNCT
chd-148	162	32	i.e.	i.e.	X
chd-148	162	33	,	,	PUNCT
chd-148	162	34	cole	cole	PROPN
chd-148	162	35	,	,	PUNCT
chd-148	162	36	c.a	c.a	PROPN
chd-148	162	37	.	.	PROPN
chd-148	162	38	,	,	PUNCT
chd-148	162	39	ayodele	ayodele	PROPN
chd-148	162	40	,	,	PUNCT
chd-148	162	41	a.a	a.a	PROPN
chd-148	162	42	.	.	PROPN
chd-148	162	43	,	,	PUNCT
chd-148	162	44	and	and	CCONJ
chd-148	162	45	fishbein	fishbein	ADV
chd-148	162	46	,	,	PUNCT
chd-148	162	47	d.a	d.a	PROPN
chd-148	162	48	.	.	PROPN
chd-148	162	49	(	(	PUNCT
chd-148	162	50	2016	2016	NUM
chd-148	162	51	)	)	PUNCT
chd-148	162	52	.	.	PUNCT
chd-148	163	1	high	high	ADJ
chd-148	163	2	hepatitis	hepatitis	PROPN
chd-148	163	3	c	c	PROPN
chd-148	163	4	infection	infection	NOUN
chd-148	163	5	rate	rate	NOUN
chd-148	163	6	among	among	ADP
chd-148	163	7	baby	baby	NOUN
chd-148	163	8	boomers	boomer	NOUN
chd-148	163	9	in	in	ADP
chd-148	163	10	an	an	DET
chd-148	163	11	urban	urban	ADJ
chd-148	163	12	primary	primary	ADJ
chd-148	163	13	care	care	NOUN
chd-148	163	14	clinic	clinic	NOUN
chd-148	163	15	:	:	PUNCT
chd-148	163	16	results	result	VERB
chd-148	163	17	from	from	ADP
chd-148	163	18	the	the	DET
chd-148	163	19	heptlc	heptlc	PROPN
chd-148	163	20	initiative	initiative	NOUN
chd-148	163	21	.	.	PUNCT
chd-148	164	1	public	public	ADJ
chd-148	164	2	health	health	PROPN
chd-148	164	3	rep	rep	PROPN
chd-148	164	4	131	131	NUM
chd-148	164	5	suppl	suppl	ADJ
chd-148	164	6	2	2	NUM
chd-148	164	7	,	,	PUNCT
chd-148	164	8	49	49	NUM
chd-148	164	9	-	-	SYM
chd-148	164	10	56	56	NUM
chd-148	164	11	.	.	PUNCT
chd-148	164	12	giannitrapani	giannitrapani	PROPN
chd-148	164	13	,	,	PUNCT
chd-148	164	14	l.	l.	PROPN
chd-148	164	15	,	,	PUNCT
chd-148	164	16	soresi	soresi	PROPN
chd-148	164	17	,	,	PUNCT
chd-148	164	18	m.	m.	NOUN
chd-148	164	19	,	,	PUNCT
chd-148	164	20	la	la	PROPN
chd-148	164	21	spada	spada	PROPN
chd-148	164	22	,	,	PUNCT
chd-148	164	23	e.	e.	PROPN
chd-148	164	24	,	,	PUNCT
chd-148	164	25	cervello	cervello	PROPN
chd-148	164	26	,	,	PUNCT
chd-148	164	27	m.	m.	NOUN
chd-148	164	28	,	,	PUNCT
chd-148	164	29	d'alessandro	d'alessandro	NOUN
chd-148	164	30	,	,	PUNCT
chd-148	164	31	n.	n.	NOUN
chd-148	164	32	,	,	PUNCT
chd-148	164	33	and	and	CCONJ
chd-148	164	34	montalto	montalto	PROPN
chd-148	164	35	,	,	PUNCT
chd-148	164	36	g.	g.	PROPN
chd-148	164	37	(	(	PUNCT
chd-148	164	38	2006	2006	NUM
chd-148	164	39	)	)	PUNCT
chd-148	164	40	.	.	PUNCT
chd-148	165	1	sex	sex	NOUN
chd-148	165	2	hormones	hormone	NOUN
chd-148	165	3	and	and	CCONJ
chd-148	165	4	risk	risk	NOUN
chd-148	165	5	of	of	ADP
chd-148	165	6	liver	liver	NOUN
chd-148	165	7	tumor	tumor	NOUN
chd-148	165	8	.	.	PUNCT
chd-148	166	1	ann	ann	PROPN
chd-148	166	2	n	n	PROPN
chd-148	166	3	y	y	PROPN
chd-148	166	4	acad	acad	PROPN
chd-148	166	5	sci	sci	PROPN
chd-148	166	6	1089	1089	NUM
chd-148	166	7	,	,	PUNCT
chd-148	166	8	228	228	NUM
chd-148	166	9	-	-	SYM
chd-148	166	10	236	236	NUM
chd-148	166	11	.	.	PUNCT
chd-148	167	1	harlan	harlan	PROPN
chd-148	167	2	,	,	PUNCT
chd-148	167	3	l.c	l.c	PROPN
chd-148	167	4	.	.	PROPN
chd-148	167	5	,	,	PUNCT
chd-148	167	6	parsons	parsons	PROPN
chd-148	167	7	,	,	PUNCT
chd-148	167	8	h.m	h.m	PROPN
chd-148	167	9	.	.	PROPN
chd-148	167	10	,	,	PUNCT
chd-148	167	11	wiggins	wiggins	PROPN
chd-148	167	12	,	,	PUNCT
chd-148	167	13	c.l	c.l	PROPN
chd-148	167	14	.	.	PROPN
chd-148	167	15	,	,	PUNCT
chd-148	167	16	stevens	stevens	PROPN
chd-148	167	17	,	,	PUNCT
chd-148	167	18	j.l	j.l	PROPN
chd-148	167	19	.	.	PROPN
chd-148	167	20	,	,	PUNCT
chd-148	167	21	and	and	CCONJ
chd-148	167	22	patt	patt	PROPN
chd-148	167	23	,	,	PUNCT
chd-148	167	24	y.z	y.z	PROPN
chd-148	167	25	.	.	PROPN
chd-148	167	26	(	(	PUNCT
chd-148	167	27	2015	2015	NUM
chd-148	167	28	)	)	PUNCT
chd-148	167	29	.	.	PUNCT
chd-148	168	1	treatment	treatment	NOUN
chd-148	168	2	of	of	ADP
chd-148	168	3	hepatocellular	hepatocellular	ADJ
chd-148	168	4	carcinoma	carcinoma	NOUN
chd-148	168	5	in	in	ADP
chd-148	168	6	the	the	DET
chd-148	168	7	community	community	NOUN
chd-148	168	8	:	:	PUNCT
chd-148	168	9	disparities	disparity	NOUN
chd-148	168	10	in	in	ADP
chd-148	168	11	standard	standard	ADJ
chd-148	168	12	therapy	therapy	NOUN
chd-148	168	13	.	.	PUNCT
chd-148	169	1	liver	liver	NOUN
chd-148	169	2	cancer	cancer	NOUN
chd-148	169	3	4	4	NUM
chd-148	169	4	,	,	PUNCT
chd-148	169	5	70	70	NUM
chd-148	169	6	-	-	SYM
chd-148	169	7	83	83	NUM
chd-148	169	8	.	.	PUNCT
chd-148	170	1	islami	islami	PROPN
chd-148	170	2	,	,	PUNCT
chd-148	170	3	f.	f.	PROPN
chd-148	170	4	,	,	PUNCT
chd-148	170	5	miller	miller	PROPN
chd-148	170	6	,	,	PUNCT
chd-148	170	7	k.d	k.d	PROPN
chd-148	170	8	.	.	PROPN
chd-148	170	9	,	,	PUNCT
chd-148	170	10	siegel	siegel	PROPN
chd-148	170	11	,	,	PUNCT
chd-148	170	12	r.l	r.l	PROPN
chd-148	170	13	.	.	PROPN
chd-148	170	14	,	,	PUNCT
chd-148	170	15	fedewa	fedewa	PROPN
chd-148	170	16	,	,	PUNCT
chd-148	170	17	s.a	s.a	PROPN
chd-148	170	18	.	.	PROPN
chd-148	170	19	,	,	PUNCT
chd-148	170	20	ward	ward	PROPN
chd-148	170	21	,	,	PUNCT
chd-148	170	22	e.m	e.m	PROPN
chd-148	170	23	.	.	PROPN
chd-148	170	24	,	,	PUNCT
chd-148	170	25	and	and	CCONJ
chd-148	170	26	jemal	jemal	ADJ
chd-148	170	27	,	,	PUNCT
chd-148	170	28	a.	a.	NOUN
chd-148	170	29	(	(	PUNCT
chd-148	170	30	2017	2017	NUM
chd-148	170	31	)	)	PUNCT
chd-148	170	32	.	.	PUNCT
chd-148	171	1	disparities	disparity	NOUN
chd-148	171	2	in	in	ADP
chd-148	171	3	liver	liver	NOUN
chd-148	171	4	cancer	cancer	NOUN
chd-148	171	5	occurrence	occurrence	NOUN
chd-148	171	6	in	in	ADP
chd-148	171	7	the	the	DET
chd-148	171	8	united	united	PROPN
chd-148	171	9	states	states	PROPN
chd-148	171	10	by	by	ADP
chd-148	171	11	race	race	NOUN
chd-148	171	12	/	/	SYM
chd-148	171	13	ethnicity	ethnicity	NOUN
chd-148	171	14	and	and	CCONJ
chd-148	171	15	state	state	NOUN
chd-148	171	16	.	.	PUNCT
chd-148	172	1	ca	can	AUX
chd-148	172	2	:	:	PUNCT
chd-148	172	3	a	a	DET
chd-148	172	4	cancer	cancer	NOUN
chd-148	172	5	journal	journal	NOUN
chd-148	172	6	for	for	ADP
chd-148	172	7	clinicians	clinician	NOUN
chd-148	172	8	67	67	NUM
chd-148	172	9	,	,	PUNCT
chd-148	172	10	273	273	NUM
chd-148	172	11	-	-	SYM
chd-148	172	12	289	289	NUM
chd-148	172	13	.	.	PUNCT
chd-148	173	1	jemal	jemal	ADJ
chd-148	173	2	,	,	PUNCT
chd-148	173	3	a.	a.	NOUN
chd-148	173	4	,	,	PUNCT
chd-148	173	5	ward	ward	NOUN
chd-148	173	6	,	,	PUNCT
chd-148	173	7	e.m	e.m	PROPN
chd-148	173	8	.	.	PROPN
chd-148	173	9	,	,	PUNCT
chd-148	173	10	johnson	johnson	PROPN
chd-148	173	11	,	,	PUNCT
chd-148	173	12	c.j	c.j	PROPN
chd-148	173	13	.	.	PROPN
chd-148	173	14	,	,	PUNCT
chd-148	173	15	cronin	cronin	PROPN
chd-148	173	16	,	,	PUNCT
chd-148	173	17	k.a	k.a	PROPN
chd-148	173	18	.	.	PROPN
chd-148	173	19	,	,	PUNCT
chd-148	173	20	ma	ma	PROPN
chd-148	173	21	,	,	PUNCT
chd-148	173	22	j.	j.	PROPN
chd-148	173	23	,	,	PUNCT
chd-148	173	24	ryerson	ryerson	PROPN
chd-148	173	25	,	,	PUNCT
chd-148	173	26	b.	b.	PROPN
chd-148	173	27	,	,	PUNCT
chd-148	173	28	mariotto	mariotto	NOUN
chd-148	173	29	,	,	PUNCT
chd-148	173	30	a.	a.	NOUN
chd-148	173	31	,	,	PUNCT
chd-148	173	32	lake	lake	PROPN
chd-148	173	33	,	,	PUNCT
chd-148	173	34	a.j	a.j	PROPN
chd-148	173	35	.	.	PROPN
chd-148	173	36	,	,	PUNCT
chd-148	173	37	wilson	wilson	PROPN
chd-148	173	38	,	,	PUNCT
chd-148	173	39	r.	r.	PROPN
chd-148	173	40	,	,	PUNCT
chd-148	173	41	sherman	sherman	PROPN
chd-148	173	42	,	,	PUNCT
chd-148	173	43	r.l	r.l	PROPN
chd-148	173	44	.	.	PROPN
chd-148	173	45	,	,	PUNCT
chd-148	173	46	et	et	PROPN
chd-148	173	47	al	al	PROPN
chd-148	173	48	.	.	PUNCT
chd-148	174	1	(	(	PUNCT
chd-148	174	2	2017	2017	NUM
chd-148	174	3	)	)	PUNCT
chd-148	174	4	.	.	PUNCT
chd-148	175	1	annual	annual	ADJ
chd-148	175	2	report	report	NOUN
chd-148	175	3	to	to	ADP
chd-148	175	4	the	the	DET
chd-148	175	5	nation	nation	NOUN
chd-148	175	6	on	on	ADP
chd-148	175	7	the	the	DET
chd-148	175	8	status	status	NOUN
chd-148	175	9	of	of	ADP
chd-148	175	10	cancer	cancer	NOUN
chd-148	175	11	,	,	PUNCT
chd-148	175	12	1975	1975	NUM
chd-148	175	13	-	-	SYM
chd-148	175	14	2014	2014	NUM
chd-148	175	15	,	,	PUNCT
chd-148	175	16	featuring	feature	VERB
chd-148	175	17	survival	survival	NOUN
chd-148	175	18	.	.	PUNCT
chd-148	176	1	j	j	PROPN
chd-148	176	2	natl	natl	PROPN
chd-148	176	3	cancer	cancer	PROPN
chd-148	176	4	inst	inst	PROPN
chd-148	176	5	109	109	NUM
chd-148	176	6	.	.	PUNCT
chd-148	177	1	koumbi	koumbi	PROPN
chd-148	177	2	,	,	PUNCT
chd-148	177	3	l.	l.	PROPN
chd-148	177	4	(	(	PUNCT
chd-148	177	5	2017	2017	NUM
chd-148	177	6	)	)	PUNCT
chd-148	177	7	.	.	PUNCT
chd-148	178	1	dietary	dietary	ADJ
chd-148	178	2	factors	factor	NOUN
chd-148	178	3	can	can	AUX
chd-148	178	4	protect	protect	VERB
chd-148	178	5	against	against	ADP
chd-148	178	6	liver	liver	NOUN
chd-148	178	7	cancer	cancer	NOUN
chd-148	178	8	development	development	NOUN
chd-148	178	9	.	.	PUNCT
chd-148	179	1	world	world	PROPN
chd-148	179	2	j	j	PROPN
chd-148	179	3	hepatol	hepatol	ADJ
chd-148	179	4	9	9	NUM
chd-148	179	5	,	,	PUNCT
chd-148	179	6	119	119	NUM
chd-148	179	7	-	-	SYM
chd-148	179	8	125	125	NUM
chd-148	179	9	.	.	PUNCT
chd-148	180	1	kurozawa	kurozawa	PROPN
chd-148	180	2	,	,	PUNCT
chd-148	180	3	y.	y.	PROPN
chd-148	180	4	,	,	PUNCT
chd-148	180	5	ogimoto	ogimoto	NOUN
chd-148	180	6	,	,	PUNCT
chd-148	180	7	i.	i.	PROPN
chd-148	180	8	,	,	PUNCT
chd-148	180	9	shibata	shibata	PROPN
chd-148	180	10	,	,	PUNCT
chd-148	180	11	a.	a.	PROPN
chd-148	180	12	,	,	PUNCT
chd-148	180	13	nose	nose	NOUN
chd-148	180	14	,	,	PUNCT
chd-148	180	15	t.	t.	PROPN
chd-148	180	16	,	,	PUNCT
chd-148	180	17	yoshimura	yoshimura	NOUN
chd-148	180	18	,	,	PUNCT
chd-148	180	19	t.	t.	PROPN
chd-148	180	20	,	,	PUNCT
chd-148	180	21	suzuki	suzuki	PROPN
chd-148	180	22	,	,	PUNCT
chd-148	180	23	h.	h.	PROPN
chd-148	180	24	,	,	PUNCT
chd-148	180	25	sakata	sakata	PROPN
chd-148	180	26	,	,	PUNCT
chd-148	180	27	r.	r.	PROPN
chd-148	180	28	,	,	PUNCT
chd-148	180	29	fujita	fujita	PROPN
chd-148	180	30	,	,	PUNCT
chd-148	180	31	y.	y.	PROPN
chd-148	180	32	,	,	PUNCT
chd-148	180	33	ichikawa	ichikawa	PROPN
chd-148	180	34	,	,	PUNCT
chd-148	180	35	s.	s.	PROPN
chd-148	180	36	,	,	PUNCT
chd-148	180	37	iwai	iwai	PROPN
chd-148	180	38	,	,	PUNCT
chd-148	180	39	n.	n.	NOUN
chd-148	180	40	,	,	PUNCT
chd-148	180	41	et	et	PROPN
chd-148	180	42	al	al	PROPN
chd-148	180	43	.	.	PROPN
chd-148	180	44	(	(	PUNCT
chd-148	180	45	2004	2004	NUM
chd-148	180	46	)	)	PUNCT
chd-148	180	47	.	.	PUNCT
chd-148	181	1	dietary	dietary	ADJ
chd-148	181	2	habits	habit	NOUN
chd-148	181	3	and	and	CCONJ
chd-148	181	4	risk	risk	NOUN
chd-148	181	5	of	of	ADP
chd-148	181	6	death	death	NOUN
chd-148	181	7	due	due	ADP
chd-148	181	8	to	to	ADP
chd-148	181	9	hepatocellular	hepatocellular	ADJ
chd-148	181	10	carcinoma	carcinoma	NOUN
chd-148	181	11	in	in	ADP
chd-148	181	12	a	a	DET
chd-148	181	13	large	large	ADJ
chd-148	181	14	scale	scale	NOUN
chd-148	181	15	cohort	cohort	NOUN
chd-148	181	16	study	study	NOUN
chd-148	181	17	in	in	ADP
chd-148	181	18	japan	japan	PROPN
chd-148	181	19	.	.	PUNCT
chd-148	182	1	univariate	univariate	ADJ
chd-148	182	2	analysis	analysis	NOUN
chd-148	182	3	of	of	ADP
chd-148	182	4	jacc	jacc	PROPN
chd-148	182	5	study	study	NOUN
chd-148	182	6	data	datum	NOUN
chd-148	182	7	.	.	PUNCT
chd-148	183	1	kurume	kurume	PROPN
chd-148	183	2	med	med	PROPN
chd-148	183	3	j	j	PROPN
chd-148	183	4	51	51	NUM
chd-148	183	5	,	,	PUNCT
chd-148	183	6	141	141	NUM
chd-148	183	7	-	-	SYM
chd-148	183	8	149	149	NUM
chd-148	183	9	.	.	PUNCT
chd-148	184	1	mcglynn	mcglynn	PROPN
chd-148	184	2	,	,	PUNCT
chd-148	184	3	k.a	k.a	PROPN
chd-148	184	4	.	.	PROPN
chd-148	184	5	,	,	PUNCT
chd-148	184	6	and	and	CCONJ
chd-148	184	7	london	london	PROPN
chd-148	184	8	,	,	PUNCT
chd-148	184	9	w.t	w.t	PROPN
chd-148	184	10	.	.	PUNCT
chd-148	184	11	(	(	PUNCT
chd-148	184	12	2011	2011	NUM
chd-148	184	13	)	)	PUNCT
chd-148	184	14	.	.	PUNCT
chd-148	185	1	the	the	DET
chd-148	185	2	global	global	ADJ
chd-148	185	3	epidemiology	epidemiology	NOUN
chd-148	185	4	of	of	ADP
chd-148	185	5	hepatocellular	hepatocellular	ADJ
chd-148	185	6	carcinoma	carcinoma	NOUN
chd-148	185	7	:	:	PUNCT
chd-148	185	8	present	present	ADJ
chd-148	185	9	and	and	CCONJ
chd-148	185	10	future	future	NOUN
chd-148	185	11	.	.	PUNCT
chd-148	186	1	clin	clin	PROPN
chd-148	186	2	liver	liver	PROPN
chd-148	186	3	dis	dis	PROPN
chd-148	186	4	15	15	NUM
chd-148	186	5	,	,	PUNCT
chd-148	186	6	223	223	NUM
chd-148	186	7	-	-	SYM
chd-148	186	8	243	243	NUM
chd-148	186	9	,	,	PUNCT
chd-148	186	10	vii	vii	PROPN
chd-148	186	11	-	-	PUNCT
chd-148	186	12	x.	x.	PROPN
chd-148	186	13	mcglynn	mcglynn	PROPN
chd-148	186	14	,	,	PUNCT
chd-148	186	15	k.a	k.a	PROPN
chd-148	186	16	.	.	PROPN
chd-148	186	17	,	,	PUNCT
chd-148	186	18	petrick	petrick	PROPN
chd-148	186	19	,	,	PUNCT
chd-148	186	20	j.l	j.l	PROPN
chd-148	186	21	.	.	PROPN
chd-148	186	22	,	,	PUNCT
chd-148	186	23	and	and	CCONJ
chd-148	186	24	london	london	PROPN
chd-148	186	25	,	,	PUNCT
chd-148	186	26	w.t	w.t	PROPN
chd-148	186	27	.	.	PUNCT
chd-148	186	28	(	(	PUNCT
chd-148	186	29	2015	2015	NUM
chd-148	186	30	)	)	PUNCT
chd-148	186	31	.	.	PUNCT
chd-148	187	1	global	global	ADJ
chd-148	187	2	epidemiology	epidemiology	NOUN
chd-148	187	3	of	of	ADP
chd-148	187	4	hepatocellular	hepatocellular	ADJ
chd-148	187	5	carcinoma	carcinoma	NOUN
chd-148	187	6	:	:	PUNCT
chd-148	187	7	an	an	DET
chd-148	187	8	emphasis	emphasis	NOUN
chd-148	187	9	on	on	ADP
chd-148	187	10	demographic	demographic	ADJ
chd-148	187	11	and	and	CCONJ
chd-148	187	12	regional	regional	ADJ
chd-148	187	13	variability	variability	NOUN
chd-148	187	14	.	.	PUNCT
chd-148	188	1	clin	clin	PROPN
chd-148	188	2	liver	liver	PROPN
chd-148	188	3	dis	dis	PROPN
chd-148	188	4	19	19	NUM
chd-148	188	5	,	,	PUNCT
chd-148	188	6	223	223	NUM
chd-148	188	7	-	-	SYM
chd-148	188	8	238	238	NUM
chd-148	188	9	.	.	PUNCT
chd-148	189	1	mcglynn	mcglynn	PROPN
chd-148	189	2	,	,	PUNCT
chd-148	189	3	k.a	k.a	PROPN
chd-148	189	4	.	.	PROPN
chd-148	189	5	,	,	PUNCT
chd-148	189	6	tsao	tsao	PROPN
chd-148	189	7	,	,	PUNCT
chd-148	189	8	l.	l.	PROPN
chd-148	189	9	,	,	PUNCT
chd-148	189	10	hsing	hsing	PROPN
chd-148	189	11	,	,	PUNCT
chd-148	189	12	a.w	a.w	PROPN
chd-148	189	13	.	.	PROPN
chd-148	189	14	,	,	PUNCT
chd-148	189	15	devesa	devesa	PROPN
chd-148	189	16	,	,	PUNCT
chd-148	189	17	s.s	s.s	PROPN
chd-148	189	18	.	.	PROPN
chd-148	189	19	,	,	PUNCT
chd-148	189	20	and	and	CCONJ
chd-148	189	21	fraumeni	fraumeni	NOUN
chd-148	189	22	,	,	PUNCT
chd-148	189	23	j.f	j.f	PROPN
chd-148	189	24	.	.	PROPN
chd-148	189	25	,	,	PUNCT
chd-148	189	26	jr	jr	PROPN
chd-148	189	27	.	.	PROPN
chd-148	189	28	(	(	PUNCT
chd-148	189	29	2001	2001	NUM
chd-148	189	30	)	)	PUNCT
chd-148	189	31	.	.	PUNCT
chd-148	190	1	international	international	ADJ
chd-148	190	2	trends	trend	NOUN
chd-148	190	3	and	and	CCONJ
chd-148	190	4	patterns	pattern	NOUN
chd-148	190	5	of	of	ADP
chd-148	190	6	primary	primary	ADJ
chd-148	190	7	liver	liver	NOUN
chd-148	190	8	cancer	cancer	NOUN
chd-148	190	9	.	.	PUNCT
chd-148	191	1	int	int	NOUN
chd-148	191	2	j	j	PROPN
chd-148	191	3	cancer	cancer	NOUN
chd-148	191	4	94	94	NUM
chd-148	191	5	,	,	PUNCT
chd-148	191	6	290	290	NUM
chd-148	191	7	-	-	SYM
chd-148	191	8	296	296	NUM
chd-148	191	9	.	.	PUNCT
chd-148	191	10	montalto	montalto	PROPN
chd-148	191	11	,	,	PUNCT
chd-148	191	12	g.	g.	PROPN
chd-148	191	13	,	,	PUNCT
chd-148	191	14	cervello	cervello	PROPN
chd-148	191	15	,	,	PUNCT
chd-148	191	16	m.	m.	NOUN
chd-148	191	17	,	,	PUNCT
chd-148	191	18	giannitrapani	giannitrapani	NOUN
chd-148	191	19	,	,	PUNCT
chd-148	191	20	l.	l.	PROPN
chd-148	191	21	,	,	PUNCT
chd-148	191	22	dantona	dantona	PROPN
chd-148	191	23	,	,	PUNCT
chd-148	191	24	f.	f.	PROPN
chd-148	191	25	,	,	PUNCT
chd-148	191	26	terranova	terranova	PROPN
chd-148	191	27	,	,	PUNCT
chd-148	191	28	a.	a.	NOUN
chd-148	191	29	,	,	PUNCT
chd-148	191	30	and	and	CCONJ
chd-148	191	31	castagnetta	castagnetta	PROPN
chd-148	191	32	,	,	PUNCT
chd-148	191	33	l.a	l.a	PROPN
chd-148	191	34	.	.	PROPN
chd-148	191	35	(	(	PUNCT
chd-148	191	36	2002	2002	NUM
chd-148	191	37	)	)	PUNCT
chd-148	191	38	.	.	PUNCT
chd-148	192	1	epidemiology	epidemiology	NOUN
chd-148	192	2	,	,	PUNCT
chd-148	192	3	risk	risk	NOUN
chd-148	192	4	factors	factor	NOUN
chd-148	192	5	,	,	PUNCT
chd-148	192	6	and	and	CCONJ
chd-148	192	7	natural	natural	ADJ
chd-148	192	8	history	history	NOUN
chd-148	192	9	of	of	ADP
chd-148	192	10	hepatocellular	hepatocellular	ADJ
chd-148	192	11	carcinoma	carcinoma	NOUN
chd-148	192	12	.	.	PUNCT
chd-148	193	1	ann	ann	PROPN
chd-148	193	2	n	n	PROPN
chd-148	193	3	y	y	PROPN
chd-148	193	4	acad	acad	PROPN
chd-148	193	5	sci	sci	PROPN
chd-148	193	6	963	963	NUM
chd-148	193	7	,	,	PUNCT
chd-148	193	8	13	13	NUM
chd-148	193	9	-	-	SYM
chd-148	193	10	20	20	NUM
chd-148	193	11	.	.	PUNCT
chd-148	193	12	nakagawa	nakagawa	PROPN
chd-148	193	13	,	,	PUNCT
chd-148	193	14	h.	h.	PROPN
chd-148	193	15	,	,	PUNCT
chd-148	193	16	maeda	maeda	PROPN
chd-148	193	17	,	,	PUNCT
chd-148	193	18	s.	s.	PROPN
chd-148	193	19	,	,	PUNCT
chd-148	193	20	yoshida	yoshida	PROPN
chd-148	193	21	,	,	PUNCT
chd-148	193	22	h.	h.	PROPN
chd-148	193	23	,	,	PUNCT
chd-148	193	24	tateishi	tateishi	PROPN
chd-148	193	25	,	,	PUNCT
chd-148	193	26	r.	r.	PROPN
chd-148	193	27	,	,	PUNCT
chd-148	193	28	masuzaki	masuzaki	PROPN
chd-148	193	29	,	,	PUNCT
chd-148	193	30	r.	r.	PROPN
chd-148	193	31	,	,	PUNCT
chd-148	193	32	ohki	ohki	PROPN
chd-148	193	33	,	,	PUNCT
chd-148	193	34	t.	t.	PROPN
chd-148	193	35	,	,	PUNCT
chd-148	193	36	hayakawa	hayakawa	PROPN
chd-148	193	37	,	,	PUNCT
chd-148	193	38	y.	y.	PROPN
chd-148	193	39	,	,	PUNCT
chd-148	193	40	kinoshita	kinoshita	PROPN
chd-148	193	41	,	,	PUNCT
chd-148	193	42	h.	h.	PROPN
chd-148	193	43	,	,	PUNCT
chd-148	193	44	yamakado	yamakado	PROPN
chd-148	193	45	,	,	PUNCT
chd-148	193	46	m.	m.	NOUN
chd-148	193	47	,	,	PUNCT
chd-148	193	48	kato	kato	PROPN
chd-148	193	49	,	,	PUNCT
chd-148	193	50	n.	n.	PROPN
chd-148	193	51	,	,	PUNCT
chd-148	193	52	et	et	PROPN
chd-148	193	53	al	al	PROPN
chd-148	193	54	.	.	PUNCT
chd-148	193	55	(	(	PUNCT
chd-148	193	56	2009	2009	NUM
chd-148	193	57	)	)	PUNCT
chd-148	193	58	.	.	PUNCT
chd-148	194	1	serum	serum	PROPN
chd-148	194	2	il-6	il-6	NOUN
chd-148	194	3	levels	level	NOUN
chd-148	194	4	and	and	CCONJ
chd-148	194	5	the	the	DET
chd-148	194	6	risk	risk	NOUN
chd-148	194	7	for	for	ADP
chd-148	194	8	hepatocarcinogenesis	hepatocarcinogenesis	NOUN
chd-148	194	9	in	in	ADP
chd-148	194	10	chronic	chronic	ADJ
chd-148	194	11	hepatitis	hepatitis	NOUN
chd-148	194	12	c	c	PROPN
chd-148	194	13	patients	patient	NOUN
chd-148	194	14	:	:	PUNCT
chd-148	194	15	an	an	DET
chd-148	194	16	analysis	analysis	NOUN
chd-148	194	17	based	base	VERB
chd-148	194	18	on	on	ADP
chd-148	194	19	gender	gender	NOUN
chd-148	194	20	differences	difference	NOUN
chd-148	194	21	.	.	PUNCT
chd-148	195	1	int	int	NOUN
chd-148	195	2	j	j	PROPN
chd-148	195	3	cancer	cancer	NOUN
chd-148	195	4	125	125	NUM
chd-148	195	5	,	,	PUNCT
chd-148	195	6	2264	2264	NUM
chd-148	195	7	-	-	SYM
chd-148	195	8	2269	2269	NUM
chd-148	195	9	.	.	PUNCT
chd-148	196	1	naugler	naugler	NOUN
chd-148	196	2	,	,	PUNCT
chd-148	196	3	w.e	w.e	PROPN
chd-148	196	4	.	.	PROPN
chd-148	196	5	,	,	PUNCT
chd-148	196	6	sakurai	sakurai	PROPN
chd-148	196	7	,	,	PUNCT
chd-148	196	8	t.	t.	PROPN
chd-148	196	9	,	,	PUNCT
chd-148	196	10	kim	kim	PROPN
chd-148	196	11	,	,	PUNCT
chd-148	196	12	s.	s.	PROPN
chd-148	196	13	,	,	PUNCT
chd-148	196	14	maeda	maeda	PROPN
chd-148	196	15	,	,	PUNCT
chd-148	196	16	s.	s.	PROPN
chd-148	196	17	,	,	PUNCT
chd-148	196	18	kim	kim	PROPN
chd-148	196	19	,	,	PUNCT
chd-148	196	20	k.	k.	PROPN
chd-148	196	21	,	,	PUNCT
chd-148	196	22	elsharkawy	elsharkawy	PROPN
chd-148	196	23	,	,	PUNCT
chd-148	196	24	a.m.	a.m.	ADV
chd-148	196	25	,	,	PUNCT
chd-148	196	26	and	and	CCONJ
chd-148	196	27	karin	karin	PROPN
chd-148	196	28	,	,	PUNCT
chd-148	196	29	m.	m.	NOUN
chd-148	196	30	(	(	PUNCT
chd-148	196	31	2007	2007	NUM
chd-148	196	32	)	)	PUNCT
chd-148	196	33	.	.	PUNCT
chd-148	197	1	gender	gender	NOUN
chd-148	197	2	disparity	disparity	NOUN
chd-148	197	3	in	in	ADP
chd-148	197	4	liver	liver	NOUN
chd-148	197	5	cancer	cancer	NOUN
chd-148	197	6	due	due	ADP
chd-148	197	7	to	to	ADP
chd-148	197	8	sex	sex	NOUN
chd-148	197	9	differences	difference	NOUN
chd-148	197	10	in	in	ADP
chd-148	197	11	myd88dependent	myd88dependent	NOUN
chd-148	197	12	il-6	il-6	NOUN
chd-148	197	13	production	production	NOUN
chd-148	197	14	.	.	PUNCT
chd-148	198	1	science	science	NOUN
chd-148	198	2	317	317	NUM
chd-148	198	3	,	,	PUNCT
chd-148	198	4	121	121	NUM
chd-148	198	5	-	-	SYM
chd-148	198	6	124	124	NUM
chd-148	198	7	.	.	PUNCT
chd-148	199	1	negri	negri	PROPN
chd-148	199	2	,	,	PUNCT
chd-148	199	3	e.	e.	PROPN
chd-148	199	4	,	,	PUNCT
chd-148	199	5	la	la	PROPN
chd-148	199	6	vecchia	vecchia	PROPN
chd-148	199	7	,	,	PUNCT
chd-148	199	8	c.	c.	PROPN
chd-148	199	9	,	,	PUNCT
chd-148	199	10	franceschi	franceschi	PROPN
chd-148	199	11	,	,	PUNCT
chd-148	199	12	s.	s.	PROPN
chd-148	199	13	,	,	PUNCT
chd-148	199	14	d'avanzo	d'avanzo	PROPN
chd-148	199	15	,	,	PUNCT
chd-148	199	16	b.	b.	PROPN
chd-148	199	17	,	,	PUNCT
chd-148	199	18	and	and	CCONJ
chd-148	199	19	parazzini	parazzini	PROPN
chd-148	199	20	,	,	PUNCT
chd-148	199	21	f.	f.	PROPN
chd-148	199	22	(	(	PUNCT
chd-148	199	23	1991	1991	NUM
chd-148	199	24	)	)	PUNCT
chd-148	199	25	.	.	PUNCT
chd-148	200	1	vegetable	vegetable	NOUN
chd-148	200	2	and	and	CCONJ
chd-148	200	3	fruit	fruit	NOUN
chd-148	200	4	consumption	consumption	NOUN
chd-148	200	5	and	and	CCONJ
chd-148	200	6	cancer	cancer	NOUN
chd-148	200	7	risk	risk	NOUN
chd-148	200	8	.	.	PUNCT
chd-148	201	1	int	int	NOUN
chd-148	201	2	j	j	PROPN
chd-148	201	3	cancer	cancer	NOUN
chd-148	201	4	48	48	NUM
chd-148	201	5	,	,	PUNCT
chd-148	201	6	350	350	NUM
chd-148	201	7	-	-	SYM
chd-148	201	8	354	354	NUM
chd-148	201	9	.	.	PUNCT
chd-148	201	10	njei	njei	PROPN
chd-148	201	11	,	,	PUNCT
chd-148	201	12	b.	b.	PROPN
chd-148	201	13	,	,	PUNCT
chd-148	201	14	rotman	rotman	PROPN
chd-148	201	15	,	,	PUNCT
chd-148	201	16	y.	y.	PROPN
chd-148	201	17	,	,	PUNCT
chd-148	201	18	ditah	ditah	PROPN
chd-148	201	19	,	,	PUNCT
chd-148	201	20	i.	i.	NOUN
chd-148	201	21	,	,	PUNCT
chd-148	201	22	and	and	CCONJ
chd-148	201	23	lim	lim	PROPN
chd-148	201	24	,	,	PUNCT
chd-148	201	25	j.k	j.k	PROPN
chd-148	201	26	.	.	PROPN
chd-148	201	27	(	(	PUNCT
chd-148	201	28	2015	2015	NUM
chd-148	201	29	)	)	PUNCT
chd-148	201	30	.	.	PUNCT
chd-148	202	1	emerging	emerge	VERB
chd-148	202	2	trends	trend	NOUN
chd-148	202	3	in	in	ADP
chd-148	202	4	hepatocellular	hepatocellular	ADJ
chd-148	202	5	carcinoma	carcinoma	NOUN
chd-148	202	6	incidence	incidence	NOUN
chd-148	202	7	and	and	CCONJ
chd-148	202	8	mortality	mortality	NOUN
chd-148	202	9	.	.	PUNCT
chd-148	203	1	hepatology	hepatology	NOUN
chd-148	203	2	61	61	NUM
chd-148	203	3	,	,	PUNCT
chd-148	203	4	191	191	NUM
chd-148	203	5	-	-	SYM
chd-148	203	6	199	199	NUM
chd-148	203	7	.	.	PUNCT
chd-148	204	1	o'keefe	o'keefe	PROPN
chd-148	204	2	,	,	PUNCT
chd-148	204	3	e.b	e.b	PROPN
chd-148	204	4	.	.	PROPN
chd-148	204	5	,	,	PUNCT
chd-148	204	6	meltzer	meltzer	PROPN
chd-148	204	7	,	,	PUNCT
chd-148	204	8	j.p	j.p	PROPN
chd-148	204	9	.	.	PROPN
chd-148	204	10	,	,	PUNCT
chd-148	204	11	and	and	CCONJ
chd-148	204	12	bethea	bethea	PROPN
chd-148	204	13	,	,	PUNCT
chd-148	204	14	t.n	t.n	PROPN
chd-148	204	15	.	.	PROPN
chd-148	204	16	(	(	PUNCT
chd-148	204	17	2015	2015	NUM
chd-148	204	18	)	)	PUNCT
chd-148	204	19	.	.	PUNCT
chd-148	205	1	health	health	NOUN
chd-148	205	2	disparities	disparity	NOUN
chd-148	205	3	and	and	CCONJ
chd-148	205	4	cancer	cancer	NOUN
chd-148	205	5	:	:	PUNCT
chd-148	205	6	racial	racial	ADJ
chd-148	205	7	disparities	disparity	NOUN
chd-148	205	8	in	in	ADP
chd-148	205	9	cancer	cancer	NOUN
chd-148	205	10	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-148	205	11	e9	e9	PROPN
chd-148	205	12	cancer	cancer	NOUN
chd-148	205	13	health	health	NOUN
chd-148	205	14	disparities	disparity	NOUN
chd-148	205	15	research	research	NOUN
chd-148	205	16	mortality	mortality	NOUN
chd-148	205	17	in	in	ADP
chd-148	205	18	the	the	DET
chd-148	205	19	united	united	PROPN
chd-148	205	20	states	states	PROPN
chd-148	205	21	,	,	PUNCT
chd-148	205	22	2000	2000	NUM
chd-148	205	23	-	-	SYM
chd-148	205	24	2010	2010	NUM
chd-148	205	25	.	.	PUNCT
chd-148	206	1	front	front	ADJ
chd-148	206	2	public	public	ADJ
chd-148	206	3	health	health	NOUN
chd-148	206	4	3	3	NUM
chd-148	206	5	,	,	PUNCT
chd-148	206	6	51	51	NUM
chd-148	206	7	.	.	PUNCT
chd-148	207	1	ohnishi	ohnishi	PROPN
chd-148	207	2	,	,	PUNCT
chd-148	207	3	s.	s.	PROPN
chd-148	207	4	,	,	PUNCT
chd-148	207	5	murakami	murakami	NOUN
chd-148	207	6	,	,	PUNCT
chd-148	207	7	t.	t.	PROPN
chd-148	207	8	,	,	PUNCT
chd-148	207	9	moriyama	moriyama	NOUN
chd-148	207	10	,	,	PUNCT
chd-148	207	11	t.	t.	PROPN
chd-148	207	12	,	,	PUNCT
chd-148	207	13	mitamura	mitamura	PROPN
chd-148	207	14	,	,	PUNCT
chd-148	207	15	k.	k.	PROPN
chd-148	207	16	,	,	PUNCT
chd-148	207	17	and	and	CCONJ
chd-148	207	18	imawari	imawari	NOUN
chd-148	207	19	,	,	PUNCT
chd-148	207	20	m.	m.	NOUN
chd-148	207	21	(	(	PUNCT
chd-148	207	22	1986	1986	NUM
chd-148	207	23	)	)	PUNCT
chd-148	207	24	.	.	PUNCT
chd-148	208	1	androgen	androgen	NOUN
chd-148	208	2	and	and	CCONJ
chd-148	208	3	estrogen	estrogen	NOUN
chd-148	208	4	receptors	receptor	NOUN
chd-148	208	5	in	in	ADP
chd-148	208	6	hepatocellular	hepatocellular	ADJ
chd-148	208	7	carcinoma	carcinoma	NOUN
chd-148	208	8	and	and	CCONJ
chd-148	208	9	in	in	ADP
chd-148	208	10	the	the	DET
chd-148	208	11	surrounding	surround	VERB
chd-148	208	12	noncancerous	noncancerous	ADJ
chd-148	208	13	liver	liver	NOUN
chd-148	208	14	tissue	tissue	NOUN
chd-148	208	15	.	.	PUNCT
chd-148	209	1	hepatology	hepatology	NOUN
chd-148	209	2	6	6	NUM
chd-148	209	3	,	,	PUNCT
chd-148	209	4	440	440	NUM
chd-148	209	5	-	-	SYM
chd-148	209	6	443	443	NUM
chd-148	209	7	.	.	PUNCT
chd-148	209	8	paladino	paladino	PROPN
chd-148	209	9	,	,	PUNCT
chd-148	209	10	n.	n.	NOUN
chd-148	209	11	,	,	PUNCT
chd-148	209	12	fainboim	fainboim	NOUN
chd-148	209	13	,	,	PUNCT
chd-148	209	14	h.	h.	PROPN
chd-148	209	15	,	,	PUNCT
chd-148	209	16	theiler	theiler	NOUN
chd-148	209	17	,	,	PUNCT
chd-148	209	18	g.	g.	PROPN
chd-148	209	19	,	,	PUNCT
chd-148	209	20	schroder	schroder	NOUN
chd-148	209	21	,	,	PUNCT
chd-148	209	22	t.	t.	PROPN
chd-148	209	23	,	,	PUNCT
chd-148	209	24	munoz	munoz	PROPN
chd-148	209	25	,	,	PUNCT
chd-148	209	26	a.e	a.e	PROPN
chd-148	209	27	.	.	PROPN
chd-148	209	28	,	,	PUNCT
chd-148	209	29	flores	flores	PROPN
chd-148	209	30	,	,	PUNCT
chd-148	209	31	a.c	a.c	PROPN
chd-148	209	32	.	.	PROPN
chd-148	209	33	,	,	PUNCT
chd-148	209	34	galdame	galdame	PROPN
chd-148	209	35	,	,	PUNCT
chd-148	209	36	o.	o.	NOUN
chd-148	209	37	,	,	PUNCT
chd-148	209	38	and	and	CCONJ
chd-148	209	39	fainboim	fainboim	NOUN
chd-148	209	40	,	,	PUNCT
chd-148	209	41	l.	l.	PROPN
chd-148	209	42	(	(	PUNCT
chd-148	209	43	2006	2006	NUM
chd-148	209	44	)	)	PUNCT
chd-148	209	45	.	.	PUNCT
chd-148	210	1	gender	gender	NOUN
chd-148	210	2	susceptibility	susceptibility	NOUN
chd-148	210	3	to	to	PART
chd-148	210	4	chronic	chronic	VERB
chd-148	210	5	hepatitis	hepatitis	PROPN
chd-148	210	6	c	c	PROPN
chd-148	210	7	virus	virus	NOUN
chd-148	210	8	infection	infection	NOUN
chd-148	210	9	associated	associate	VERB
chd-148	210	10	with	with	ADP
chd-148	210	11	interleukin	interleukin	NOUN
chd-148	210	12	10	10	NUM
chd-148	210	13	promoter	promoter	NOUN
chd-148	210	14	polymorphism	polymorphism	NOUN
chd-148	210	15	.	.	PUNCT
chd-148	211	1	j	j	PROPN
chd-148	211	2	virol	virol	PROPN
chd-148	211	3	80	80	NUM
chd-148	211	4	,	,	PUNCT
chd-148	211	5	9144	9144	NUM
chd-148	211	6	-	-	SYM
chd-148	211	7	9150	9150	NUM
chd-148	211	8	.	.	PUNCT
chd-148	212	1	persico	persico	PROPN
chd-148	212	2	,	,	PUNCT
chd-148	212	3	m.	m.	NOUN
chd-148	212	4	,	,	PUNCT
chd-148	212	5	capasso	capasso	NOUN
chd-148	212	6	,	,	PUNCT
chd-148	212	7	m.	m.	NOUN
chd-148	212	8	,	,	PUNCT
chd-148	212	9	persico	persico	PROPN
chd-148	212	10	,	,	PUNCT
chd-148	212	11	e.	e.	PROPN
chd-148	212	12	,	,	PUNCT
chd-148	212	13	masarone	masarone	PROPN
chd-148	212	14	,	,	PUNCT
chd-148	212	15	m.	m.	NOUN
chd-148	212	16	,	,	PUNCT
chd-148	212	17	renzo	renzo	NOUN
chd-148	212	18	,	,	PUNCT
chd-148	212	19	a.	a.	NOUN
chd-148	212	20	,	,	PUNCT
chd-148	212	21	spano	spano	PROPN
chd-148	212	22	,	,	PUNCT
chd-148	212	23	d.	d.	PROPN
chd-148	212	24	,	,	PUNCT
chd-148	212	25	bruno	bruno	PROPN
chd-148	212	26	,	,	PUNCT
chd-148	212	27	s.	s.	PROPN
chd-148	212	28	,	,	PUNCT
chd-148	212	29	and	and	CCONJ
chd-148	212	30	iolascon	iolascon	NOUN
chd-148	212	31	,	,	PUNCT
chd-148	212	32	a.	a.	NOUN
chd-148	212	33	(	(	PUNCT
chd-148	212	34	2006	2006	NUM
chd-148	212	35	)	)	PUNCT
chd-148	212	36	.	.	PUNCT
chd-148	213	1	interleukin10	interleukin10	PROPN
chd-148	213	2	1082	1082	NUM
chd-148	213	3	gg	gg	PROPN
chd-148	213	4	polymorphism	polymorphism	NOUN
chd-148	213	5	influences	influence	VERB
chd-148	213	6	the	the	DET
chd-148	213	7	occurrence	occurrence	NOUN
chd-148	213	8	and	and	CCONJ
chd-148	213	9	the	the	DET
chd-148	213	10	clinical	clinical	ADJ
chd-148	213	11	characteristics	characteristic	NOUN
chd-148	213	12	of	of	ADP
chd-148	213	13	hepatitis	hepatitis	PROPN
chd-148	213	14	c	c	PROPN
chd-148	213	15	virus	virus	NOUN
chd-148	213	16	infection	infection	NOUN
chd-148	213	17	.	.	PUNCT
chd-148	214	1	j	j	PROPN
chd-148	214	2	hepatol	hepatol	ADJ
chd-148	214	3	45	45	NUM
chd-148	214	4	,	,	PUNCT
chd-148	214	5	779	779	NUM
chd-148	214	6	-	-	SYM
chd-148	214	7	785	785	NUM
chd-148	214	8	.	.	PUNCT
chd-148	215	1	petrick	petrick	PROPN
chd-148	215	2	,	,	PUNCT
chd-148	215	3	j.l	j.l	PROPN
chd-148	215	4	.	.	PROPN
chd-148	215	5	,	,	PUNCT
chd-148	215	6	braunlin	braunlin	NOUN
chd-148	215	7	,	,	PUNCT
chd-148	215	8	m.	m.	NOUN
chd-148	215	9	,	,	PUNCT
chd-148	215	10	laversanne	laversanne	PROPN
chd-148	215	11	,	,	PUNCT
chd-148	215	12	m.	m.	NOUN
chd-148	215	13	,	,	PUNCT
chd-148	215	14	valery	valery	PROPN
chd-148	215	15	,	,	PUNCT
chd-148	215	16	p.c	p.c	PROPN
chd-148	215	17	.	.	PROPN
chd-148	215	18	,	,	PUNCT
chd-148	215	19	bray	bray	PROPN
chd-148	215	20	,	,	PUNCT
chd-148	215	21	f.	f.	PROPN
chd-148	215	22	,	,	PUNCT
chd-148	215	23	and	and	CCONJ
chd-148	215	24	mcglynn	mcglynn	PROPN
chd-148	215	25	,	,	PUNCT
chd-148	215	26	k.a	k.a	PROPN
chd-148	215	27	.	.	PROPN
chd-148	215	28	(	(	PUNCT
chd-148	215	29	2016	2016	NUM
chd-148	215	30	)	)	PUNCT
chd-148	215	31	.	.	PUNCT
chd-148	216	1	international	international	ADJ
chd-148	216	2	trends	trend	NOUN
chd-148	216	3	in	in	ADP
chd-148	216	4	liver	liver	NOUN
chd-148	216	5	cancer	cancer	NOUN
chd-148	216	6	incidence	incidence	NOUN
chd-148	216	7	,	,	PUNCT
chd-148	216	8	overall	overall	ADJ
chd-148	216	9	and	and	CCONJ
chd-148	216	10	by	by	ADP
chd-148	216	11	histologic	histologic	ADJ
chd-148	216	12	subtype	subtype	NOUN
chd-148	216	13	,	,	PUNCT
chd-148	216	14	19782007	19782007	NUM
chd-148	216	15	.	.	PUNCT
chd-148	217	1	int	int	PROPN
chd-148	217	2	j	j	PROPN
chd-148	217	3	cancer	cancer	NOUN
chd-148	217	4	139	139	NUM
chd-148	217	5	,	,	PUNCT
chd-148	217	6	1534	1534	NUM
chd-148	217	7	-	-	SYM
chd-148	217	8	1545	1545	NUM
chd-148	217	9	.	.	PUNCT
chd-148	218	1	rogers	roger	NOUN
chd-148	218	2	,	,	PUNCT
chd-148	218	3	a.b	a.b	PROPN
chd-148	218	4	.	.	PROPN
chd-148	218	5	,	,	PUNCT
chd-148	218	6	theve	theve	PROPN
chd-148	218	7	,	,	PUNCT
chd-148	218	8	e.j	e.j	PROPN
chd-148	218	9	.	.	PROPN
chd-148	218	10	,	,	PUNCT
chd-148	218	11	feng	feng	PROPN
chd-148	218	12	,	,	PUNCT
chd-148	218	13	y.	y.	PROPN
chd-148	218	14	,	,	PUNCT
chd-148	218	15	fry	fry	PROPN
chd-148	218	16	,	,	PUNCT
chd-148	218	17	r.c	r.c	PROPN
chd-148	218	18	.	.	PROPN
chd-148	218	19	,	,	PUNCT
chd-148	218	20	taghizadeh	taghizadeh	PROPN
chd-148	218	21	,	,	PUNCT
chd-148	218	22	k.	k.	PROPN
chd-148	218	23	,	,	PUNCT
chd-148	218	24	clapp	clapp	PROPN
chd-148	218	25	,	,	PUNCT
chd-148	218	26	k.m	k.m	PROPN
chd-148	218	27	.	.	PROPN
chd-148	218	28	,	,	PUNCT
chd-148	218	29	boussahmain	boussahmain	NOUN
chd-148	218	30	,	,	PUNCT
chd-148	218	31	c.	c.	NOUN
chd-148	218	32	,	,	PUNCT
chd-148	218	33	cormier	cormier	NOUN
chd-148	218	34	,	,	PUNCT
chd-148	218	35	k.s	k.s	PROPN
chd-148	218	36	.	.	PROPN
chd-148	218	37	,	,	PUNCT
chd-148	218	38	and	and	CCONJ
chd-148	218	39	fox	fox	PROPN
chd-148	218	40	,	,	PUNCT
chd-148	218	41	j.g	j.g	PROPN
chd-148	218	42	.	.	PROPN
chd-148	218	43	(	(	PUNCT
chd-148	218	44	2007	2007	NUM
chd-148	218	45	)	)	PUNCT
chd-148	218	46	.	.	PUNCT
chd-148	219	1	hepatocellular	hepatocellular	ADJ
chd-148	219	2	carcinoma	carcinoma	NOUN
chd-148	219	3	associated	associate	VERB
chd-148	219	4	with	with	ADP
chd-148	219	5	livergender	livergender	ADJ
chd-148	219	6	disruption	disruption	NOUN
chd-148	219	7	in	in	ADP
chd-148	219	8	male	male	ADJ
chd-148	219	9	mice	mouse	NOUN
chd-148	219	10	.	.	PUNCT
chd-148	220	1	cancer	cancer	NOUN
chd-148	220	2	res	re	NOUN
chd-148	220	3	67	67	NUM
chd-148	220	4	,	,	PUNCT
chd-148	220	5	1153611546	1153611546	NUM
chd-148	220	6	.	.	PUNCT
chd-148	221	1	ruggieri	ruggieri	PROPN
chd-148	221	2	,	,	PUNCT
chd-148	221	3	a.	a.	NOUN
chd-148	221	4	,	,	PUNCT
chd-148	221	5	barbati	barbati	PROPN
chd-148	221	6	,	,	PUNCT
chd-148	221	7	c.	c.	NOUN
chd-148	221	8	,	,	PUNCT
chd-148	221	9	and	and	CCONJ
chd-148	221	10	malorni	malorni	NOUN
chd-148	221	11	,	,	PUNCT
chd-148	221	12	w.	w.	NOUN
chd-148	221	13	(	(	PUNCT
chd-148	221	14	2010	2010	NUM
chd-148	221	15	)	)	PUNCT
chd-148	221	16	.	.	PUNCT
chd-148	222	1	cellular	cellular	ADJ
chd-148	222	2	and	and	CCONJ
chd-148	222	3	molecular	molecular	ADJ
chd-148	222	4	mechanisms	mechanism	NOUN
chd-148	222	5	involved	involve	VERB
chd-148	222	6	in	in	ADP
chd-148	222	7	hepatocellular	hepatocellular	ADJ
chd-148	222	8	carcinoma	carcinoma	NOUN
chd-148	222	9	gender	gender	NOUN
chd-148	222	10	disparity	disparity	NOUN
chd-148	222	11	.	.	PUNCT
chd-148	223	1	int	int	NOUN
chd-148	223	2	j	j	PROPN
chd-148	223	3	cancer	cancer	NOUN
chd-148	223	4	127	127	NUM
chd-148	223	5	,	,	PUNCT
chd-148	223	6	499	499	NUM
chd-148	223	7	-	-	SYM
chd-148	223	8	504	504	NUM
chd-148	223	9	.	.	PUNCT
chd-148	224	1	ryerson	ryerson	NOUN
chd-148	224	2	,	,	PUNCT
chd-148	224	3	a.b	a.b	PROPN
chd-148	224	4	.	.	PROPN
chd-148	224	5	,	,	PUNCT
chd-148	224	6	eheman	eheman	NOUN
chd-148	224	7	,	,	PUNCT
chd-148	224	8	c.r	c.r	PROPN
chd-148	224	9	.	.	PROPN
chd-148	224	10	,	,	PUNCT
chd-148	224	11	altekruse	altekruse	PROPN
chd-148	224	12	,	,	PUNCT
chd-148	224	13	s.f	s.f	PROPN
chd-148	224	14	.	.	PROPN
chd-148	224	15	,	,	PUNCT
chd-148	224	16	ward	ward	PROPN
chd-148	224	17	,	,	PUNCT
chd-148	224	18	j.w	j.w	PROPN
chd-148	224	19	.	.	PROPN
chd-148	224	20	,	,	PUNCT
chd-148	224	21	jemal	jemal	PROPN
chd-148	224	22	,	,	PUNCT
chd-148	224	23	a.	a.	PROPN
chd-148	224	24	,	,	PUNCT
chd-148	224	25	sherman	sherman	PROPN
chd-148	224	26	,	,	PUNCT
chd-148	224	27	r.l	r.l	PROPN
chd-148	224	28	.	.	PROPN
chd-148	224	29	,	,	PUNCT
chd-148	224	30	henley	henley	PROPN
chd-148	224	31	,	,	PUNCT
chd-148	224	32	s.j	s.j	PROPN
chd-148	224	33	.	.	PROPN
chd-148	224	34	,	,	PUNCT
chd-148	224	35	holtzman	holtzman	PROPN
chd-148	224	36	,	,	PUNCT
chd-148	224	37	d.	d.	PROPN
chd-148	224	38	,	,	PUNCT
chd-148	224	39	lake	lake	PROPN
chd-148	224	40	,	,	PUNCT
chd-148	224	41	a.	a.	NOUN
chd-148	224	42	,	,	PUNCT
chd-148	224	43	noone	noone	NOUN
chd-148	224	44	,	,	PUNCT
chd-148	224	45	a.m.	a.m.	ADV
chd-148	224	46	,	,	PUNCT
chd-148	224	47	et	et	PROPN
chd-148	224	48	al	al	PROPN
chd-148	224	49	.	.	PUNCT
chd-148	225	1	(	(	PUNCT
chd-148	225	2	2016	2016	NUM
chd-148	225	3	)	)	PUNCT
chd-148	225	4	.	.	PUNCT
chd-148	226	1	annual	annual	ADJ
chd-148	226	2	report	report	NOUN
chd-148	226	3	to	to	ADP
chd-148	226	4	the	the	DET
chd-148	226	5	nation	nation	NOUN
chd-148	226	6	on	on	ADP
chd-148	226	7	the	the	DET
chd-148	226	8	status	status	NOUN
chd-148	226	9	of	of	ADP
chd-148	226	10	cancer	cancer	NOUN
chd-148	226	11	,	,	PUNCT
chd-148	226	12	1975	1975	NUM
chd-148	226	13	-	-	SYM
chd-148	226	14	2012	2012	NUM
chd-148	226	15	,	,	PUNCT
chd-148	226	16	featuring	feature	VERB
chd-148	226	17	the	the	DET
chd-148	226	18	increasing	increase	VERB
chd-148	226	19	incidence	incidence	NOUN
chd-148	226	20	of	of	ADP
chd-148	226	21	liver	liver	NOUN
chd-148	226	22	cancer	cancer	NOUN
chd-148	226	23	.	.	PUNCT
chd-148	227	1	cancer	cancer	NOUN
chd-148	227	2	122	122	NUM
chd-148	227	3	,	,	PUNCT
chd-148	227	4	13121337	13121337	NUM
chd-148	227	5	.	.	PUNCT
chd-148	228	1	schutte	schutte	NOUN
chd-148	228	2	,	,	PUNCT
chd-148	228	3	k.	k.	PROPN
chd-148	228	4	,	,	PUNCT
chd-148	228	5	schulz	schulz	PROPN
chd-148	228	6	,	,	PUNCT
chd-148	228	7	c.	c.	PROPN
chd-148	228	8	,	,	PUNCT
chd-148	228	9	and	and	CCONJ
chd-148	228	10	malfertheiner	malfertheiner	NOUN
chd-148	228	11	,	,	PUNCT
chd-148	228	12	p.	p.	NOUN
chd-148	228	13	(	(	PUNCT
chd-148	228	14	2016	2016	NUM
chd-148	228	15	)	)	PUNCT
chd-148	228	16	.	.	PUNCT
chd-148	229	1	nutrition	nutrition	NOUN
chd-148	229	2	and	and	CCONJ
chd-148	229	3	hepatocellular	hepatocellular	ADJ
chd-148	229	4	cancer	cancer	NOUN
chd-148	229	5	.	.	PUNCT
chd-148	230	1	gastrointest	gastroint	ADJ
chd-148	230	2	tumors	tumor	NOUN
chd-148	230	3	2	2	NUM
chd-148	230	4	,	,	PUNCT
chd-148	230	5	188194	188194	NUM
chd-148	230	6	.	.	PUNCT
chd-148	231	1	setiawan	setiawan	PROPN
chd-148	231	2	,	,	PUNCT
chd-148	231	3	v.w	v.w	PROPN
chd-148	231	4	.	.	PROPN
chd-148	231	5	,	,	PUNCT
chd-148	231	6	wei	wei	PROPN
chd-148	231	7	,	,	PUNCT
chd-148	231	8	p.c	p.c	PROPN
chd-148	231	9	.	.	PROPN
chd-148	231	10	,	,	PUNCT
chd-148	231	11	hernandez	hernandez	PROPN
chd-148	231	12	,	,	PUNCT
chd-148	231	13	b.y	b.y	PROPN
chd-148	231	14	.	.	PROPN
chd-148	231	15	,	,	PUNCT
chd-148	231	16	lu	lu	PROPN
chd-148	231	17	,	,	PUNCT
chd-148	231	18	s.c	s.c	PROPN
chd-148	231	19	.	.	PROPN
chd-148	231	20	,	,	PUNCT
chd-148	231	21	monroe	monroe	PROPN
chd-148	231	22	,	,	PUNCT
chd-148	231	23	k.r	k.r	PROPN
chd-148	231	24	.	.	PROPN
chd-148	231	25	,	,	PUNCT
chd-148	231	26	le	le	PROPN
chd-148	231	27	marchand	marchand	PROPN
chd-148	231	28	,	,	PUNCT
chd-148	231	29	l.	l.	PROPN
chd-148	231	30	,	,	PUNCT
chd-148	231	31	and	and	CCONJ
chd-148	231	32	yuan	yuan	NOUN
chd-148	231	33	,	,	PUNCT
chd-148	231	34	j.m	j.m	PROPN
chd-148	231	35	.	.	PROPN
chd-148	231	36	(	(	PUNCT
chd-148	231	37	2016	2016	NUM
chd-148	231	38	)	)	PUNCT
chd-148	231	39	.	.	PUNCT
chd-148	232	1	disparity	disparity	NOUN
chd-148	232	2	in	in	ADP
chd-148	232	3	liver	liver	NOUN
chd-148	232	4	cancer	cancer	NOUN
chd-148	232	5	incidence	incidence	NOUN
chd-148	232	6	and	and	CCONJ
chd-148	232	7	chronic	chronic	ADJ
chd-148	232	8	liver	liver	NOUN
chd-148	232	9	disease	disease	NOUN
chd-148	232	10	mortality	mortality	NOUN
chd-148	232	11	by	by	ADP
chd-148	232	12	nativity	nativity	NOUN
chd-148	232	13	in	in	ADP
chd-148	232	14	hispanics	hispanic	NOUN
chd-148	232	15	:	:	PUNCT
chd-148	232	16	the	the	DET
chd-148	232	17	multiethnic	multiethnic	ADJ
chd-148	232	18	cohort	cohort	NOUN
chd-148	232	19	.	.	PUNCT
chd-148	233	1	cancer	cancer	NOUN
chd-148	233	2	122	122	NUM
chd-148	233	3	,	,	PUNCT
chd-148	233	4	1444	1444	NUM
chd-148	233	5	-	-	SYM
chd-148	233	6	1452	1452	NUM
chd-148	233	7	.	.	PUNCT
chd-148	234	1	shrestha	shrestha	PROPN
chd-148	234	2	,	,	PUNCT
chd-148	234	3	a.	a.	NOUN
chd-148	234	4	(	(	PUNCT
chd-148	234	5	2018	2018	NUM
chd-148	234	6	)	)	PUNCT
chd-148	234	7	.	.	PUNCT
chd-148	235	1	liver	liver	NOUN
chd-148	235	2	cancer	cancer	NOUN
chd-148	235	3	in	in	ADP
chd-148	235	4	nepal	nepal	ADJ
chd-148	235	5	.	.	PUNCT
chd-148	236	1	euroasian	euroasian	PROPN
chd-148	236	2	j	j	PROPN
chd-148	236	3	hepatogastroenterol	hepatogastroenterol	PROPN
chd-148	236	4	8	8	NUM
chd-148	236	5	,	,	PUNCT
chd-148	236	6	63	63	NUM
chd-148	236	7	-	-	SYM
chd-148	236	8	65	65	NUM
chd-148	236	9	.	.	PUNCT
chd-148	237	1	sia	sia	PROPN
chd-148	237	2	,	,	PUNCT
chd-148	237	3	d.	d.	PROPN
chd-148	237	4	,	,	PUNCT
chd-148	237	5	villanueva	villanueva	PROPN
chd-148	237	6	,	,	PUNCT
chd-148	237	7	a.	a.	NOUN
chd-148	237	8	,	,	PUNCT
chd-148	237	9	friedman	friedman	PROPN
chd-148	237	10	,	,	PUNCT
chd-148	237	11	s.l	s.l	PROPN
chd-148	237	12	.	.	PROPN
chd-148	237	13	,	,	PUNCT
chd-148	237	14	and	and	CCONJ
chd-148	237	15	llovet	llovet	NOUN
chd-148	237	16	,	,	PUNCT
chd-148	237	17	j.m	j.m	PROPN
chd-148	237	18	.	.	PROPN
chd-148	237	19	(	(	PUNCT
chd-148	237	20	2017	2017	NUM
chd-148	237	21	)	)	PUNCT
chd-148	237	22	.	.	PUNCT
chd-148	238	1	liver	liver	NOUN
chd-148	238	2	cancer	cancer	NOUN
chd-148	238	3	cell	cell	NOUN
chd-148	238	4	of	of	ADP
chd-148	238	5	origin	origin	NOUN
chd-148	238	6	,	,	PUNCT
chd-148	238	7	molecular	molecular	ADJ
chd-148	238	8	class	class	NOUN
chd-148	238	9	,	,	PUNCT
chd-148	238	10	and	and	CCONJ
chd-148	238	11	effects	effect	NOUN
chd-148	238	12	on	on	ADP
chd-148	238	13	patient	patient	ADJ
chd-148	238	14	prognosis	prognosis	NOUN
chd-148	238	15	.	.	PUNCT
chd-148	239	1	gastroenterology	gastroenterology	NOUN
chd-148	239	2	152	152	NUM
chd-148	239	3	,	,	PUNCT
chd-148	239	4	745	745	NUM
chd-148	239	5	-	-	SYM
chd-148	239	6	761	761	NUM
chd-148	239	7	.	.	PUNCT
chd-148	240	1	siegel	siegel	PROPN
chd-148	240	2	,	,	PUNCT
chd-148	240	3	r.l	r.l	PROPN
chd-148	240	4	.	.	PROPN
chd-148	240	5	,	,	PUNCT
chd-148	240	6	miller	miller	PROPN
chd-148	240	7	,	,	PUNCT
chd-148	240	8	k.d	k.d	PROPN
chd-148	240	9	.	.	PROPN
chd-148	240	10	,	,	PUNCT
chd-148	240	11	and	and	CCONJ
chd-148	240	12	jemal	jemal	ADJ
chd-148	240	13	,	,	PUNCT
chd-148	240	14	a.	a.	NOUN
chd-148	240	15	(	(	PUNCT
chd-148	240	16	2019	2019	NUM
chd-148	240	17	)	)	PUNCT
chd-148	240	18	.	.	PUNCT
chd-148	241	1	cancer	cancer	NOUN
chd-148	241	2	statistics	statistic	NOUN
chd-148	241	3	,	,	PUNCT
chd-148	241	4	2019	2019	NUM
chd-148	241	5	.	.	PUNCT
chd-148	242	1	ca	ca	NOUN
chd-148	242	2	:	:	PUNCT
chd-148	242	3	a	a	DET
chd-148	242	4	cancer	cancer	NOUN
chd-148	242	5	journal	journal	NOUN
chd-148	242	6	for	for	ADP
chd-148	242	7	clinicians	clinician	NOUN
chd-148	242	8	69	69	NUM
chd-148	242	9	,	,	PUNCT
chd-148	242	10	7	7	NUM
chd-148	242	11	-	-	SYM
chd-148	242	12	34	34	NUM
chd-148	242	13	.	.	PUNCT
chd-148	243	1	singh	singh	PROPN
chd-148	243	2	,	,	PUNCT
chd-148	243	3	s.k	s.k	PROPN
chd-148	243	4	.	.	PROPN
chd-148	243	5	,	,	PUNCT
chd-148	243	6	mishra	mishra	PROPN
chd-148	243	7	,	,	PUNCT
chd-148	243	8	m.k	m.k	PROPN
chd-148	243	9	.	.	PROPN
chd-148	243	10	,	,	PUNCT
chd-148	243	11	eltoum	eltoum	PROPN
chd-148	243	12	,	,	PUNCT
chd-148	243	13	i.a	i.a	PROPN
chd-148	243	14	.	.	PROPN
chd-148	243	15	,	,	PUNCT
chd-148	243	16	bae	bae	PROPN
chd-148	243	17	,	,	PUNCT
chd-148	243	18	s.	s.	PROPN
chd-148	243	19	,	,	PUNCT
chd-148	243	20	lillard	lillard	PROPN
chd-148	243	21	,	,	PUNCT
chd-148	243	22	j.w	j.w	PROPN
chd-148	243	23	.	.	PROPN
chd-148	243	24	,	,	PUNCT
chd-148	243	25	jr	jr	PROPN
chd-148	243	26	.	.	PROPN
chd-148	243	27	,	,	PUNCT
chd-148	243	28	and	and	CCONJ
chd-148	243	29	singh	singh	PROPN
chd-148	243	30	,	,	PUNCT
chd-148	243	31	r.	r.	PROPN
chd-148	243	32	(	(	PUNCT
chd-148	243	33	2018	2018	NUM
chd-148	243	34	)	)	PUNCT
chd-148	243	35	.	.	PUNCT
chd-148	244	1	ccr5	ccr5	PROPN
chd-148	244	2	/	/	SYM
chd-148	244	3	ccl5	ccl5	PROPN
chd-148	244	4	axis	axis	NOUN
chd-148	244	5	interaction	interaction	NOUN
chd-148	244	6	promotes	promote	VERB
chd-148	244	7	migratory	migratory	NOUN
chd-148	244	8	and	and	CCONJ
chd-148	244	9	invasiveness	invasiveness	NOUN
chd-148	244	10	of	of	ADP
chd-148	244	11	pancreatic	pancreatic	ADJ
chd-148	244	12	cancer	cancer	NOUN
chd-148	244	13	cells	cell	NOUN
chd-148	244	14	.	.	PUNCT
chd-148	245	1	sci	sci	PROPN
chd-148	245	2	rep	rep	PROPN
chd-148	245	3	8	8	NUM
chd-148	245	4	,	,	PUNCT
chd-148	245	5	1323	1323	NUM
chd-148	245	6	.	.	PUNCT
chd-148	246	1	sripa	sripa	PROPN
chd-148	246	2	,	,	PUNCT
chd-148	246	3	b.	b.	PROPN
chd-148	246	4	,	,	PUNCT
chd-148	246	5	brindley	brindley	PROPN
chd-148	246	6	,	,	PUNCT
chd-148	246	7	p.j	p.j	PROPN
chd-148	246	8	.	.	PROPN
chd-148	246	9	,	,	PUNCT
chd-148	246	10	mulvenna	mulvenna	PROPN
chd-148	246	11	,	,	PUNCT
chd-148	246	12	j.	j.	PROPN
chd-148	246	13	,	,	PUNCT
chd-148	246	14	laha	laha	PROPN
chd-148	246	15	,	,	PUNCT
chd-148	246	16	t.	t.	PROPN
chd-148	246	17	,	,	PUNCT
chd-148	246	18	smout	smout	PROPN
chd-148	246	19	,	,	PUNCT
chd-148	246	20	m.j	m.j	PROPN
chd-148	246	21	.	.	PROPN
chd-148	246	22	,	,	PUNCT
chd-148	246	23	mairiang	mairiang	PROPN
chd-148	246	24	,	,	PUNCT
chd-148	246	25	e.	e.	PROPN
chd-148	246	26	,	,	PUNCT
chd-148	246	27	bethony	bethony	NOUN
chd-148	246	28	,	,	PUNCT
chd-148	246	29	j.m	j.m	PROPN
chd-148	246	30	.	.	PROPN
chd-148	246	31	,	,	PUNCT
chd-148	246	32	and	and	CCONJ
chd-148	246	33	loukas	loukas	PROPN
chd-148	246	34	,	,	PUNCT
chd-148	246	35	a.	a.	NOUN
chd-148	246	36	(	(	PUNCT
chd-148	246	37	2012	2012	NUM
chd-148	246	38	)	)	PUNCT
chd-148	246	39	.	.	PUNCT
chd-148	247	1	the	the	DET
chd-148	247	2	tumorigenic	tumorigenic	ADJ
chd-148	247	3	liver	liver	NOUN
chd-148	247	4	fluke	fluke	NOUN
chd-148	247	5	opisthorchis	opisthorchis	PRON
chd-148	247	6	viverrini	viverrini	NOUN
chd-148	247	7	--	--	PUNCT
chd-148	247	8	multiple	multiple	ADJ
chd-148	247	9	pathways	pathway	NOUN
chd-148	247	10	to	to	ADP
chd-148	247	11	cancer	cancer	NOUN
chd-148	247	12	.	.	PUNCT
chd-148	248	1	trends	trend	NOUN
chd-148	248	2	parasitol	parasitol	VERB
chd-148	248	3	28	28	NUM
chd-148	248	4	,	,	PUNCT
chd-148	248	5	395	395	NUM
chd-148	248	6	-	-	SYM
chd-148	248	7	407	407	NUM
chd-148	248	8	.	.	PUNCT
chd-148	249	1	suneetha	suneetha	PROPN
chd-148	249	2	,	,	PUNCT
chd-148	249	3	p.v	p.v	PROPN
chd-148	249	4	.	.	PROPN
chd-148	249	5	,	,	PUNCT
chd-148	249	6	sarin	sarin	NOUN
chd-148	249	7	,	,	PUNCT
chd-148	249	8	s.k	s.k	PROPN
chd-148	249	9	.	.	PROPN
chd-148	249	10	,	,	PUNCT
chd-148	249	11	goyal	goyal	PROPN
chd-148	249	12	,	,	PUNCT
chd-148	249	13	a.	a.	PROPN
chd-148	249	14	,	,	PUNCT
chd-148	249	15	kumar	kumar	PROPN
chd-148	249	16	,	,	PUNCT
chd-148	249	17	g.t	g.t	PROPN
chd-148	249	18	.	.	PROPN
chd-148	249	19	,	,	PUNCT
chd-148	249	20	shukla	shukla	NOUN
chd-148	249	21	,	,	PUNCT
chd-148	249	22	d.k	d.k	PROPN
chd-148	249	23	.	.	PROPN
chd-148	249	24	,	,	PUNCT
chd-148	249	25	and	and	CCONJ
chd-148	249	26	hissar	hissar	VERB
chd-148	249	27	,	,	PUNCT
chd-148	249	28	s.	s.	PROPN
chd-148	249	29	(	(	PUNCT
chd-148	249	30	2006	2006	NUM
chd-148	249	31	)	)	PUNCT
chd-148	249	32	.	.	PUNCT
chd-148	250	1	association	association	NOUN
chd-148	250	2	between	between	ADP
chd-148	250	3	vitamin	vitamin	NOUN
chd-148	250	4	d	d	NOUN
chd-148	250	5	receptor	receptor	NOUN
chd-148	250	6	,	,	PUNCT
chd-148	250	7	ccr5	ccr5	PROPN
chd-148	250	8	,	,	PUNCT
chd-148	250	9	tnf	tnf	PROPN
chd-148	250	10	-	-	PUNCT
chd-148	250	11	alpha	alpha	PROPN
chd-148	250	12	and	and	CCONJ
chd-148	250	13	tnf	tnf	PROPN
chd-148	250	14	-	-	PUNCT
chd-148	250	15	beta	beta	NOUN
chd-148	250	16	gene	gene	NOUN
chd-148	250	17	polymorphisms	polymorphism	NOUN
chd-148	250	18	and	and	CCONJ
chd-148	250	19	hbv	hbv	NOUN
chd-148	250	20	infection	infection	NOUN
chd-148	250	21	and	and	CCONJ
chd-148	250	22	severity	severity	NOUN
chd-148	250	23	of	of	ADP
chd-148	250	24	liver	liver	NOUN
chd-148	250	25	disease	disease	NOUN
chd-148	250	26	.	.	PUNCT
chd-148	251	1	j	j	PROPN
chd-148	251	2	hepatol	hepatol	ADJ
chd-148	251	3	44	44	NUM
chd-148	251	4	,	,	PUNCT
chd-148	251	5	856	856	NUM
chd-148	251	6	-	-	SYM
chd-148	251	7	863	863	NUM
chd-148	251	8	.	.	PUNCT
chd-148	252	1	talamini	talamini	PROPN
chd-148	252	2	,	,	PUNCT
chd-148	252	3	r.	r.	PROPN
chd-148	252	4	,	,	PUNCT
chd-148	252	5	polesel	polesel	PROPN
chd-148	252	6	,	,	PUNCT
chd-148	252	7	j.	j.	PROPN
chd-148	252	8	,	,	PUNCT
chd-148	252	9	montella	montella	NOUN
chd-148	252	10	,	,	PUNCT
chd-148	252	11	m.	m.	NOUN
chd-148	252	12	,	,	PUNCT
chd-148	252	13	dal	dal	NOUN
chd-148	252	14	maso	maso	PROPN
chd-148	252	15	,	,	PUNCT
chd-148	252	16	l.	l.	PROPN
chd-148	252	17	,	,	PUNCT
chd-148	252	18	crispo	crispo	PROPN
chd-148	252	19	,	,	PUNCT
chd-148	252	20	a.	a.	NOUN
chd-148	252	21	,	,	PUNCT
chd-148	252	22	tommasi	tommasi	PROPN
chd-148	252	23	,	,	PUNCT
chd-148	252	24	l.g	l.g	PROPN
chd-148	252	25	.	.	PROPN
chd-148	252	26	,	,	PUNCT
chd-148	252	27	izzo	izzo	PROPN
chd-148	252	28	,	,	PUNCT
chd-148	252	29	f.	f.	PROPN
chd-148	252	30	,	,	PUNCT
chd-148	252	31	crovatto	crovatto	NOUN
chd-148	252	32	,	,	PUNCT
chd-148	252	33	m.	m.	NOUN
chd-148	252	34	,	,	PUNCT
chd-148	252	35	la	la	PROPN
chd-148	252	36	vecchia	vecchia	PROPN
chd-148	252	37	,	,	PUNCT
chd-148	252	38	c.	c.	NOUN
chd-148	252	39	,	,	PUNCT
chd-148	252	40	and	and	CCONJ
chd-148	252	41	franceschi	franceschi	PROPN
chd-148	252	42	,	,	PUNCT
chd-148	252	43	s.	s.	PROPN
chd-148	252	44	(	(	PUNCT
chd-148	252	45	2006	2006	NUM
chd-148	252	46	)	)	PUNCT
chd-148	252	47	.	.	PUNCT
chd-148	253	1	food	food	NOUN
chd-148	253	2	groups	group	NOUN
chd-148	253	3	and	and	CCONJ
chd-148	253	4	risk	risk	NOUN
chd-148	253	5	of	of	ADP
chd-148	253	6	hepatocellular	hepatocellular	ADJ
chd-148	253	7	carcinoma	carcinoma	NOUN
chd-148	253	8	:	:	PUNCT
chd-148	253	9	a	a	DET
chd-148	253	10	multicenter	multicenter	ADJ
chd-148	253	11	case	case	NOUN
chd-148	253	12	-	-	PUNCT
chd-148	253	13	control	control	NOUN
chd-148	253	14	study	study	NOUN
chd-148	253	15	in	in	ADP
chd-148	253	16	italy	italy	PROPN
chd-148	253	17	.	.	PUNCT
chd-148	254	1	int	int	PROPN
chd-148	254	2	j	j	PROPN
chd-148	254	3	cancer	cancer	NOUN
chd-148	254	4	119	119	NUM
chd-148	254	5	,	,	PUNCT
chd-148	254	6	2916	2916	NUM
chd-148	254	7	-	-	SYM
chd-148	254	8	2921	2921	NUM
chd-148	254	9	.	.	PUNCT
chd-148	255	1	tanaka	tanaka	PROPN
chd-148	255	2	,	,	PUNCT
chd-148	255	3	k.	k.	PROPN
chd-148	255	4	,	,	PUNCT
chd-148	255	5	tsuji	tsuji	PROPN
chd-148	255	6	,	,	PUNCT
chd-148	255	7	i.	i.	PROPN
chd-148	255	8	,	,	PUNCT
chd-148	255	9	tamakoshi	tamakoshi	PROPN
chd-148	255	10	,	,	PUNCT
chd-148	255	11	a.	a.	NOUN
chd-148	255	12	,	,	PUNCT
chd-148	255	13	matsuo	matsuo	PROPN
chd-148	255	14	,	,	PUNCT
chd-148	255	15	k.	k.	PROPN
chd-148	255	16	,	,	PUNCT
chd-148	255	17	wakai	wakai	PROPN
chd-148	255	18	,	,	PUNCT
chd-148	255	19	k.	k.	PROPN
chd-148	255	20	,	,	PUNCT
chd-148	255	21	nagata	nagata	PROPN
chd-148	255	22	,	,	PUNCT
chd-148	255	23	c.	c.	PROPN
chd-148	255	24	,	,	PUNCT
chd-148	255	25	mizoue	mizoue	NOUN
chd-148	255	26	,	,	PUNCT
chd-148	255	27	t.	t.	PROPN
chd-148	255	28	,	,	PUNCT
chd-148	255	29	inoue	inoue	PROPN
chd-148	255	30	,	,	PUNCT
chd-148	255	31	m.	m.	NOUN
chd-148	255	32	,	,	PUNCT
chd-148	255	33	tsugane	tsugane	PROPN
chd-148	255	34	,	,	PUNCT
chd-148	255	35	s.	s.	PROPN
chd-148	255	36	,	,	PUNCT
chd-148	255	37	and	and	CCONJ
chd-148	255	38	sasazuki	sasazuki	PROPN
chd-148	255	39	,	,	PUNCT
chd-148	255	40	s.	s.	PROPN
chd-148	255	41	(	(	PUNCT
chd-148	255	42	2014	2014	NUM
chd-148	255	43	)	)	PUNCT
chd-148	255	44	.	.	PUNCT
chd-148	256	1	diabetes	diabetes	NOUN
chd-148	256	2	mellitus	mellitus	NOUN
chd-148	256	3	and	and	CCONJ
chd-148	256	4	liver	liver	NOUN
chd-148	256	5	cancer	cancer	NOUN
chd-148	256	6	risk	risk	NOUN
chd-148	256	7	:	:	PUNCT
chd-148	256	8	an	an	DET
chd-148	256	9	evaluation	evaluation	NOUN
chd-148	256	10	based	base	VERB
chd-148	256	11	on	on	ADP
chd-148	256	12	a	a	DET
chd-148	256	13	systematic	systematic	ADJ
chd-148	256	14	review	review	NOUN
chd-148	256	15	of	of	ADP
chd-148	256	16	epidemiologic	epidemiologic	ADJ
chd-148	256	17	evidence	evidence	NOUN
chd-148	256	18	among	among	ADP
chd-148	256	19	the	the	DET
chd-148	256	20	japanese	japanese	ADJ
chd-148	256	21	population	population	NOUN
chd-148	256	22	.	.	PUNCT
chd-148	257	1	jpn	jpn	PROPN
chd-148	257	2	j	j	PROPN
chd-148	257	3	clin	clin	PROPN
chd-148	257	4	oncol	oncol	PROPN
chd-148	257	5	44	44	NUM
chd-148	257	6	,	,	PUNCT
chd-148	257	7	986	986	NUM
chd-148	257	8	-	-	SYM
chd-148	257	9	999	999	NUM
chd-148	257	10	.	.	PUNCT
chd-148	258	1	tanimizu	tanimizu	PROPN
chd-148	258	2	,	,	PUNCT
chd-148	258	3	n.	n.	PROPN
chd-148	258	4	,	,	PUNCT
chd-148	258	5	nakamura	nakamura	PROPN
chd-148	258	6	,	,	PUNCT
chd-148	258	7	y.	y.	PROPN
chd-148	258	8	,	,	PUNCT
chd-148	258	9	ichinohe	ichinohe	NOUN
chd-148	258	10	,	,	PUNCT
chd-148	258	11	n.	n.	NOUN
chd-148	258	12	,	,	PUNCT
chd-148	258	13	mizuguchi	mizuguchi	NOUN
chd-148	258	14	,	,	PUNCT
chd-148	258	15	t.	t.	NOUN
chd-148	258	16	,	,	PUNCT
chd-148	258	17	hirata	hirata	NOUN
chd-148	258	18	,	,	PUNCT
chd-148	258	19	k.	k.	PROPN
chd-148	258	20	,	,	PUNCT
chd-148	258	21	and	and	CCONJ
chd-148	258	22	mitaka	mitaka	PROPN
chd-148	258	23	,	,	PUNCT
chd-148	258	24	t.	t.	PROPN
chd-148	258	25	(	(	PUNCT
chd-148	258	26	2013	2013	NUM
chd-148	258	27	)	)	PUNCT
chd-148	258	28	.	.	PUNCT
chd-148	259	1	hepatic	hepatic	ADJ
chd-148	259	2	biliary	biliary	ADJ
chd-148	259	3	epithelial	epithelial	ADJ
chd-148	259	4	cells	cell	NOUN
chd-148	259	5	acquire	acquire	VERB
chd-148	259	6	epithelial	epithelial	ADJ
chd-148	259	7	integrity	integrity	NOUN
chd-148	259	8	but	but	CCONJ
chd-148	259	9	lose	lose	VERB
chd-148	259	10	plasticity	plasticity	NOUN
chd-148	259	11	to	to	PART
chd-148	259	12	differentiate	differentiate	VERB
chd-148	259	13	into	into	ADP
chd-148	259	14	hepatocytes	hepatocyte	NOUN
chd-148	259	15	in	in	ADP
chd-148	259	16	vitro	vitro	NOUN
chd-148	259	17	during	during	ADP
chd-148	259	18	development	development	NOUN
chd-148	259	19	.	.	PUNCT
chd-148	260	1	j	j	PROPN
chd-148	260	2	cell	cell	NOUN
chd-148	260	3	sci	sci	PROPN
chd-148	260	4	126	126	NUM
chd-148	260	5	,	,	PUNCT
chd-148	260	6	5239	5239	NUM
chd-148	260	7	-	-	SYM
chd-148	260	8	5246	5246	NUM
chd-148	260	9	.	.	PUNCT
chd-148	261	1	thio	thio	NOUN
chd-148	261	2	,	,	PUNCT
chd-148	261	3	c.l	c.l	PROPN
chd-148	261	4	.	.	PROPN
chd-148	261	5	,	,	PUNCT
chd-148	261	6	astemborski	astemborski	PROPN
chd-148	261	7	,	,	PUNCT
chd-148	261	8	j.	j.	PROPN
chd-148	261	9	,	,	PUNCT
chd-148	261	10	bashirova	bashirova	PROPN
chd-148	261	11	,	,	PUNCT
chd-148	261	12	a.	a.	NOUN
chd-148	261	13	,	,	PUNCT
chd-148	261	14	mosbruger	mosbruger	NOUN
chd-148	261	15	,	,	PUNCT
chd-148	261	16	t.	t.	PROPN
chd-148	261	17	,	,	PUNCT
chd-148	261	18	greer	greer	PROPN
chd-148	261	19	,	,	PUNCT
chd-148	261	20	s.	s.	PROPN
chd-148	261	21	,	,	PUNCT
chd-148	261	22	witt	witt	PROPN
chd-148	261	23	,	,	PUNCT
chd-148	261	24	m.d	m.d	PROPN
chd-148	261	25	.	.	PROPN
chd-148	261	26	,	,	PUNCT
chd-148	261	27	goedert	goedert	PROPN
chd-148	261	28	,	,	PUNCT
chd-148	261	29	j.j	j.j	PROPN
chd-148	261	30	.	.	PROPN
chd-148	261	31	,	,	PUNCT
chd-148	261	32	hilgartner	hilgartner	PROPN
chd-148	261	33	,	,	PUNCT
chd-148	261	34	m.	m.	NOUN
chd-148	261	35	,	,	PUNCT
chd-148	261	36	majeske	majeske	PROPN
chd-148	261	37	,	,	PUNCT
chd-148	261	38	a.	a.	PROPN
chd-148	261	39	,	,	PUNCT
chd-148	261	40	o'brien	o'brien	PROPN
chd-148	261	41	,	,	PUNCT
chd-148	261	42	s.j	s.j	PROPN
chd-148	261	43	.	.	PROPN
chd-148	261	44	,	,	PUNCT
chd-148	261	45	et	et	PROPN
chd-148	261	46	al	al	PROPN
chd-148	261	47	.	.	PUNCT
chd-148	261	48	(	(	PUNCT
chd-148	261	49	2007	2007	NUM
chd-148	261	50	)	)	PUNCT
chd-148	261	51	.	.	PUNCT
chd-148	262	1	genetic	genetic	ADJ
chd-148	262	2	protection	protection	NOUN
chd-148	262	3	against	against	ADP
chd-148	262	4	hepatitis	hepatitis	PROPN
chd-148	262	5	b	b	PROPN
chd-148	262	6	virus	virus	NOUN
chd-148	262	7	conferred	confer	VERB
chd-148	262	8	by	by	ADP
chd-148	262	9	ccr5delta32	ccr5delta32	NOUN
chd-148	262	10	:	:	PUNCT
chd-148	262	11	evidence	evidence	NOUN
chd-148	262	12	that	that	SCONJ
chd-148	262	13	ccr5	ccr5	NOUN
chd-148	262	14	contributes	contribute	VERB
chd-148	262	15	to	to	ADP
chd-148	262	16	viral	viral	ADJ
chd-148	262	17	persistence	persistence	NOUN
chd-148	262	18	.	.	PUNCT
chd-148	263	1	j	j	PROPN
chd-148	263	2	virol	virol	PROPN
chd-148	263	3	81	81	NUM
chd-148	263	4	,	,	PUNCT
chd-148	263	5	441	441	NUM
chd-148	263	6	-	-	SYM
chd-148	263	7	445	445	NUM
chd-148	263	8	.	.	PUNCT
chd-148	264	1	tien	tien	PROPN
chd-148	264	2	kuo	kuo	PROPN
chd-148	264	3	,	,	PUNCT
chd-148	264	4	m.	m.	NOUN
chd-148	264	5	,	,	PUNCT
chd-148	264	6	and	and	CCONJ
chd-148	264	7	savaraj	savaraj	VERB
chd-148	264	8	,	,	PUNCT
chd-148	264	9	n.	n.	PROPN
chd-148	264	10	(	(	PUNCT
chd-148	264	11	2006	2006	NUM
chd-148	264	12	)	)	PUNCT
chd-148	264	13	.	.	PUNCT
chd-148	265	1	roles	role	NOUN
chd-148	265	2	of	of	ADP
chd-148	265	3	reactive	reactive	ADJ
chd-148	265	4	oxygen	oxygen	NOUN
chd-148	265	5	species	specie	NOUN
chd-148	265	6	in	in	ADP
chd-148	265	7	hepatocarcinogenesis	hepatocarcinogenesis	NOUN
chd-148	265	8	and	and	CCONJ
chd-148	265	9	drug	drug	NOUN
chd-148	265	10	resistance	resistance	NOUN
chd-148	265	11	gene	gene	NOUN
chd-148	265	12	expression	expression	NOUN
chd-148	265	13	in	in	ADP
chd-148	265	14	liver	liver	NOUN
chd-148	265	15	cancers	cancer	NOUN
chd-148	265	16	.	.	PUNCT
chd-148	266	1	mol	mol	ADP
chd-148	266	2	carcinog	carcinog	PROPN
chd-148	266	3	45	45	NUM
chd-148	266	4	,	,	PUNCT
chd-148	266	5	701709	701709	NUM
chd-148	266	6	.	.	PUNCT
chd-148	267	1	vastag	vastag	PROPN
chd-148	267	2	,	,	PUNCT
chd-148	267	3	b.	b.	PROPN
chd-148	267	4	(	(	PUNCT
chd-148	267	5	2004	2004	NUM
chd-148	267	6	)	)	PUNCT
chd-148	267	7	.	.	PUNCT
chd-148	268	1	obesity	obesity	NOUN
chd-148	268	2	is	be	AUX
chd-148	268	3	now	now	ADV
chd-148	268	4	on	on	ADP
chd-148	268	5	everyone	everyone	PRON
chd-148	268	6	's	's	PART
chd-148	268	7	plate	plate	NOUN
chd-148	268	8	.	.	PUNCT
chd-148	269	1	jama	jama	PROPN
chd-148	269	2	291	291	NUM
chd-148	269	3	,	,	PUNCT
chd-148	269	4	1186	1186	NUM
chd-148	269	5	-	-	SYM
chd-148	269	6	1188	1188	NUM
chd-148	269	7	.	.	PUNCT
chd-148	270	1	waxman	waxman	PROPN
chd-148	270	2	,	,	PUNCT
chd-148	270	3	d.j	d.j	PROPN
chd-148	270	4	.	.	PROPN
chd-148	270	5	,	,	PUNCT
chd-148	270	6	and	and	CCONJ
chd-148	270	7	holloway	holloway	PROPN
chd-148	270	8	,	,	PUNCT
chd-148	270	9	m.g	m.g	PROPN
chd-148	270	10	.	.	PROPN
chd-148	270	11	(	(	PUNCT
chd-148	270	12	2009	2009	NUM
chd-148	270	13	)	)	PUNCT
chd-148	270	14	.	.	PUNCT
chd-148	271	1	sex	sex	NOUN
chd-148	271	2	differences	difference	NOUN
chd-148	271	3	in	in	ADP
chd-148	271	4	the	the	DET
chd-148	271	5	expression	expression	NOUN
chd-148	271	6	of	of	ADP
chd-148	271	7	hepatic	hepatic	ADJ
chd-148	271	8	drug	drug	NOUN
chd-148	271	9	metabolizing	metabolize	VERB
chd-148	271	10	enzymes	enzyme	NOUN
chd-148	271	11	.	.	PUNCT
chd-148	272	1	mol	mol	ADP
chd-148	272	2	pharmacol	pharmacol	PROPN
chd-148	272	3	76	76	NUM
chd-148	272	4	,	,	PUNCT
chd-148	272	5	215	215	NUM
chd-148	272	6	-	-	SYM
chd-148	272	7	228	228	NUM
chd-148	272	8	.	.	PUNCT
chd-148	273	1	wilkin	wilkin	PROPN
chd-148	273	2	,	,	PUNCT
chd-148	273	3	t.j	t.j	PROPN
chd-148	273	4	.	.	PROPN
chd-148	273	5	,	,	PUNCT
chd-148	273	6	su	su	PROPN
chd-148	273	7	,	,	PUNCT
chd-148	273	8	z.	z.	PROPN
chd-148	273	9	,	,	PUNCT
chd-148	273	10	krambrink	krambrink	PROPN
chd-148	273	11	,	,	PUNCT
chd-148	273	12	a.	a.	NOUN
chd-148	273	13	,	,	PUNCT
chd-148	273	14	long	long	ADV
chd-148	273	15	,	,	PUNCT
chd-148	273	16	j.	j.	PROPN
chd-148	273	17	,	,	PUNCT
chd-148	273	18	greaves	greave	NOUN
chd-148	273	19	,	,	PUNCT
chd-148	273	20	w.	w.	PROPN
chd-148	273	21	,	,	PUNCT
chd-148	273	22	gross	gross	PROPN
chd-148	273	23	,	,	PUNCT
chd-148	273	24	r.	r.	PROPN
chd-148	273	25	,	,	PUNCT
chd-148	273	26	hughes	hughes	PROPN
chd-148	273	27	,	,	PUNCT
chd-148	273	28	m.d	m.d	PROPN
chd-148	273	29	.	.	PROPN
chd-148	273	30	,	,	PUNCT
chd-148	273	31	flexner	flexner	NOUN
chd-148	273	32	,	,	PUNCT
chd-148	273	33	c.	c.	PROPN
chd-148	273	34	,	,	PUNCT
chd-148	273	35	skolnik	skolnik	PROPN
chd-148	273	36	,	,	PUNCT
chd-148	273	37	p.r	p.r	PROPN
chd-148	273	38	.	.	PROPN
chd-148	273	39	,	,	PUNCT
chd-148	273	40	coakley	coakley	PROPN
chd-148	273	41	,	,	PUNCT
chd-148	273	42	e.	e.	PROPN
chd-148	273	43	,	,	PUNCT
chd-148	273	44	et	et	PROPN
chd-148	273	45	al	al	PROPN
chd-148	273	46	.	.	PUNCT
chd-148	274	1	(	(	PUNCT
chd-148	274	2	2010	2010	NUM
chd-148	274	3	)	)	PUNCT
chd-148	274	4	.	.	PUNCT
chd-148	275	1	three	three	NUM
chd-148	275	2	-	-	PUNCT
chd-148	275	3	year	year	NOUN
chd-148	275	4	safety	safety	NOUN
chd-148	275	5	and	and	CCONJ
chd-148	275	6	efficacy	efficacy	NOUN
chd-148	275	7	of	of	ADP
chd-148	275	8	vicriviroc	vicriviroc	NOUN
chd-148	275	9	,	,	PUNCT
chd-148	275	10	a	a	DET
chd-148	275	11	ccr5	ccr5	NOUN
chd-148	275	12	antagonist	antagonist	NOUN
chd-148	275	13	,	,	PUNCT
chd-148	275	14	in	in	ADP
chd-148	275	15	hiv-1	hiv-1	ADV
chd-148	275	16	-	-	PUNCT
chd-148	275	17	infected	infect	VERB
chd-148	275	18	treatmentexperienced	treatmentexperienced	ADJ
chd-148	275	19	patients	patient	NOUN
chd-148	275	20	.	.	PUNCT
chd-148	276	1	j	j	PROPN
chd-148	276	2	acquir	acquir	PROPN
chd-148	276	3	immune	immune	VERB
chd-148	276	4	defic	defic	ADJ
chd-148	276	5	syndr	syndr	NOUN
chd-148	276	6	54	54	NUM
chd-148	276	7	,	,	PUNCT
chd-148	276	8	470	470	NUM
chd-148	276	9	-	-	SYM
chd-148	276	10	476	476	NUM
chd-148	276	11	.	.	PUNCT
chd-148	277	1	wong	wong	PROPN
chd-148	277	2	,	,	PUNCT
chd-148	277	3	v.w	v.w	PROPN
chd-148	277	4	.	.	PROPN
chd-148	277	5	,	,	PUNCT
chd-148	277	6	yu	yu	PROPN
chd-148	277	7	,	,	PUNCT
chd-148	277	8	j.	j.	PROPN
chd-148	277	9	,	,	PUNCT
chd-148	277	10	cheng	cheng	PROPN
chd-148	277	11	,	,	PUNCT
chd-148	277	12	a.s	a.s	PROPN
chd-148	277	13	.	.	PROPN
chd-148	277	14	,	,	PUNCT
chd-148	277	15	wong	wong	PROPN
chd-148	277	16	,	,	PUNCT
chd-148	277	17	g.l	g.l	PROPN
chd-148	277	18	.	.	PROPN
chd-148	277	19	,	,	PUNCT
chd-148	277	20	chan	chan	PROPN
chd-148	277	21	,	,	PUNCT
chd-148	277	22	h.y	h.y	PROPN
chd-148	277	23	.	.	PROPN
chd-148	277	24	,	,	PUNCT
chd-148	277	25	chu	chu	PROPN
chd-148	277	26	,	,	PUNCT
chd-148	277	27	e.s	e.s	PROPN
chd-148	277	28	.	.	PROPN
chd-148	277	29	,	,	PUNCT
chd-148	277	30	ng	ng	PROPN
chd-148	277	31	,	,	PUNCT
chd-148	277	32	e.k	e.k	PROPN
chd-148	277	33	.	.	PROPN
chd-148	277	34	,	,	PUNCT
chd-148	277	35	chan	chan	PROPN
chd-148	277	36	,	,	PUNCT
chd-148	277	37	f.k	f.k	PROPN
chd-148	277	38	.	.	PROPN
chd-148	277	39	,	,	PUNCT
chd-148	277	40	sung	sung	PROPN
chd-148	277	41	,	,	PUNCT
chd-148	277	42	j.j	j.j	PROPN
chd-148	277	43	.	.	PROPN
chd-148	277	44	,	,	PUNCT
chd-148	277	45	and	and	CCONJ
chd-148	277	46	chan	chan	PROPN
chd-148	277	47	,	,	PUNCT
chd-148	277	48	h.l	h.l	PROPN
chd-148	277	49	.	.	PROPN
chd-148	277	50	(	(	PUNCT
chd-148	277	51	2009	2009	NUM
chd-148	277	52	)	)	PUNCT
chd-148	277	53	.	.	PUNCT
chd-148	278	1	high	high	ADJ
chd-148	278	2	serum	serum	NOUN
chd-148	278	3	interleukin-6	interleukin-6	PROPN
chd-148	278	4	level	level	NOUN
chd-148	278	5	predicts	predict	VERB
chd-148	278	6	future	future	ADJ
chd-148	278	7	hepatocellular	hepatocellular	ADJ
chd-148	278	8	carcinoma	carcinoma	NOUN
chd-148	278	9	development	development	NOUN
chd-148	278	10	in	in	ADP
chd-148	278	11	patients	patient	NOUN
chd-148	278	12	with	with	ADP
chd-148	278	13	chronic	chronic	ADJ
chd-148	279	1	hepatitis	hepatitis	PROPN
chd-148	279	2	b.	b.	PROPN
chd-148	280	1	int	int	PROPN
chd-148	281	1	j	j	PROPN
chd-148	281	2	cancer	cancer	NOUN
chd-148	281	3	124	124	NUM
chd-148	281	4	,	,	PUNCT
chd-148	281	5	2766	2766	NUM
chd-148	281	6	-	-	SYM
chd-148	281	7	2770	2770	NUM
chd-148	281	8	.	.	PUNCT
chd-148	282	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-148	282	2	e10	e10	NUM
chd-148	282	3	cancer	cancer	NOUN
chd-148	282	4	health	health	NOUN
chd-148	282	5	disparities	disparity	NOUN
chd-148	282	6	research	research	PROPN
chd-148	282	7	zhang	zhang	PROPN
chd-148	282	8	,	,	PUNCT
chd-148	282	9	w.	w.	PROPN
chd-148	282	10	,	,	PUNCT
chd-148	282	11	xiang	xiang	PROPN
chd-148	282	12	,	,	PUNCT
chd-148	282	13	y.b	y.b	PROPN
chd-148	282	14	.	.	PROPN
chd-148	282	15	,	,	PUNCT
chd-148	282	16	li	li	PROPN
chd-148	282	17	,	,	PUNCT
chd-148	282	18	h.l	h.l	PROPN
chd-148	282	19	.	.	PROPN
chd-148	282	20	,	,	PUNCT
chd-148	282	21	yang	yang	PROPN
chd-148	282	22	,	,	PUNCT
chd-148	282	23	g.	g.	PROPN
chd-148	282	24	,	,	PUNCT
chd-148	282	25	cai	cai	PROPN
chd-148	282	26	,	,	PUNCT
chd-148	282	27	h.	h.	PROPN
chd-148	282	28	,	,	PUNCT
chd-148	282	29	ji	ji	PROPN
chd-148	282	30	,	,	PUNCT
chd-148	282	31	b.t	b.t	PROPN
chd-148	282	32	.	.	PROPN
chd-148	282	33	,	,	PUNCT
chd-148	282	34	gao	gao	PROPN
chd-148	282	35	,	,	PUNCT
chd-148	282	36	y.t	y.t	PROPN
chd-148	282	37	.	.	PROPN
chd-148	282	38	,	,	PUNCT
chd-148	282	39	zheng	zheng	PROPN
chd-148	282	40	,	,	PUNCT
chd-148	282	41	w.	w.	PROPN
chd-148	282	42	,	,	PUNCT
chd-148	282	43	and	and	CCONJ
chd-148	282	44	shu	shu	PROPN
chd-148	282	45	,	,	PUNCT
chd-148	282	46	x.o	x.o	PROPN
chd-148	282	47	.	.	PROPN
chd-148	282	48	(	(	PUNCT
chd-148	282	49	2013	2013	NUM
chd-148	282	50	)	)	PUNCT
chd-148	282	51	.	.	PUNCT
chd-148	283	1	vegetable	vegetable	NOUN
chd-148	283	2	-	-	PUNCT
chd-148	283	3	based	base	VERB
chd-148	283	4	dietary	dietary	ADJ
chd-148	283	5	pattern	pattern	NOUN
chd-148	283	6	and	and	CCONJ
chd-148	283	7	liver	liver	NOUN
chd-148	283	8	cancer	cancer	NOUN
chd-148	283	9	risk	risk	NOUN
chd-148	283	10	:	:	PUNCT
chd-148	283	11	results	result	NOUN
chd-148	283	12	from	from	ADP
chd-148	283	13	the	the	DET
chd-148	283	14	shanghai	shanghai	PROPN
chd-148	283	15	women	woman	NOUN
chd-148	283	16	's	's	PART
chd-148	283	17	and	and	CCONJ
chd-148	283	18	men	man	NOUN
chd-148	283	19	's	's	PART
chd-148	283	20	health	health	NOUN
chd-148	283	21	studies	study	NOUN
chd-148	283	22	.	.	PUNCT
chd-148	284	1	cancer	cancer	NOUN
chd-148	284	2	sci	sci	PROPN
chd-148	284	3	104	104	NUM
chd-148	284	4	,	,	PUNCT
chd-148	284	5	1353	1353	NUM
chd-148	284	6	-	-	SYM
chd-148	284	7	1361	1361	NUM
chd-148	284	8	.	.	PUNCT
chd-148	285	1	zhang	zhang	PROPN
chd-148	285	2	,	,	PUNCT
chd-148	285	3	y.	y.	PROPN
chd-148	285	4	,	,	PUNCT
chd-148	285	5	ren	ren	PROPN
chd-148	285	6	,	,	PUNCT
chd-148	285	7	j.s	j.s	PROPN
chd-148	285	8	.	.	PROPN
chd-148	285	9	,	,	PUNCT
chd-148	285	10	shi	shi	PROPN
chd-148	285	11	,	,	PUNCT
chd-148	285	12	j.f	j.f	PROPN
chd-148	285	13	.	.	PROPN
chd-148	285	14	,	,	PUNCT
chd-148	285	15	li	li	PROPN
chd-148	285	16	,	,	PUNCT
chd-148	285	17	n.	n.	PROPN
chd-148	285	18	,	,	PUNCT
chd-148	285	19	wang	wang	PROPN
chd-148	285	20	,	,	PUNCT
chd-148	285	21	y.t	y.t	PROPN
chd-148	285	22	.	.	PROPN
chd-148	285	23	,	,	PUNCT
chd-148	285	24	qu	qu	PROPN
chd-148	285	25	,	,	PUNCT
chd-148	285	26	c.	c.	PROPN
chd-148	285	27	,	,	PUNCT
chd-148	285	28	zhang	zhang	PROPN
chd-148	285	29	,	,	PUNCT
chd-148	285	30	y.	y.	PROPN
chd-148	285	31	,	,	PUNCT
chd-148	285	32	and	and	CCONJ
chd-148	285	33	dai	dai	PROPN
chd-148	285	34	,	,	PUNCT
chd-148	285	35	m.	m.	NOUN
chd-148	285	36	(	(	PUNCT
chd-148	285	37	2015	2015	NUM
chd-148	285	38	)	)	PUNCT
chd-148	285	39	.	.	PUNCT
chd-148	286	1	international	international	ADJ
chd-148	286	2	trends	trend	NOUN
chd-148	286	3	in	in	ADP
chd-148	286	4	primary	primary	ADJ
chd-148	286	5	liver	liver	NOUN
chd-148	286	6	cancer	cancer	NOUN
chd-148	286	7	incidence	incidence	NOUN
chd-148	286	8	from	from	ADP
chd-148	286	9	1973	1973	NUM
chd-148	286	10	to	to	ADP
chd-148	286	11	2007	2007	NUM
chd-148	286	12	.	.	PUNCT
chd-148	287	1	bmc	bmc	ADJ
chd-148	287	2	cancer	cancer	NOUN
chd-148	287	3	15	15	NUM
chd-148	287	4	,	,	PUNCT
chd-148	287	5	94	94	NUM
chd-148	287	6	.	.	PUNCT